Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
40766189	s-dgpabg	— (—)	11038	11851	100.00%	Distribution not available
40766189	s-dgpabg	eliau/ml (u/ml)	976	1023	0.00%
40766189	s-dgpabg	u/ml (u/ml)	391	458	0.00%
40766189	s-gliadiinipeptidit,deamidoidut,iga-vasta-aineet	u/ml (u/ml)	299	304	0.00%
40766189	s-gliadiinipeptidit,deamidoidut,iga-vasta-aineet	— (—)	5	5	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Non-invasive ventilation

944

2057

4.61

307.65

1.1

19.82

5.89

u/ml

1.18

360

Coeliac disease

615

1267

5.37

285.38

1.4

1.1

22.66

3.34

u/ml

10.50

181

163

Irritable bowel syndrome

1010

3050

3.50

274.39

1.1

2.80

7.19

u/ml

3.17

104

439

Diseases of the digestive system

1085

4214

2.65

184.57

1.3

1.1

19.18

4.39

u/ml

8.71

219

450

Gastro-oesophageal reflux disease

1593

6570

2.20

175.83

1.1

5.55

5.42

u/ml

0.04

140

897

Diseases of oesophagus, stomach and duodenum

2564

8392

1.89

173.65

1.1

7.80

4.84

u/ml

1.48

259

1188

Other diseases of intestines

2685

8626

1.84

166.17

1.1

4.58

5.64

u/ml

0.50

314

1268

Pain in joint

1450

4605

2.13

139.31

1.1

4.63

5.82

u/ml

0.48

140

731

Autoimmune diseases

2698

8025

1.74

135.64

1.1

10.06

3.49

u/ml

5.30

345

1107

Used for control exclusion in common control thyroid runs

2579

7529

1.76

134.62

1.1

8.98

3.42

u/ml

4.45

323

1043

Autoimmune diseases excluding thyroid diseases

2463

7935

1.75

127.89

1.1

11.58

3.52

u/ml

6.75

313

1090

Functional dyspepsia

693

2629

2.73

125.04

1.1

6.96

6.29

u/ml

0.10

356

Autoimmune diseases excluding thyroid diseases, strict definition

2397

7755

1.75

124.47

1.1

11.75

3.43

u/ml

6.96

307

1069

Dermatitis and eczema

2518

9939

1.69

118.82

1.1

6.06

5.24

u/ml

0.28

288

1357

Other functional intestinal disorders

977

4200

2.27

118.32

1.1

6.69

7.53

u/ml

0.13

521

Symptoms and signs involving the digestive system and abdomen

2336

6814

1.74

117.07

1.1

5.57

5.73

u/ml

0.06

278

1001

Abdominal and pelvic pain

2305

6813

1.72

111.63

1.1

5.24

5.73

u/ml

0.21

272

1000

Gastrointestinal diseases

1574

4155

1.93

108.83

1.1

6.62

3.36

u/ml

2.07

197

677

Anaemias

760

2100

2.48

103.40

1.1

7.82

6.64

u/ml

0.18

101

363

Headache

1621

7745

1.78

97.02

1.1

4.91

5.47

u/ml

0.26

185

1135

Other special examinations and investigations of persons without complaint or reported diagnosis

1549

4291

1.85

95.59

1.1

5.83

4.74

u/ml

0.33

152

727

Any gastric operation

2056

6174

1.69

93.56

1.1

6.12

4.93

u/ml

0.50

237

986

GASTRO-related operations

2056

6174

1.69

93.56

1.1

6.12

4.93

u/ml

0.50

237

986

Constipation

1740

7320

1.73

91.66

1.1

3.78

6.54

u/ml

1.70

145

955

Other and unspecified iron deficiency

684

3110

2.26

82.54

1.1

7.64

6.87

u/ml

0.16

380

Medical observation and evaluation for suspected diseases and conditions

1479

4291

1.79

82.06

1.1

7.34

4.74

u/ml

0.58

153

727

Examination and observation for other reasons

1272

4254

1.85

81.04

1.1

6.22

4.76

u/ml

0.42

179

722

Nutritional anaemias

930

4635

1.99

80.94

1.1

7.39

7.08

u/ml

0.06

527

Noninfective enteritis and colitis

1062

5724

1.89

79.55

1.1

5.30

6.07

u/ml

0.18

795

Other specific joint derangements/joint disorders

1763

7269

1.65

77.42

1.1

4.17

5.25

u/ml

0.60

186

1098

Diverticular disease of intestine

1173

4286

1.84

76.07

1.1

3.74

8.10

u/ml

3.51

101

548

Symptoms and signs involving the circulatory and respiratory systems

2384

7837

1.54

74.69

1.1

5.24

5.28

u/ml

0.01

288

1186

Benign neoplasm of colon, rectum, anus and anal canal

1008

4899

1.89

74.36

1.1

6.23

8.00

u/ml

0.39

490

Iron deficiency anaemia

803

4009

2.02

73.56

1.1

7.88

7.16

u/ml

0.14

474

Migraine

1289

6378

1.75

73.27

1.1

3.42

5.54

u/ml

1.62

163

977

Other soft tissue disorders, not elsewhere classified

1996

7929

1.57

71.45

1.1

3.33

5.46

u/ml

1.66

192

1173

Other antidepressants

2211

7535

1.55

71.14

1.1

3.08

6.47

u/ml

5.49

246

1036

Osteoporosis

473

1873

2.47

69.99

1.1

12.84

8.74

u/ml

0.28

149

Hypothyroidism, strict autoimmune

1560

6346

1.65

68.48

1.1

4.88

3.44

u/ml

0.72

193

852

Inflammatory bowel disease treatment related agents

2470

9510

1.49

68.01

1.1

6.03

5.31

u/ml

0.20

238

1372

Autoimmune diseases related-to ILD

1778

10073

1.57

67.27

1.1

4.11

5.40

u/ml

0.68

178

1380

Low back pain

1557

7481

1.62

66.13

1.1

7.73

5.56

u/ml

0.67

151

1103

Other dorsopathies, not elsewhere classified

2257

7950

1.51

65.85

1.1

5.25

5.41

u/ml

0.05

249

1173

Other intervertebral disc disorders

1703

6588

1.60

65.59

1.1

4.41

5.70

u/ml

0.86

174

961

Pain (limb, back, neck, head abdominally)

1555

4767

1.65

65.10

1.1

6.34

6.16

u/ml

0.05

183

742

Dorsalgia

2184

7889

1.52

64.42

1.1

5.39

5.40

u/ml

0.00

230

1169

Dermatitis

1194

7106

1.71

63.74

1.1

7.23

5.88

u/ml

0.22

937

Depression or dysthymia

1450

4944

1.66

63.46

1.1

4.25

6.33

u/ml

1.21

176

666

Benign neoplasm: Colon

821

4290

1.90

63.35

1.1

6.11

8.53

u/ml

0.50

410

Other noninfective gastroenteritis and colitis

553

2592

2.19

62.05

1.1

4.51

7.12

u/ml

0.99

330

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1915

9131

1.52

60.42

1.1

8.94

5.08

u/ml

1.46

195

1234

Other headache syndromes

958

5472

1.78

59.65

1.1

2.24

6.39

u/ml

5.95

788

Episodal and paroxysmal disorders

2437

8629

1.46

59.60

1.1

3.91

5.86

u/ml

1.85

282

1215

Oral corticosteroids

2165

8911

1.49

59.35

1.1

6.50

5.21

u/ml

0.35

210

1275

Neurological diseases

2033

6825

1.52

59.17

1.1

3.99

5.61

u/ml

1.25

235

1058

Diseases of liver

638

3212

2.03

59.01

1.1

8.92

7.19

u/ml

0.19

402

Hypothyroidism (congenital or acquired)

792

2393

1.94

57.78

1.1

5.19

6.02

u/ml

0.19

114

432

Benign neoplasm of colon, rectum, anus and anal canal

969

3947

1.78

57.04

1.1

5.81

8.35

u/ml

0.61

443

Hypothyroidism and >3 levothyroxin purchases

784

2384

1.93

56.35

1.1

5.19

6.01

u/ml

0.19

114

428

Hypothyroidism, levothyroxine purchases

784

2384

1.93

56.35

1.1

5.19

6.01

u/ml

0.19

114

428

Recurrent or chronic depression

949

3906

1.78

56.30

1.1

3.23

5.77

u/ml

2.16

130

611

Hypothyroidism, other/unspecified

1859

8216

1.51

56.18

1.1

4.99

5.62

u/ml

0.23

229

1089

Pain in throat and chest

1763

7136

1.53

55.25

1.1

3.96

5.60

u/ml

1.51

206

1074

Follow-up examination after treatment for conditions other than malignant neoplasms

938

3502

1.78

54.34

1.1

9.52

4.77

u/ml

0.89

592

Soft tissue disorders

2256

8127

1.46

54.34

1.1

4.95

5.60

u/ml

0.24

246

1190

Abnormalities of breathing

1934

7786

1.49

54.02

1.1

4.99

5.30

u/ml

0.10

195

1177

Care involving use of rehabilitation procedures

1247

7419

1.62

53.92

1.1

11.21

5.69

u/ml

1.11

994

Dorsopathies

2263

8021

1.45

53.92

1.1

5.26

5.43

u/ml

0.06

254

1179

Disorders of the thyroid gland

1941

8637

1.48

53.90

1.1

4.87

5.56

u/ml

0.28

245

1143

Other gastritis (incl. Duodenitis)

393

1698

2.37

53.73

1.1

11.31

7.52

u/ml

0.27

183

Diseases of the skin and subcutaneous tissue

2171

7505

1.46

53.53

1.1

8.78

4.85

u/ml

1.81

257

1074

Hypothyreosis and Thyroxine purchase for inclusion criteria

1900

8522

1.49

53.38

1.1

5.15

5.57

u/ml

0.15

231

1136

Chronic diseases of tonsils and adenoids

1749

7396

1.51

53.09

1.1

6.11

5.86

u/ml

0.06

233

1038

Complications of medical and surgical care

1359

8283

1.58

52.94

1.1

5.83

5.86

u/ml

0.01

127

1066

Pruritus

284

1067

2.77

52.89

1.1

14.81

5.28

u/ml

0.41

133

Depression

2039

9718

1.46

52.51

1.1

4.17

5.37

u/ml

0.70

206

1382

Lower back pain or/and sciatica

2075

10004

1.45

52.30

1.1

6.33

5.16

u/ml

0.44

210

1383

Other and unspecified nerve root and plexus disorders, also in other diseases

405

1798

2.32

52.26

1.1

3.76

7.05

u/ml

1.12

253

General symptoms and signs

2368

8363

1.43

51.92

1.1

5.34

5.47

u/ml

0.04

275

1201

First line medication for Crohn's disease

2363

9119

1.43

51.63

1.1

6.48

5.30

u/ml

0.36

245

1323

Osteopathies and chondropathies

1011

5770

1.69

51.50

1.1

8.61

6.54

u/ml

0.36

725

Other diseases of upper respiratory tract

2228

8146

1.44

50.65

1.1

4.58

6.02

u/ml

0.63

273

1057

ILD medications

2390

9339

1.42

50.52

1.1

6.53

5.28

u/ml

0.39

244

1347

ILD medications: prednisolone, methylprednisolone, prednisone

2260

9033

1.43

49.82

1.1

6.69

5.21

u/ml

0.46

236

1308

Neurotic, stress-related and somatoform disorders

1930

9509

1.46

49.75

1.1

4.91

5.24

u/ml

0.10

205

1378

Nerve, nerve root and plexus disorders

2034

8904

1.45

49.67

1.1

7.53

5.04

u/ml

0.65

168

1248

Mood [affective] disorders

2135

9897

1.43

49.49

1.1

4.05

5.39

u/ml

0.89

218

1387

Anxiety disorders, excluding more controls

1784

8070

1.48

49.28

1.1

5.17

5.48

u/ml

0.09

187

1196

Myalgia

515

2568

2.05

49.24

1.1

2.62

6.67

u/ml

2.55

389

Benign neoplasm: Colon

816

3556

1.78

49.24

1.1

5.54

8.27

u/ml

0.60

388

Mood disorders

2135

9902

1.43

48.96

1.1

4.05

5.39

u/ml

0.89

218

1387

Type 1 diabetes, wide definition, subgroup 1

511

2552

2.05

48.56

1.2

1.1

15.25

6.21

u/ml

1.00

406

Anxiety disorders

1936

9559

1.45

48.53

1.1

4.91

5.27

u/ml

0.11

205

1379

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1104

6891

1.62

48.19

1.1

6.17

6.26

u/ml

0.02

107

863

Selective serotonin reuptake inhibitors

2062

7594

1.44

47.61

1.1

2.70

6.49

u/ml

7.50

257

1040

Other and unspecified dermatitis

961

5856

1.67

47.09

1.1

7.27

5.97

u/ml

0.16

780

Persons encountering health services for examination and investigation

1338

4291

1.58

46.96

1.1

5.88

4.74

u/ml

0.36

149

727

Mood disorders, excluding more controls

1957

8328

1.44

46.70

1.1

3.99

5.32

u/ml

0.81

196

1198

Endocrine, nutritional and metabolic diseases

1920

6764

1.46

46.63

1.1

4.79

5.26

u/ml

0.19

237

1054

Chronic gastritis

426

2018

2.15

46.46

1.1

18.12

9.28

u/ml

0.61

200

Migraine, single triptan purchase ok & required. ICD-code if available is included

1752

8195

1.46

45.68

1.1

2.76

5.78

u/ml

4.80

260

1151

Triptan medication for migraine, single purchase ok

1752

8195

1.46

45.68

1.1

2.76

5.78

u/ml

4.80

260

1151

Other joint disorders

1997

7473

1.44

45.29

1.1

4.73

5.43

u/ml

0.24

242

1117

Codeine

2029

7866

1.43

45.25

1.1

5.00

5.32

u/ml

0.10

224

1181

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1026

6417

1.62

45.11

1.1

6.12

6.30

u/ml

0.04

800

Asthma (mode)

1613

5994

1.49

44.76

1.1

5.06

5.55

u/ml

0.14

187

877

Short Achilles tendon (acquired)

111

259

4.67

44.58

1.1

19.10

6.31

u/ml

—

Neurological diseases, wide definition

828

2387

1.77

44.15

1.1

4.36

5.83

u/ml

0.57

109

453

Pain in limb

1518

7437

1.49

44.14

1.1

4.65

5.48

u/ml

0.29

148

1084

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

875

2562

1.73

43.93

1.1

4.43

6.24

u/ml

0.69

119

459

Asthma, excluding more controls

1611

5830

1.49

43.71

1.1

5.01

5.48

u/ml

0.14

189

864

Type 1 diabetes, wide definition

519

2703

1.96

43.69

1.2

1.1

15.25

6.48

u/ml

0.95

418

Asthma

1630

5957

1.48

43.49

1.1

5.05

5.56

u/ml

0.16

190

874

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

953

5796

1.63

43.08

1.1

2.43

6.27

u/ml

5.96

115

802

Collagenous colitis

215

780

2.87

42.97

1.1

1.68

4.35

u/ml

1.26

Codeine or tramadol medication

2305

9292

1.39

42.93

1.1

4.99

5.33

u/ml

0.12

253

1288

Dysphagia

388

1838

2.15

42.44

1.1

5.14

9.18

u/ml

0.69

215

Disorders of synovium and tendon

1036

5928

1.59

42.13

1.1

5.75

5.99

u/ml

0.06

107

864

Disorders of thyroid, IBD co-morbidities

427

1501

2.12

42.01

1.1

3.41

6.58

u/ml

1.45

280

Other diseases of liver

356

1649

2.22

41.53

1.1

7.92

7.07

u/ml

0.05

206

Insulin, fast-acting

678

3893

1.77

41.51

1.1

13.81

6.17

u/ml

0.99

530

Malaise and fatigue

867

4400

1.66

41.41

1.1

5.67

6.86

u/ml

0.35

544

Atopic dermatitis

1275

7261

1.52

41.21

1.1

4.15

4.89

u/ml

0.39

182

1134

Infections, IBD-co-morbidities

326

1033

2.35

41.17

1.1

12.80

7.48

u/ml

0.30

192

Type 1 diabetes

563

3068

1.87

41.13

1.1

13.77

6.50

u/ml

0.85

473

Parasetamol

1776

6356

1.44

40.39

1.1

6.17

5.31

u/ml

0.24

196

1003

Hypothyroidism, strict autoimmune, 3 medication purchases required

1679

8034

1.44

40.33

1.1

5.08

5.46

u/ml

0.13

202

1054

Abnormalities of heart beat

645

3654

1.78

40.11

1.1

4.48

6.95

u/ml

0.89

484

Other and unspecified anaemias

595

3210

1.82

39.99

1.1

12.22

7.94

u/ml

0.51

312

Insulin, fast-acting or short human

679

3944

1.75

39.91

1.1

13.81

6.02

u/ml

1.02

527

Diaphragmatic hernia

579

3217

1.83

39.73

1.1

8.83

7.88

u/ml

0.14

323

Intestinal infectious diseases

1846

10323

1.40

39.50

1.1

5.54

5.38

u/ml

0.04

197

1412

Depression medications

856

2580

1.70

39.49

1.1

3.19

6.33

u/ml

2.48

123

462

Nausea and vomiting

478

2461

1.94

39.48

1.1

8.92

8.04

u/ml

0.11

335

Dizziness and giddiness

1324

7291

1.49

39.01

1.1

5.27

6.30

u/ml

0.43

122

923

Other anaemias

597

3247

1.80

38.70

1.1

11.96

7.90

u/ml

0.49

314

Haemorrhoids and perianal venous thrombosis

435

2224

1.98

38.49

1.1

3.58

9.81

u/ml

2.51

245

Lumbar disc prolapse

1158

6102

1.52

38.08

1.1

4.10

5.80

u/ml

1.14

137

883

Budesonide

313

1428

2.26

38.07

1.1

3.23

5.62

u/ml

0.70

206

Symptoms and signs concerning food and fluid intake

217

847

2.64

37.33

1.1

12.74

7.42

u/ml

0.25

Chronic sinusitis

815

5070

1.63

36.84

1.1

2.87

6.35

u/ml

2.73

100

711

Arthropathies

2019

7490

1.38

36.78

1.1

3.91

5.43

u/ml

1.15

228

1119

Noninfectious colitis NAS

295

1335

2.27

36.61

1.2

1.1

3.84

5.05

u/ml

0.33

177

Asthma (only as main-diagnosis)

1429

5957

1.46

36.46

1.1

4.85

5.56

u/ml

0.20

162

874

Abnormal weight loss

192

717

2.78

36.33

1.1

14.78

5.74

u/ml

0.40

Other symptoms and signs involving the digestive system and abdomen

323

1518

2.18

36.32

1.1

3.69

7.33

u/ml

1.08

206

Aplastic and other anaemias

634

3511

1.73

36.22

1.1

16.75

8.47

u/ml

0.72

345

Continuous positive airway pressure

321

1286

2.19

36.02

1.1

4.26

7.62

u/ml

1.17

213

Asthma, including avohilmo

2324

10135

1.34

35.95

1.1

5.78

5.29

u/ml

0.15

277

1375

Sleep disorders (combined)

1852

8827

1.39

35.92

1.1

4.48

5.66

u/ml

0.76

218

1177

Triptan medication for migraine, min. 3 purchases

1314

7148

1.47

35.89

1.1

2.79

4.90

u/ml

2.32

208

1061

Shoulder lesions

1338

5609

1.47

35.88

1.1

2.85

6.09

u/ml

3.55

118

788

Opioids

2086

8066

1.37

35.86

1.1

4.85

5.34

u/ml

0.17

228

1207

Asthma (only as main-diagnosis), excluding more controls

1414

5830

1.46

35.70

1.1

4.85

5.48

u/ml

0.17

162

864

Coxibs

563

1647

1.84

35.30

1.1

2.13

8.16

u/ml

4.37

191

Anxiety (asthma-related co-morbidities)

1347

7377

1.46

35.22

1.1

5.37

4.83

u/ml

0.13

150

1209

Other pulmonary diagnosis

1688

6021

1.42

35.18

1.1

7.01

5.51

u/ml

0.38

198

886

Chronic laryngitis and laryngotracheitis

261

1140

2.35

35.16

1.1

2.93

9.71

u/ml

2.26

129

Chronic rhinitis, nasopharyngitis and pharyngitis

616

3616

1.73

35.08

1.1

2.57

6.69

u/ml

3.23

519

Inflammatory bowel disease

650

3875

1.71

35.00

1.1

5.51

5.89

u/ml

0.06

570

Weight loss

207

823

2.60

34.52

1.1

12.63

5.58

u/ml

0.39

Other diseases of hard tissues of teeth

1245

6367

1.47

34.38

1.1

4.64

5.33

u/ml

0.24

148

918

Diseases of the musculoskeletal system and connective tissue

1270

4322

1.49

34.33

1.1

4.34

5.77

u/ml

0.81

158

711

Heartburn

215

872

2.54

34.26

1.1

2.71

6.88

u/ml

1.09

115

Acute upper respiratory infections

2027

9429

1.36

34.20

1.1

7.58

5.21

u/ml

0.78

230

1259

Sub-endpoint used in defining T1D endpoints

569

3236

1.76

34.08

1.1

14.02

5.64

u/ml

1.01

453

Hernia of abdominal wall, postoperative

287

1321

2.21

33.93

1.1

12.97

7.70

u/ml

0.25

197

All anxiety disorders

1374

7776

1.44

33.77

1.1

5.25

4.88

u/ml

0.09

155

1237

Visual disturbances and blindness

882

5712

1.56

33.65

1.1

5.51

6.85

u/ml

0.44

705

Special screening examination for infectious and parasitic diseases

616

2701

1.73

33.57

1.1

4.69

4.29

u/ml

0.07

120

553

Falls/tendency to fall

2314

8746

1.33

33.52

1.1

6.53

4.83

u/ml

0.70

251

1271

Symptoms and signs involving cognition, perception, emotional state and behaviour

1760

9045

1.37

32.83

1.1

4.44

5.65

u/ml

0.77

170

1223

Temporomandibular joint disorders

348

1750

2.03

32.69

1.1

5.01

6.75

u/ml

0.42

288

Excluding asthma or asthma-COPD overlap

1669

6021

1.40

32.63

1.1

7.02

5.51

u/ml

0.36

191

886

Cervical disc disorders

588

3475

1.71

32.58

1.1

4.32

7.70

u/ml

1.30

462

Other diseases of anus and rectum

439

2384

1.87

32.41

1.1

6.34

9.85

u/ml

0.61

286

ILD differential diagnosis

1659

5994

1.40

32.14

1.1

6.99

5.55

u/ml

0.34

192

877

COPD differential diagnosis

1659

5998

1.40

32.02

1.1

6.99

5.55

u/ml

0.34

192

877

Diseases of the eye and adnexa

1866

6881

1.37

31.95

1.1

4.83

4.93

u/ml

0.04

257

1055

Fibromyalgia

224

960

2.42

31.84

1.1

1.57

6.54

u/ml

1.91

146

Insulin, intermediate and long-acting

875

5610

1.55

31.84

1.1

12.70

6.37

u/ml

0.88

727

Sleep apnoea, including avohilmo

1715

8158

1.38

31.68

1.1

5.31

5.85

u/ml

0.19

191

1092

General examination and investigation of persons without complaint and reported diagnosis

1183

4290

1.48

31.67

1.1

5.51

4.74

u/ml

0.24

129

727

Rheumatism, unspecified

279

1317

2.17

31.17

1.1

1.29

8.54

u/ml

2.59

155

Nonalcoholic fatty liver disease

200

824

2.51

30.98

1.1

3.29

5.40

u/ml

—

114

Migraine with aura

577

3449

1.71

30.97

1.1

3.07

5.55

u/ml

1.02

529

Other systemic involvement of connective tissue (FG)

465

2607

1.80

30.47

1.1

4.71

7.75

u/ml

0.97

344

Abnormal findings on examination of blood, without diagnosis

656

3799

1.63

30.08

1.1

10.02

7.69

u/ml

0.37

433

Systemic connective tissue disorders

606

3704

1.66

29.67

1.1

4.57

7.13

u/ml

1.00

439

Disturbances of skin sensation

567

3416

1.69

29.51

1.1

8.98

5.51

u/ml

0.39

497

Temporomandibular joint disorders, including avohilmo

933

6296

1.50

29.35

1.1

4.19

4.97

u/ml

0.29

107

930

Sciatica+with lumbago

882

5581

1.52

29.26

1.1

2.92

6.01

u/ml

3.23

809

Dyshidrosis [pompholyx]

152

4.92

29.04

1.2

1.1

3.58

4.61

u/ml

—

Other disorders of urethra and urinary system

1300

6957

1.41

28.91

1.1

5.84

5.91

u/ml

0.02

111

879

Somatoform disorder

347

1826

1.94

28.72

1.1

5.70

7.17

u/ml

0.24

262

Allergic contact dermatitis

311

1578

2.02

28.71

1.1

12.17

6.02

u/ml

0.28

226

Vasomotor and allergic rhinitis

797

5163

1.54

28.52

1.1

3.55

5.87

u/ml

1.79

110

784

Disorders of skin appendages

945

6436

1.49

28.43

1.1

6.50

5.54

u/ml

0.18

126

898

Other disorders of lacrimal gland

592

3643

1.65

28.27

1.1

7.45

7.47

u/ml

0.00

454

Visual disturbances

809

5361

1.53

27.90

1.1

5.57

6.87

u/ml

0.42

679

Asthma, unspecified (mode)

957

5163

1.48

27.88

1.1

6.10

6.11

u/ml

0.00

101

721

Iron deficiency

252

3.84

27.64

1.1

1.77

5.75

u/ml

0.84

Asthma, unspecified (mode), excluding more controls

946

5057

1.48

27.50

1.1

6.10

5.99

u/ml

0.02

101

715

Dyspnoea

1524

8629

1.36

27.49

1.1

4.65

5.93

u/ml

0.55

119

1174

Behavioural syndromes associated with physiological disturbances and physical factors

705

4558

1.57

27.35

1.1

6.04

5.01

u/ml

0.19

103

664

Spinal stenosis

664

3292

1.60

27.04

1.1

3.80

9.20

u/ml

2.39

350

Benign neoplasm: Colon, unspecified

336

1783

1.91

26.93

1.1

6.51

10.17

u/ml

0.60

147

Sleep apnoea

1550

7797

1.36

26.89

1.1

4.96

6.21

u/ml

0.62

171

1017

Diseases of the ear and mastoid process

2341

9240

1.29

26.84

1.1

5.66

5.03

u/ml

0.24

287

1306

Disorders of lacrimal system

711

4624

1.56

26.81

1.1

6.08

7.37

u/ml

0.15

557

Other and unspecified polyneuropathies, also in other diseases

273

1357

2.05

26.53

1.1

24.01

8.35

u/ml

0.47

141

IBD patients in KELA-register

470

2774

1.72

26.49

1.1

4.91

5.51

u/ml

0.08

434

Symptoms and signs involving the skin and subcutaneous tissue

1210

8688

1.40

26.44

1.1

7.49

5.51

u/ml

0.33

123

1148

Procreative management

700

3826

1.57

26.29

1.1

3.38

5.54

u/ml

1.04

598

Deviated nasal septum

515

3113

1.67

26.27

1.1

2.33

6.98

u/ml

4.55

430

Disorders of gallbladder, biliary tract and pancreas

1685

8172

1.34

26.26

1.1

5.52

5.72

u/ml

0.05

174

1077

Complications of surgical and medical care, not elsewhere classified

1729

9394

1.33

26.20

1.1

5.90

5.28

u/ml

0.16

176

1267

Other external causes of accidental injury

1728

6497

1.34

26.17

1.1

7.00

4.94

u/ml

0.77

214

960

Tonsillectomy and adenotomy

1344

6841

1.38

25.98

1.1

4.74

4.94

u/ml

0.07

197

1077

Other systemic involvement of connective tissue

475

2826

1.71

25.93

1.1

4.81

8.23

u/ml

1.12

331

Urticaria and erythema

724

4766

1.54

25.90

1.1

6.58

6.00

u/ml

0.08

654

Other arrhythmias

1144

6247

1.41

25.80

1.1

4.91

5.51

u/ml

0.20

109

876

Dentofacial anomalies [including malocclusion]

582

3610

1.62

25.79

1.1

5.03

4.90

u/ml

0.03

550

Haemorrhage from respiratory passages

460

2519

1.71

25.41

1.1

9.54

9.98

u/ml

0.03

282

Pain and other conditions associated with female genital organs and menstrual cycle

504

2937

1.68

25.41

1.1

3.49

4.72

u/ml

0.48

464

Other enthesopathies

522

3200

1.65

25.34

1.1

6.19

7.27

u/ml

0.21

493

Complications of procedures, not elsewhere classified

1394

8935

1.36

25.11

1.1

5.53

5.45

u/ml

0.02

146

1200

Carpal tunnel syndrome

1012

6439

1.43

25.03

1.1

11.21

5.91

u/ml

0.66

872

Persons encountering health services for specific procedures and health care

2038

9816

1.29

24.90

1.1

8.74

4.96

u/ml

1.49

184

1404

Other/unspecified dorsalgia

645

4151

1.56

24.89

1.1

3.63

6.65

u/ml

1.40

579

Cholecystectomy

1157

7383

1.40

24.85

1.1

3.73

6.49

u/ml

1.36

127

891

Acute upper respiratory infections of multiple and unspecified sites

1456

8137

1.35

24.81

1.1

5.99

5.02

u/ml

0.24

156

1183

Migraine without aura

487

2959

1.68

24.73

1.1

3.72

5.41

u/ml

0.75

465

Diarrhoea and gastroenteritis of presumed infectious origin

1309

8770

1.37

24.72

1.1

6.85

5.36

u/ml

0.36

140

1233

Disorders of other endocrine glands

799

5338

1.49

24.49

1.1

8.20

6.38

u/ml

0.20

690

Faecal incontinence

157

645

2.50

24.48

1.1

14.41

10.63

u/ml

—

Chronic lower respiratory diseases

2337

9994

1.27

24.39

1.1

6.05

5.24

u/ml

0.27

279

1368

Polyneuropathies and other disorders of the peripheral nervous system

305

1622

1.91

24.37

1.1

24.01

7.62

u/ml

0.50

168

Other bacterial intestinal infections

295

1553

1.93

24.36

1.1

10.44

9.17

u/ml

0.05

160

Type 1 diabetes, strict (exclude DM2)

265

1347

2.02

24.32

1.2

1.1

16.52

4.18

u/ml

0.97

234

Hypothyroidism, drug reimbursement

346

1346

1.87

24.30

1.1

7.33

8.19

u/ml

0.12

241

Accidents

1711

6497

1.33

24.26

1.1

7.20

4.94

u/ml

0.85

208

960

Benign neoplasm: Colon, unspecified

336

1837

1.85

24.18

1.1

6.51

9.44

u/ml

0.52

164

Insulin, fast-acting (human)

315

1702

1.89

24.12

1.2

1.1

18.96

5.01

u/ml

0.84

264

5-aminosalicylic acid

429

2535

1.72

24.12

1.1

2.96

5.91

u/ml

1.26

414

Impingement syndrome of shoulder

382

2183

1.78

24.11

1.1

1.66

8.29

u/ml

4.22

293

Urticaria

614

3975

1.57

23.83

1.1

7.01

5.68

u/ml

0.18

560

Inflammatory bowel disease, strict (require KELA)

470

2855

1.67

23.82

1.1

4.91

5.68

u/ml

0.11

434

Type 1 diabetes, definitions combined

265

1360

2.00

23.66

1.2

1.1

16.52

4.90

u/ml

0.89

237

Genitourinary diseases

1193

4305

1.40

23.63

1.1

4.89

5.90

u/ml

0.36

166

660

Other diseases of urinary system

1917

8370

1.30

23.44

1.1

4.33

5.73

u/ml

0.55

232

1107

Rotator cuff syndrome

929

4824

1.44

23.34

1.1

3.01

6.53

u/ml

3.14

644

Certain infectious and parasitic diseases

2025

7908

1.29

23.32

1.1

6.61

5.32

u/ml

0.42

230

1124

Diseases of male genital organs

745

2485

1.53

23.23

1.1

5.96

5.32

u/ml

0.17

365

Acetic acid derivatives and related substances

510

1604

1.67

23.21

1.1

2.04

7.99

u/ml

4.37

186

Cholelithiasis

1394

7308

1.35

23.17

1.1

4.49

6.07

u/ml

0.61

137

926

Benign neoplasms

1925

8373

1.29

22.82

1.1

5.53

5.08

u/ml

0.14

256

1194

Flat foot [pes planus] (acquired)

179

806

2.28

22.70

1.1

9.28

7.52

u/ml

0.13

108

Thyroiditis, ILD-related definition

254

1308

1.99

22.63

1.1

6.09

5.75

u/ml

0.03

186

2155

8991

1.27

22.58

1.1

7.52

4.87

u/ml

0.89

225

1219

Pain associated with micturition

222

1091

2.08

22.50

1.0

1.1

5.11

5.50

u/ml

0.03

123

Inflammatory diseases of prostate (prostatitis)

166

725

2.33

22.47

1.1

10.46

9.08

u/ml

—

Lichen simplex chronicus and prurigo

129

505

2.64

22.41

1.1

8.78

4.36

u/ml

0.36

Cholelithiasis, broad definition with cholecystitis

1437

7431

1.33

22.34

1.1

4.48

6.02

u/ml

0.61

141

944

Subjective visual disturbances

424

2556

1.69

22.15

1.1

5.05

7.42

u/ml

0.62

318

Other specified/unspecified arthritis

456

2799

1.65

22.12

1.1

3.07

7.72

u/ml

2.52

409

Insulin, combination of fast acting with intermediate-acting or long-acting

930

6101

1.42

21.89

1.1

12.36

6.17

u/ml

0.93

798

Menorrhagia

752

2803

1.50

21.87

1.1

6.31

5.64

u/ml

0.14

399

Inflammatory diseases of female pelvic organs

1283

7225

1.35

21.86

1.1

5.13

5.03

u/ml

0.02

144

996

Dental operations

1072

3947

1.40

21.76

1.1

6.17

5.31

u/ml

0.15

106

586

Cough

673

4338

1.50

21.71

1.1

3.61

7.37

u/ml

2.28

576

Voice disturbances

447

2748

1.65

21.62

1.1

6.66

6.72

u/ml

0.00

349

Other arthrosis

787

3870

1.47

21.56

1.1

6.88

7.05

u/ml

0.03

516

Ulcerative colitis

454

2805

1.64

21.52

1.1

7.02

6.13

u/ml

0.11

419

Exposure to unspecified factor

1772

10757

1.29

21.48

1.1

6.69

5.20

u/ml

0.52

206

1440

Fall on same level

2222

9920

1.26

21.39

1.1

7.14

4.92

u/ml

0.95

238

1407

Preparation and fitting of bite rail to mouth

282

1532

1.88

21.34

1.1

2.51

7.31

u/ml

2.24

226

Asthma (diagnoses ohter than nonallergic)

1576

10416

1.30

21.33

1.1

5.04

5.38

u/ml

0.09

171

1390

Spondylopathies

1234

5556

1.36

21.18

1.1

3.60

6.21

u/ml

2.05

103

774

Disorders of eyelid, lacrimal system and orbit

1401

8358

1.32

21.08

1.1

4.38

6.28

u/ml

0.57

144

1048

Excessive, frequent and irregular menstruation

892

3487

1.44

20.95

1.1

5.89

5.15

u/ml

0.19

106

507

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

147

449

2.45

20.92

1.1

18.28

9.17

u/ml

0.53

Polyuria

313

1765

1.80

20.78

1.1

6.83

7.43

u/ml

0.06

178

ILD medications: immunosuppressive drugs

1093

7740

1.37

20.73

1.1

4.08

5.68

u/ml

0.76

1123

Endometriosis

757

3083

1.48

20.71

1.1

4.25

5.41

u/ml

0.36

441

Bacterial intestinal infections, IBD co-morbidities

290

1607

1.83

20.47

1.1

11.32

7.78

u/ml

0.15

171

Cervicalgia

334

1929

1.76

20.44

1.1

5.48

8.05

u/ml

0.42

264

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

891

5905

1.41

20.43

1.1

3.94

7.46

u/ml

2.71

663

Migraine with aura and triptan purchases

365

2171

1.72

20.30

1.1

1.77

5.35

u/ml

3.29

346

Diseases of oral cavity, salivary glands and jaws

1667

6631

1.30

20.23

1.1

6.43

5.34

u/ml

0.30

197

929

Tramadol

1345

6553

1.33

20.14

1.1

4.23

5.64

u/ml

0.86

113

961

TMD related operations

330

1912

1.76

20.12

1.1

2.69

7.09

u/ml

2.26

275

Dental operations, only avohilmo

1134

4265

1.37

20.07

1.1

7.79

5.36

u/ml

0.45

117

621

Sleep disorders

416

2566

1.65

19.96

1.1

3.35

5.97

u/ml

1.20

359

Finngen Rheumatological endpoints

1875

8452

1.27

19.90

1.1

3.37

5.44

u/ml

2.46

192

1259

Other arthritis (FG)

514

3330

1.56

19.89

1.1

2.93

7.83

u/ml

3.28

484

Abnormal serum enzyme levels

350

2034

1.72

19.86

1.1

7.86

7.98

u/ml

0.01

216

Insulin medication

929

5749

1.39

19.67

1.1

12.36

6.11

u/ml

0.95

779

Enthesopathies of lower limb, excluding foot

374

2252

1.68

19.66

1.1

5.27

7.30

u/ml

0.37

331

Any operation in hilmo

119

222

2.78

19.51

1.1

1.0

7.57

1.98

u/ml

0.54

Sicca syndrome [Sjögren]

175

833

2.16

19.46

1.1

6.66

5.26

u/ml

0.17

100

Transport accidents

865

5504

1.41

19.42

1.1

3.93

4.63

u/ml

0.30

844

Other diseases of the digestive system

396

2424

1.65

19.41

1.1

4.45

4.71

u/ml

0.05

214

Pure hypercholesterolaemia

1020

5008

1.38

19.40

1.1

6.68

7.20

u/ml

0.09

596

Other female pelvic inflammatory diseases

324

1891

1.75

19.28

1.1

4.65

6.65

u/ml

0.44

243

Atopic dermatitis, strict definition with reimbursement

668

4468

1.47

19.08

1.1

4.15

5.07

u/ml

0.35

711

Type 1 diabetes, strict definition

224

1173

1.96

19.01

1.1

17.55

4.62

u/ml

0.94

211

Presence of other devices

300

1715

1.77

18.97

1.1

24.09

8.88

u/ml

0.79

139

Pollen allergy

441

2766

1.61

18.97

1.1

3.60

5.31

u/ml

0.76

417

Paralytic ileus and intestinal obstruction

308

1774

1.75

18.95

1.1

1.05

10.57

u/ml

5.34

208

Non-selective monoamine reuptake inhibitors

577

3752

1.51

18.91

1.1

2.07

9.16

u/ml

7.17

451

Undetermined asthma, excluding more controls

225

1181

1.94

18.86

1.1

1.27

8.08

u/ml

3.68

163

Symptoms and signs involving the urinary system

1154

6710

1.34

18.79

1.1

4.76

6.65

u/ml

0.71

840

Undetermined asthma

225

1184

1.93

18.72

1.1

1.27

8.32

u/ml

3.78

160

Asthma/COPD (KELA code 203)

1775

9943

1.27

18.72

1.1

6.84

5.08

u/ml

0.52

205

1357

Type 1 diabetes, strict definition, subgroup 1

217

1133

1.97

18.63

1.1

17.75

4.69

u/ml

0.90

207

Other disorders of skin and subcutaneous tissue

1034

7046

1.35

18.62

1.1

12.12

6.08

u/ml

1.05

845

Diseases of the respiratory system

1270

4810

1.33

18.55

1.1

7.23

5.40

u/ml

0.46

153

678

Fenamates

274

1016

1.84

18.49

1.1

1.21

9.11

u/ml

4.84

128

Symptoms and signs involving speech and voice

512

3375

1.54

18.36

1.1

6.37

6.72

u/ml

0.03

415

Chronic periapical parodontitis

316

1855

1.73

18.30

1.1

6.29

7.41

u/ml

0.18

269

Any reimbursement code in KELA

1386

5329

1.31

18.28

1.1

6.32

4.68

u/ml

0.60

154

930

Vocal cord dysfunction

240

1203

1.88

18.28

1.1

1.89

6.30

u/ml

2.38

225

Bronchitis

1949

10294

1.25

18.11

1.1

5.78

5.19

u/ml

0.17

196

1406

Disorders of conjunctiva

1538

10142

1.28

18.02

1.1

4.00

5.66

u/ml

1.36

217

1359

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

342

2067

1.68

17.85

1.1

2.37

6.64

u/ml

2.19

307

Allergic rhinitis

670

4643

1.45

17.84

1.1

3.95

5.66

u/ml

0.88

684

Nonorganic sleeping disorders, excluding more controls

359

2199

1.66

17.79

1.1

3.46

5.54

u/ml

0.83

349

Fissure and fistula of anal and rectal regions

361

2211

1.65

17.77

1.1

3.06

7.98

u/ml

2.45

305

Other symptoms and signs involving the circulatory and respiratory systems

125

539

2.38

17.68

1.1

7.40

6.14

u/ml

—

Other extrapyramidal and movement disorders in other diseases

328

1964

1.69

17.68

1.1

3.64

8.73

u/ml

1.58

212

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

569

3866

1.49

17.67

1.1

5.98

6.62

u/ml

0.10

511

Psychiatric diseases

2055

8317

1.24

17.66

1.1

6.45

5.53

u/ml

0.25

217

1202

External causes of morbidity and mortality

1379

5323

1.31

17.61

1.1

7.15

5.11

u/ml

0.62

163

821

Cystitis

1570

7556

1.28

17.59

1.1

4.69

5.71

u/ml

0.36

236

971

Asthma-related infections

981

7197

1.35

17.59

1.1

7.11

5.86

u/ml

0.22

950

Asthma, hospital admission 2, infections

981

7197

1.35

17.59

1.1

7.11

5.86

u/ml

0.22

950

Ethmoidectomy

234

1276

1.87

17.57

1.1

4.62

5.80

u/ml

0.13

172

Fibroblastic disorders

307

1807

1.72

17.57

1.1

17.97

8.48

u/ml

0.49

216

Other disorders of patella

343

2087

1.67

17.45

1.1

3.35

6.63

u/ml

1.50

362

Sensorineural hearing loss

1026

5365

1.35

17.27

1.1

9.56

7.46

u/ml

0.37

611

Other diseases of lip and oral mucosa

247

1375

1.83

17.27

1.1

5.92

8.40

u/ml

0.23

175

Other specified/unspecified systemic involvement of connective tissue

125

546

2.36

17.26

1.1

6.59

4.37

u/ml

0.32

Ulcerative colitis (strict definition, all Crohn cases excluded)

276

1591

1.77

17.20

1.1

1.43

5.51

u/ml

3.71

246

FESS (DNB20)

226

1228

1.88

17.18

1.1

4.62

5.76

u/ml

0.13

165

Polyarthrosis

274

1509

1.76

17.06

1.1

3.57

7.97

u/ml

1.26

160

Neuromuscular dysfunction of bladder

152

721

2.16

17.04

1.1

1.45

5.84

u/ml

—

Noninflammatory disorders of female genital tract

974

3616

1.37

16.93

1.1

4.99

5.12

u/ml

0.03

124

524

Striking against or struck by other objects

580

3991

1.47

16.84

1.1

3.21

6.47

u/ml

2.19

573

Exposure to other specified factors

1317

9642

1.29

16.84

1.1

5.66

5.37

u/ml

0.07

160

1333

Factors influencing health status and contact with health services

552

1842

1.51

16.74

1.1

5.25

5.43

u/ml

0.03

332

Insomnia

305

1822

1.70

16.72

1.1

3.81

6.34

u/ml

0.81

249

788

5691

1.39

16.60

1.1

3.87

6.05

u/ml

1.03

790

Cardiovascular diseases

1467

6274

1.28

16.59

1.1

5.84

4.64

u/ml

0.49

186

1038

Propionic acid derivatives

547

1831

1.51

16.53

1.1

3.12

8.27

u/ml

2.54

210

Benign neoplasms

1616

7270

1.27

16.51

1.1

5.35

4.95

u/ml

0.12

235

1074

Other diseases of stomach and duodenum

101

408

2.54

16.50

1.1

30.61

6.57

u/ml

—

Ulcerative colitis (strict definition, require KELA)

315

1904

1.68

16.49

1.1

2.56

5.65

u/ml

1.36

280

Other disorders of skin and subcutaneous tissue, not elsewhere classified

225

1236

1.85

16.48

1.1

8.07

6.38

u/ml

0.18

141

Allergic asthma (mode), excluding more controls

504

3327

1.51

16.47

1.1

6.87

5.09

u/ml

0.22

541

Allergic asthma (mode)

504

3328

1.50

16.46

1.1

6.87

5.11

u/ml

0.22

544

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

305

1830

1.70

16.43

1.1

2.56

5.76

u/ml

1.41

272

Obesity related asthma

522

3541

1.49

16.36

1.1

2.87

6.67

u/ml

2.38

491

Asthma, hospital admissions , main diagnosis only

1478

10513

1.27

16.30

1.1

4.96

5.51

u/ml

0.15

165

1409

Concussion

886

5690

1.36

16.20

1.1

5.20

5.75

u/ml

0.16

888

Generalized anxiety disorder

348

2171

1.63

16.14

1.1

3.90

5.32

u/ml

0.42

355

Acute sinusitis

990

6982

1.33

16.09

1.1

8.85

4.91

u/ml

0.72

117

1068

Paracetamol of NSAID medication

382

1188

1.64

16.04

1.1

5.93

9.54

u/ml

0.68

152

Benign neoplasm: Ascending colon

178

915

1.98

16.00

1.1

9.54

5.24

u/ml

0.31

Deforming dorsopathies

452

2992

1.53

15.97

1.1

3.92

7.30

u/ml

1.30

408

Cardiac arrhythmias

1214

6205

1.30

15.97

1.1

4.88

5.40

u/ml

0.18

140

986

KRA_PSY_EATING, excluding more controls

237

1337

1.81

15.94

1.1

4.69

4.17

u/ml

0.13

226

Conjunctivitis

1413

9776

1.27

15.66

1.1

3.67

5.62

u/ml

1.76

205

1320

Benign neoplasm: Ascending colon

178

923

1.96

15.62

1.1

9.54

6.41

u/ml

0.21

Fracture of lumbar spine and pelvis

286

1707

1.69

15.57

1.1

16.58

6.79

u/ml

0.52

160

Benign neoplasm of other and ill-defined parts of digestive system

256

1487

1.75

15.53

1.1

8.22

6.58

u/ml

0.11

158

Other and unspecified urticaria

372

2380

1.59

15.47

1.1

7.56

6.41

u/ml

0.09

326

Use of hypnotics and sedatives

1843

8665

1.24

15.46

1.1

3.68

5.71

u/ml

1.64

187

1218

Diseases of inner ear

759

5444

1.38

15.35

1.1

6.97

7.31

u/ml

0.06

625

Syncope and collapse

640

4032

1.42

15.28

1.1

4.50

7.46

u/ml

1.06

475

Other anxiety disorders

944

6336

1.33

15.27

1.1

4.17

4.97

u/ml

0.37

101

1007

Other nutritional deficiencies

1146

8713

1.29

15.24

1.1

3.95

5.53

u/ml

1.17

134

1249

Atopic dermatitis, strict definition

647

4540

1.41

15.23

1.1

4.18

5.21

u/ml

0.40

693

Endometriosis of pelvic peritoneum

350

2191

1.60

15.12

1.1

3.26

5.35

u/ml

0.95

350

Vitamin B12 deficiency anaemia

147

721

2.07

15.08

1.1

11.15

7.71

u/ml

0.24

Thyrotoxicosis, other and/or unspecified

342

2159

1.61

15.05

1.1

3.76

6.36

u/ml

0.74

276

Glomerular disorders in diseases classified elsewhere

173

901

1.96

15.02

1.1

22.66

6.39

u/ml

0.70

104

Dental caries 2

1481

9327

1.26

14.95

1.1

3.16

5.63

u/ml

3.64

199

1361

Dental caries 2, only avohilmo

1462

9230

1.26

14.94

1.1

3.05

5.60

u/ml

3.89

196

1352

Crohn's disease of small intestine

143

700

2.10

14.90

1.0

1.1

3.66

3.69

u/ml

0.00

105

Pain in thoracic spine

255

1498

1.73

14.89

1.1

4.51

7.50

u/ml

0.66

221

Bullous disorders

100

423

2.43

14.88

1.2

1.1

38.09

6.39

u/ml

0.89

Injuries to the knee and lower leg

2163

10272

1.21

14.84

1.1

7.21

5.09

u/ml

0.93

257

1377

Diseases of pulp and periapical tissues

545

3802

1.45

14.78

1.1

5.45

5.75

u/ml

0.06

579

Migraine without aura and triptan purchases

366

2361

1.58

14.78

1.1

2.18

5.23

u/ml

2.74

377

Other enthesopathy of foot (+metatarsalgia)

179

949

1.92

14.77

1.1

3.34

7.51

u/ml

0.75

122

Disorders of vestibular function (Vertigo)

652

4663

1.40

14.73

1.1

7.59

7.77

u/ml

0.02

517

Dental caries 2 and operation codes

1457

9278

1.26

14.73

1.1

3.20

5.67

u/ml

3.51

192

1361

Ovarian cyst

771

3261

1.38

14.68

1.1

7.75

5.23

u/ml

0.61

474

Hyperplasia of prostate

360

1287

1.61

14.63

1.1

7.75

7.69

u/ml

0.01

155

Implicit bacterial Sepsis

456

2815

1.50

14.63

1.1

7.72

8.86

u/ml

0.13

275

Nonorganic sleeping disorders

359

2309

1.58

14.62

1.1

3.46

6.42

u/ml

1.17

325

Crohn disease

244

1425

1.74

14.62

1.1

8.78

4.59

u/ml

0.37

219

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

410

2.46

14.57

1.1

28.51

3.08

u/ml

—

Intestinal malabsorption

398

2.47

14.51

1.2

1.1

17.89

4.30

u/ml

0.59

Benign neoplasm: Stomach

149

748

2.03

14.43

1.1

11.72

6.91

u/ml

0.25

Any mental disorder

2045

8456

1.22

14.39

1.1

6.58

5.51

u/ml

0.29

214

1211

Other disorders of ear

1430

7616

1.26

14.38

1.1

6.74

6.10

u/ml

0.16

137

981

Benign neoplasm of other and ill-defined parts of digestive system

256

1522

1.71

14.32

1.1

8.22

7.04

u/ml

0.08

152

Recurring oral aphthae, including avohilmo

240

1405

1.74

14.27

1.1

4.85

5.77

u/ml

0.17

170

Diseases of tongue

113

513

2.26

14.27

1.1

2.01

6.26

u/ml

1.29

Metabolic disorders

1520

7597

1.25

14.27

1.1

6.87

5.75

u/ml

0.22

130

1043

Oxicams

345

1227

1.61

14.21

1.1

5.85

8.66

u/ml

0.58

140

Antihypertensive medication - note that there are other indications

1415

6172

1.26

14.18

1.1

6.46

4.80

u/ml

0.61

180

1009

Sequelae of injuries of upper limb

172

914

1.92

14.13

1.1

8.83

4.71

u/ml

0.44

120

Abnormal findings on antenatal screening of mother

235

1377

1.75

14.11

1.1

6.61

2.71

u/ml

0.61

245

Other disorders of fluid, electrolyte and acid-base balance

370

2324

1.55

14.05

1.1

23.52

9.43

u/ml

0.31

227

Polycystic ovarian syndrome

162

850

1.97

14.04

1.1

1.82

4.49

u/ml

1.34

147

Diseases of salivary glands

305

1905

1.62

14.04

1.1

2.12

7.22

u/ml

3.08

270

Soft tissue disorders related to use, overuse and pressure

373

2439

1.55

14.02

1.1

3.28

7.96

u/ml

2.26

321

False labour

725

3336

1.38

14.00

1.1

4.16

4.47

u/ml

0.08

605

Oter anti-inflammatory and antirheumatic agents, non-steroids

287

952

1.69

13.99

1.1

4.46

8.89

u/ml

1.40

104

Irregular menses

1017

6384

1.30

13.92

1.1

5.13

4.65

u/ml

0.10

141

956

Oedema, not elsewhere classified

426

2852

1.50

13.92

1.1

15.18

7.97

u/ml

0.43

341

Conductive and sensorineural hearing loss

1095

5899

1.29

13.88

1.1

8.50

7.09

u/ml

0.27

706

Diabetic retinopathy, strict definition

246

1277

1.72

13.82

1.1

28.93

3.62

u/ml

1.09

111

Gastroduodenal ulcer

270

1638

1.66

13.73

1.1

6.18

9.33

u/ml

0.53

153

Other symptoms and signs involving cognitive functions and awareness

550

3648

1.42

13.71

1.1

3.15

8.47

u/ml

2.77

395

Other neurological diseases

989

6136

1.30

13.66

1.1

5.84

6.98

u/ml

0.27

722

Sequelae of injuries, of poisoning and of other consequences of external causes

375

2471

1.54

13.66

1.1

12.18

6.49

u/ml

0.44

347

Implicit Sepsis

1062

6426

1.29

13.65

1.1

6.55

6.14

u/ml

0.08

796

Type1 diabetes, definitions combined, early onset

180

982

1.88

13.59

1.1

19.41

4.09

u/ml

0.77

163

GI-bleeding

369

2428

1.53

13.44

1.1

4.25

4.68

u/ml

0.09

215

Cervicobrachial syndrome

355

2321

1.55

13.41

1.1

5.76

7.33

u/ml

0.30

338

Gingivitis and periodontal diseases

1575

6596

1.24

13.32

1.1

6.93

5.35

u/ml

0.42

190

924

Convalescence

109

503

2.23

13.30

1.1

6.76

5.81

u/ml

—

Other diseases of intestine

155

812

1.94

13.24

1.1

4.21

10.37

u/ml

—

Extrapyramidal and movement disorders

462

3193

1.46

13.23

1.1

5.67

8.80

u/ml

0.80

339

Symptoms and signs involving the nervous and musculoskeletal systems

888

6818

1.31

13.13

1.1

7.27

6.05

u/ml

0.16

880

Reimbursement for rheumatic diseases

927

7148

1.30

13.09

1.1

3.72

6.34

u/ml

1.47

923

Infections of the skin and subcutaneous tissue

953

7364

1.30

13.04

1.1

6.68

5.66

u/ml

0.17

101

1053

Acute gastritis

113

533

2.16

12.96

1.1

5.49

5.73

u/ml

—

Postprocedural disorders of nervous system

165

893

1.90

12.94

1.1

3.29

4.49

u/ml

0.19

141

Other diseases of oesophagus

128

633

2.06

12.92

1.2

1.1

13.67

6.82

u/ml

—

Benign neoplasm: Stomach

149

779

1.95

12.89

1.1

11.72

8.03

u/ml

0.18

Viral Sepsis

268

1659

1.64

12.84

1.1

7.67

6.94

u/ml

0.08

183

Eating disorders

262

1620

1.65

12.74

1.1

4.64

4.47

u/ml

0.04

242

Implicit viral Sepsis

267

1655

1.63

12.73

1.1

7.67

6.92

u/ml

0.08

182

Enterocolitis due to Clostridium difficile

149

782

1.94

12.70

1.1

28.11

7.59

u/ml

—

Mixed connective tissue disease

126

626

2.07

12.70

1.1

4.49

u/ml

0.00

Polyarthropathies

1116

5865

1.28

12.70

1.1

3.86

5.75

u/ml

1.14

848

Metatarsalgia

162

880

1.88

12.48

1.1

3.74

6.65

u/ml

0.43

113

Eating disorder

237

1439

1.68

12.44

1.1

4.69

4.76

u/ml

0.02

222

COPD/asthma/ILD related infections

1963

8206

1.20

12.42

1.1

9.19

4.88

u/ml

1.45

216

1149

COPD/asthma related infections

1963

8206

1.20

12.42

1.1

9.19

4.88

u/ml

1.45

216

1149

Bacterial Sepsis

527

3348

1.41

12.39

1.1

7.49

8.41

u/ml

0.12

349

Other sleep disorders

172

954

1.83

12.36

1.1

2.40

6.42

u/ml

1.57

133

Polycystic ovarian syndrome, consortium definition

1448

7110

1.24

12.35

1.1

5.71

4.92

u/ml

0.20

164

982

Female infertility

657

2989

1.37

12.22

1.1

2.25

4.77

u/ml

2.53

465

Unspecified urinary incontinence

144

759

1.94

12.20

1.1

6.46

6.96

u/ml

—

Anti-inflammatory and antirheumatic products, non-steroids

519

1831

1.43

12.19

1.1

3.25

8.27

u/ml

2.35

210

Ovarian dysfunction

195

1132

1.77

12.18

1.1

2.37

4.43

u/ml

1.05

200

Mycoses

391

2664

1.48

12.16

1.1

4.24

7.50

u/ml

1.43

329

Asthma and allergy

291

1842

1.58

12.13

1.1

4.22

5.70

u/ml

0.29

299

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1029

8005

1.27

12.10

1.1

4.04

5.52

u/ml

0.89

164

1113

Fever of other and unknown origin

855

6119

1.30

12.09

1.1

3.70

6.13

u/ml

1.93

835

Bacterial pneumonia, not elsewhere classified

538

3429

1.40

12.07

1.1

11.85

7.46

u/ml

0.43

406

Ulcerative colitis, NAS

243

1494

1.65

12.06

1.1

9.67

5.76

u/ml

0.34

224

Second line medication for Crohn's disease

926

7237

1.29

12.04

1.1

5.15

5.91

u/ml

0.15

986

Abnormal findings on diagnostic imaging of lung

546

3848

1.39

12.01

1.1

5.43

9.37

u/ml

1.64

368

Papulosquamous disorders

571

4170

1.38

12.00

1.1

6.31

6.65

u/ml

0.06

537

Psychotic depression

111

537

2.11

11.98

1.1

2.55

5.29

u/ml

0.68

Arthropathies in other diseases classified elsewhere

273

2.61

11.96

1.1

12.30

3.64

u/ml

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

153

830

1.88

11.88

1.1

1.86

5.45

u/ml

—

107

Dental caries

394

2674

1.47

11.87

1.1

12.18

6.57

u/ml

0.40

408

Dental caries 3 and operation codes

1534

6448

1.23

11.86

1.1

8.16

5.19

u/ml

0.85

166

931

Female infertility, cervigal, vaginal, other or unspecified origin

592

2893

1.38

11.86

1.1

2.44

4.81

u/ml

2.15

456

Hernia

1521

8488

1.22

11.83

1.1

8.24

5.37

u/ml

0.76

176

1118

Disorders of ocular muscles, binocular movement, accommodation and refraction

832

6378

1.30

11.82

1.1

6.81

5.65

u/ml

0.19

102

886

Arthrosis

1132

4940

1.27

11.82

1.1

5.60

5.99

u/ml

0.10

125

703

Dentinal caries

352

2350

1.51

11.81

1.1

12.80

6.29

u/ml

0.41

349

Asthma and allergy, excluding more controls

291

1854

1.57

11.81

1.1

4.22

5.57

u/ml

0.26

302

Dental caries 1 and operation codes

1447

6049

1.23

11.79

1.1

7.73

5.29

u/ml

0.64

150

885

Other disorders of glucose regulation and pancreatic internal secretion

141

748

1.92

11.73

1.1

28.63

5.00

u/ml

0.60

Ganglion

359

2426

1.50

11.68

1.1

4.28

6.28

u/ml

0.68

379

Spondylosis

678

4362

1.34

11.67

1.1

3.83

7.38

u/ml

2.05

557

Persons encountering health services in circumstances related to reproduction

1061

5707

1.27

11.58

1.1

6.58

5.39

u/ml

0.25

150

875

Tongue abnormality

105

505

2.13

11.58

1.1

2.93

6.02

u/ml

—

Restless leg syndrome

186

1078

1.75

11.57

1.1

2.86

4.84

u/ml

0.68

128

Fall on same level involving ice and snow

883

6898

1.29

11.56

1.1

6.86

6.32

u/ml

0.11

884

Glucagon-like peptide-1 (GLP-1) analogues

661

4067

1.35

11.56

1.1

4.66

8.82

u/ml

1.50

428

Follow-up care involving plastic surgery

372

2.33

11.43

1.1

4.47

6.05

u/ml

—

Renal failure

464

3010

1.42

11.38

1.1

24.68

8.88

u/ml

1.10

276

Other eating disorders

143

774

1.90

11.35

1.1

5.83

5.37

u/ml

0.07

123

Plantar fascial fibromatosis

161

900

1.82

11.35

1.1

9.11

9.79

u/ml

—

115

Allergic conjunctivitis

1064

8394

1.26

11.25

1.1

3.98

5.48

u/ml

0.96

168

1160

Special screening examination for other diseases and disorders

142

765

1.89

11.24

1.1

5.37

4.92

u/ml

0.05

109

Hypoglycaemia, other or unspecified

116

586

2.02

11.17

1.2

1.1

34.50

4.91

u/ml

—

Post-traumatic stress disorder

196

1170

1.71

11.06

1.1

7.01

4.70

u/ml

0.36

202

Radiculopathy

207

1250

1.67

11.00

1.1

5.48

7.71

u/ml

0.23

144

Gastric ulcer

188

1107

1.71

10.96

1.1

5.17

9.23

u/ml

0.56

100

Bacterial pneumonia (organism specified)

587

3970

1.36

10.95

1.1

11.15

6.77

u/ml

0.46

465

Abnormal findings on diagnostic imaging of other body structures

190

1126

1.71

10.92

1.1

3.14

7.84

u/ml

—

119

Thyrotoxicosis with diffuse goitre

250

1589

1.60

10.89

1.1

5.01

5.80

u/ml

0.15

208

Benign neoplasm: Transverse colon

129

683

1.92

10.81

1.1

7.20

6.27

u/ml

—

Intestinal stricture

365

2513

1.46

10.78

1.1

1.24

7.76

u/ml

5.18

255

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1802

0.48

10.77

1.1

5.56

9.63

u/ml

—

162

Other hearing loss

291

1880

1.53

10.75

1.1

6.74

9.53

u/ml

0.30

164

Rosacea

192

1147

1.70

10.75

1.1

10.88

5.04

u/ml

0.33

139

Lateral epicondylitis

217

1337

1.65

10.73

1.1

10.05

8.91

u/ml

0.10

203

Condition for Implicit Sepsis (Organ dysfunction codes)

1297

7719

1.23

10.69

1.1

6.24

5.77

u/ml

0.13

998

Hyperhidrosis

295

2.46

10.69

1.0

1.1

1.62

5.76

u/ml

—

Other maternal disorders predominantly related to pregnancy

1164

5925

1.24

10.63

1.1

6.52

4.54

u/ml

0.50

151

885

Other shoulder lesions

155

875

1.80

10.61

1.1

1.70

5.44

u/ml

1.72

122

Nummular dermatitis

121

632

1.95

10.59

1.1

10.61

4.51

u/ml

0.92

Injuries to the abdomen, lower back, lumbar spine and pelvis

560

4133

1.36

10.58

1.1

7.48

6.49

u/ml

0.15

502

Leisure time condition

276

1810

1.54

10.45

1.1

3.65

6.76

u/ml

0.77

228

Injuries to the neck

383

2681

1.44

10.44

1.1

4.96

6.44

u/ml

0.31

387

Other disorders of teeth and supporting structures

292

1939

1.52

10.38

1.1

4.58

7.70

u/ml

0.69

267

Bacterial pneumoniae

559

3679

1.35

10.37

1.1

11.39

7.23

u/ml

0.42

436

Neoplasms

1594

7132

1.20

10.36

1.1

5.78

5.04

u/ml

0.24

224

1055

Thyrotoxicosis

400

2828

1.43

10.32

1.1

4.47

6.53

u/ml

0.65

353

Obesity due to excess calories

781

6104

1.29

10.30

1.1

4.27

5.60

u/ml

0.58

886

Chronic kidney disease

296

1965

1.51

10.25

1.1

26.72

8.81

u/ml

0.79

164

Glaucoma suspect

435

3123

1.40

10.22

1.1

5.10

9.63

u/ml

0.68

296

Erosion of teeth, including avohilmo

383

2601

1.44

10.19

1.1

2.96

5.49

u/ml

1.63

379

Benign neoplasm: Transverse colon

129

697

1.88

10.19

1.1

7.20

7.73

u/ml

—

Other retinal disorders

792

4966

1.29

10.18

1.1

16.52

7.15

u/ml

1.12

519

Presence of cardiac and vascular implants and grafts

467

2552

1.39

10.15

1.1

13.25

9.63

u/ml

0.30

222

Disorders of vitreous body and globe

621

4599

1.33

10.09

1.1

10.80

8.18

u/ml

0.26

459

Spondylolisthesis/Spondylolysis

249

1608

1.57

10.09

1.1

3.12

7.02

u/ml

1.11

209

Injuries to the ankle and foot

1257

9447

1.22

10.03

1.1

4.02

5.19

u/ml

0.79

162

1383

Other disorders of kidney and ureter

166

973

1.73

9.96

1.1

30.71

6.49

u/ml

0.84

100

Benign neoplasm: Rectum

214

1339

1.62

9.95

1.1

7.45

10.42

u/ml

0.28

127

Internal derangement of knee

573

4303

1.34

9.94

1.1

2.89

6.13

u/ml

2.32

646

Other/unspecified enthesopathies of lower limb, excluding foot

124

668

1.89

9.93

1.1

7.37

5.44

u/ml

0.15

100

Chronic pancreatitis

152

870

1.77

9.91

1.1

2.49

7.63

u/ml

1.50

102

Crohn disease (strict definition, all UC cases excluded)

104

530

2.01

9.89

1.0

1.1

3.22

4.29

u/ml

0.15

Benign neoplasm: Rectum

214

1342

1.61

9.86

1.1

7.45

9.51

u/ml

0.20

128

Lichen ruber planus, wide definition including periferal and oral lichen planus

289

1941

1.51

9.79

1.1

7.99

7.34

u/ml

0.07

203

Other bullous disorders

217

2.63

9.70

1.3

1.1

49.17

4.48

u/ml

0.93

Benign neoplasm: Rectum, anus and anal canal

236

1520

1.57

9.69

1.1

7.20

9.95

u/ml

0.27

136

Disorders of vitreous body

602

4483

1.32

9.69

1.1

10.89

8.22

u/ml

0.25

451

Blepharochalasis

354

2481

1.44

9.59

1.1

1.93

11.94

u/ml

5.40

221

Heart failure, not strict

956

5288

1.25

9.57

1.1

14.70

6.93

u/ml

0.91

622

Benign neoplasm: Rectum, anus and anal canal

236

1526

1.56

9.54

1.1

7.20

9.69

u/ml

0.25

143

Panic disorder

304

2077

1.48

9.53

1.1

4.70

4.73

u/ml

0.01

335

Dislocation, sprain and strain of joints and ligaments of knee

1061

8047

1.23

9.45

1.1

5.09

5.04

u/ml

0.01

148

1174

L04AX Other immunosuppressants

877

7022

1.26

9.44

1.1

3.62

6.16

u/ml

1.31

953

Intracranial trauma

980

5911

1.25

9.43

1.1

5.50

5.68

u/ml

0.05

105

919

Fibrosis and cirrhosis of liver

103

533

1.97

9.33

1.1

4.60

4.16

u/ml

—

Diabetic nephropathy

188

1144

1.64

9.31

1.1

24.41

5.42

u/ml

0.87

Achilles tendinitis

149

865

1.75

9.29

1.1

4.72

8.15

u/ml

0.54

119

Other symptoms and signs involving the nervous and musculoskeletal systems

641

4953

1.30

9.27

1.1

4.02

6.17

u/ml

0.83

675

Benign neoplasm: Sigmoid colon

212

1347

1.59

9.27

1.1

1.74

10.61

u/ml

3.73

126

Acne

235

1532

1.56

9.27

1.1

4.90

4.07

u/ml

0.19

233

Use of pramipexole

273

1834

1.50

9.25

1.1

14.48

7.76

u/ml

0.36

186

Candidiasis

218

1398

1.58

9.22

1.1

5.57

6.13

u/ml

0.10

179

Gonarthrosis

917

4207

1.26

9.19

1.1

4.86

6.66

u/ml

0.75

566

Unspecified fall

706

5487

1.28

9.15

1.1

5.04

6.90

u/ml

0.56

697

Atypical facial pain

448

2.06

9.15

1.1

5.57

5.08

u/ml

0.04

Bacterial infection, other or unspecified

647

4518

1.30

9.08

1.1

10.75

7.28

u/ml

0.31

500

Excessive vomiting in pregnancy

179

1102

1.66

9.06

1.1

0.96

3.77

u/ml

3.73

186

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1459

0.52

9.01

1.1

38.90

10.80

u/ml

—

104

Viral and other specified intestinal infections

423

3021

1.38

8.99

1.1

2.39

4.82

u/ml

2.39

435

Mouth breathing

568

4336

1.32

8.96

1.1

6.34

6.23

u/ml

0.02

598

Ventral hernia

296

2034

1.47

8.95

1.1

14.12

7.87

u/ml

0.30

230

Other metabolic disorders

218

1408

1.57

8.95

1.1

4.53

6.35

u/ml

0.37

189

Diseases of middle ear and mastoid

1078

7256

1.22

8.93

1.1

6.50

4.97

u/ml

0.37

147

1054

Other follicular disorders

131

744

1.80

8.91

1.0

1.1

1.53

3.67

u/ml

1.07

105

Fracture of femur

273

1682

1.49

8.90

1.1

22.68

9.04

u/ml

—

132

All influenza

357

2542

1.42

8.89

1.1

10.03

5.99

u/ml

0.68

321

Persons encountering health services in other circumstances

640

4973

1.30

8.86

1.1

8.53

6.11

u/ml

0.31

685

Lactose intolerance

289

2.32

8.85

1.2

1.1

3.64

6.15

u/ml

0.42

Benign neoplasm: Sigmoid colon

212

1364

1.57

8.80

1.1

1.74

10.61

u/ml

2.85

123

Sudden idiopathic hearing loss

133

760

1.78

8.80

1.1

3.07

6.09

u/ml

—

Carbimazole or st.post thyroidectomy, condition for graves disease

340

2409

1.43

8.78

1.1

6.60

6.11

u/ml

0.06

308

Diseases of external ear

465

3464

1.35

8.77

1.1

13.65

7.70

u/ml

0.47

442

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

163

985

1.67

8.77

1.1

7.81

6.86

u/ml

0.06

117

Other and unspecified rosacea

138

799

1.76

8.77

1.1

13.95

5.21

u/ml

0.38

102

Other or unspecified ileus, impaction or obstruction

192

1207

1.60

8.76

1.1

1.02

10.63

u/ml

3.81

125

Fracture of rib(s), sternum and thoracic spine

343

2432

1.42

8.74

1.1

3.00

7.80

u/ml

2.54

267

Other inflammatory liver diseases

103

546

1.92

8.73

1.1

5.25

5.21

u/ml

—

Endometriosis ASRM stages 1,2

356

2551

1.41

8.66

1.1

3.26

5.44

u/ml

0.96

389

Redundant prepuce, phimosis and paraphimosis

254

1697

1.50

8.65

1.1

4.65

5.85

u/ml

0.33

271

Injuries to the thorax

575

4421

1.31

8.64

1.1

4.34

7.21

u/ml

1.42

569

Other skin changes

219

1427

1.55

8.62

1.1

1.59

8.15

u/ml

2.84

152

Anankastic personality disorder

425

2.06

8.62

1.0

1.1

2.59

4.44

u/ml

—

Other diseases of jaws

114

627

1.85

8.61

1.1

6.21

7.12

u/ml

0.09

Other disorders of eyelid

514

3760

1.33

8.60

1.1

1.84

9.39

u/ml

6.94

358

Hypertension, essential

1280

6092

1.20

8.58

1.1

7.91

5.32

u/ml

0.67

142

882

Adenomyosis (Endometriosis of uterus)

218

1422

1.55

8.58

1.1

5.87

6.64

u/ml

0.08

189

Other heart diseases, wide

1637

8665

1.18

8.56

1.1

7.04

5.13

u/ml

0.55

189

1249

Transient ischemic attack

580

3693

1.31

8.56

1.1

6.15

9.65

u/ml

0.65

319

Benign neoplasm: Caecum

123

693

1.80

8.55

1.1

5.82

6.84

u/ml

—

Dislocation, sprain and strain of joints and ligaments at neck level

271

1851

1.48

8.55

1.1

4.23

5.75

u/ml

0.28

276

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1226

0.49

8.52

1.1

38.90

9.75

u/ml

—

Unspecified/other endometriosis

206

1332

1.57

8.50

1.1

1.28

5.54

u/ml

2.66

222

Kyphosis

3.45

8.49

1.1

—

9.07

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

203

1307

1.58

8.48

1.1

4.76

6.26

u/ml

0.27

177

Hypertensive diseases (excluding secondary)

1006

4773

1.23

8.48

1.1

8.19

4.93

u/ml

0.74

119

776

Pain, not elsewhere classified

414

3047

1.37

8.47

1.1

7.94

6.98

u/ml

0.07

438

Cellulitis

308

2157

1.44

8.47

1.1

3.59

6.80

u/ml

1.28

288

Drug-induced osteoporosis with pathological fracture

112

3.18

8.44

1.0

1.1

—

9.14

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1941

9575

1.16

8.36

1.1

4.93

5.40

u/ml

0.22

241

1291

Cervicocranial syndrome

161

984

1.66

8.34

1.1

5.12

6.83

u/ml

0.17

138

Glomerular diseases

236

1575

1.51

8.32

1.1

17.68

6.31

u/ml

0.64

195

Disorders of lipoprotein metabolism and other lipidaemias

1106

5745

1.22

8.32

1.1

6.09

6.50

u/ml

0.09

724

Autoimmune hyperthyroidism

114

635

1.83

8.31

1.1

3.23

3.39

u/ml

—

Hyperkinetic disorders, excluding more controls

234

1520

1.52

8.30

1.1

3.41

3.79

u/ml

0.11

254

Lichen planus

179

1125

1.61

8.29

1.1

8.49

8.85

u/ml

0.03

106

Ulcerative proctitis

112

621

1.84

8.29

1.1

1.13

3.66

u/ml

—

Exclusions for E4_PCOS_BROAD

274

1887

1.47

8.26

1.1

4.72

7.20

u/ml

0.48

246

Dental caries 1

1262

5391

1.20

8.14

1.1

9.29

5.31

u/ml

0.97

129

768

Colonic or urogenital fistula

376

2745

1.38

8.13

1.1

3.02

7.02

u/ml

2.21

338

Secondary hypertension

111

610

1.83

8.13

1.2

1.1

8.64

7.21

u/ml

—

Dental caries, including avohilmo

1261

5389

1.20

8.12

1.1

9.29

5.31

u/ml

0.97

129

768

Skin changes due to chronic exposure to nonionizing radiation

364

2497

1.39

8.09

1.1

17.14

11.06

u/ml

0.37

138

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

128

744

1.75

8.08

1.1

10.11

3.42

u/ml

0.40

113

Persons encountering health services in other circumstances, wide

2124

9612

1.15

8.08

1.1

5.00

5.40

u/ml

0.19

253

1291

Complications of internal orthopaedic prosthetic devices, implants and grafts

249

1692

1.48

8.03

1.1

13.84

9.67

u/ml

0.25

147

Unspecified haematuria

449

2880

1.34

8.03

1.1

6.20

8.35

u/ml

0.38

309

Intestinal adhesions without obstruction

102

555

1.86

7.97

1.0

1.1

0.76

8.52

u/ml

—

Benign neoplasm: Caecum

123

709

1.76

7.95

1.1

5.82

7.82

u/ml

—

Other disorders of bone

317

2260

1.42

7.94

1.1

1.57

6.75

u/ml

4.17

317

Other/unspecified synovitis and tenosynovitis

170

1067

1.61

7.93

1.1

7.54

7.68

u/ml

0.01

141

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

489

3731

1.32

7.90

1.1

3.65

5.57

u/ml

0.78

576

Mucosal proctocolitis

209

1379

1.54

7.85

1.1

1.48

5.42

u/ml

3.15

222

Other reaction to severe stress, and adjustment disorders

687

5480

1.26

7.81

1.1

3.92

4.94

u/ml

0.42

883

Graves disease, strict definition

178

1136

1.59

7.80

1.1

4.61

4.53

u/ml

0.01

153

Trochanteric bursitis

187

1205

1.57

7.80

1.1

4.88

9.08

u/ml

0.70

140

Disorders of parathyroid gland

253

1713

1.47

7.80

1.1

27.75

8.92

u/ml

0.54

154

397

2765

1.36

7.76

1.1

14.31

9.85

u/ml

0.33

178

Dental caries 1, only avohilmo

1280

5504

1.19

7.75

1.1

9.15

5.34

u/ml

0.94

132

779

Other disorders of penis

109

611

1.81

7.74

1.1

7.30

7.15

u/ml

—

Rheumatoid arthritis

436

2977

1.34

7.73

1.1

3.52

7.70

u/ml

2.22

406

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

136

813

1.70

7.73

1.1

6.65

4.41

u/ml

—

Cholangitis (primary sclerosing, PSC)

448

1.95

7.72

1.2

1.1

5.81

7.11

u/ml

—

Other disorders of eye and adnexa

224

1507

1.51

7.68

1.1

4.36

6.33

u/ml

0.44

204

Disorders of muscles

147

898

1.66

7.67

1.1

22.68

5.79

u/ml

0.57

123

Appendectomy

1124

9085

1.20

7.67

1.1

6.68

5.05

u/ml

0.37

123

1326

Female genital prolapse

475

2069

1.34

7.65

1.1

11.96

6.12

u/ml

0.59

276

Senile cataract

731

3619

1.26

7.64

1.1

10.10

7.79

u/ml

0.41

389

Oxycodone

389

2788

1.36

7.60

1.1

6.82

8.93

u/ml

0.33

327

Hypertension

1330

6372

1.19

7.59

1.1

7.86

5.31

u/ml

0.68

147

929

Contraceptive management

742

4190

1.25

7.58

1.1

7.88

5.15

u/ml

0.48

681

Coxarthrosis [arthrosis of hip](FG)

637

3634

1.27

7.57

1.1

5.53

9.21

u/ml

1.31

438

Lichen planus, including avohilmo

239

1636

1.48

7.49

1.1

8.87

6.83

u/ml

0.21

162

Disorders of lens

839

4302

1.24

7.48

1.1

10.65

7.27

u/ml

0.74

517

Type of accident

420

3162

1.34

7.48

1.1

6.80

6.72

u/ml

0.01

415

Gonarthrosis [arthrosis of knee](FG)

1054

5155

1.21

7.47

1.1

4.58

7.08

u/ml

1.41

104

696

Congenital malformations, deformations and chromosomal abnormalities

1075

8634

1.20

7.44

1.1

4.83

5.21

u/ml

0.11

128

1293

Dental pulpitis 2, only avohilmo

1160

4968

1.20

7.44

1.1

8.80

5.58

u/ml

0.68

120

706

Infections with a predominantly sexual mode of transmission

600

4738

1.28

7.43

1.1

6.12

4.95

u/ml

0.16

737

Hypertensive diseases

1330

6387

1.18

7.41

1.1

7.86

5.30

u/ml

0.68

147

932

Hernia of abdominal wall

577

4535

1.28

7.41

1.1

11.50

6.44

u/ml

0.51

580

Stomatitis and related lesions

133

800

1.69

7.41

1.1

4.11

6.82

u/ml

0.43

118

Sequelae of external causes of morbidity and mortality

318

2298

1.40

7.37

1.1

6.46

8.30

u/ml

0.29

266

Personality disorders, excluding more controls

470

3604

1.32

7.37

1.1

3.52

4.93

u/ml

0.51

613

Neuralgia and neuritis, unspecified

435

1.95

7.36

1.1

1.57

4.68

u/ml

—

Crohn disease (strict definition, require KELA)

119

697

1.74

7.36

1.1

11.39

3.46

u/ml

0.42

107

Crushed, pushed or stepped on by crowd or human stampede

134

810

1.68

7.36

1.1

11.53

4.06

u/ml

0.99

121

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

755

3959

1.25

7.33

1.1

3.46

3.62

u/ml

0.04

682

Glaucoma

630

4391

1.27

7.30

1.1

4.83

9.05

u/ml

0.92

395

Direct fill therapy

212

1426

1.50

7.29

1.1

7.35

6.72

u/ml

0.07

194

Dental caries 3

1346

5845

1.18

7.27

1.1

8.97

5.16

u/ml

1.03

140

822

Bipolar affective disorders

334

2443

1.38

7.23

1.1

3.16

5.26

u/ml

0.93

397

Acne vulgaris

185

1214

1.55

7.23

1.1

5.50

4.18

u/ml

0.25

184

Dermatographic urticaria

125

746

1.71

7.23

1.1

9.24

3.98

u/ml

0.56

109

Gout

242

1519

1.46

7.22

1.1

12.38

10.26

u/ml

0.15

158

Other disorders of the musculoskeletal system and connective tissue

192

1268

1.53

7.20

1.1

13.26

8.16

u/ml

0.23

144

Dental pulpitis 2

1141

4898

1.20

7.19

1.1

9.06

5.57

u/ml

0.72

115

702

Other specified/unspecified bacterial intestinal infections

524

1.85

7.19

1.1

2.91

6.40

u/ml

—

Dermatitis herpetiformis

146

2.70

7.17

1.4

1.1

54.01

6.20

u/ml

—

Coxarthrosis

590

3146

1.28

7.16

1.1

4.73

8.36

u/ml

1.49

389

Acute appendicitis, no complications

942

7816

1.21

7.15

1.1

6.43

4.95

u/ml

0.29

105

1178

Brachial plexus disorders

160

1018

1.60

7.14

1.1

4.62

6.31

u/ml

0.21

169

Injuries to the hip and thigh

563

4051

1.28

7.14

1.1

11.10

8.02

u/ml

0.29

451

Fitting and adjustment of other devices

366

2524

1.36

7.13

1.1

10.37

9.94

u/ml

0.04

219

Missing teeth due to accident, extraction or parodontitis

146

908

1.63

7.12

1.1

4.55

7.52

u/ml

—

109

Hallux valgus (acquired)

480

2667

1.31

7.11

1.1

10.57

7.86

u/ml

0.19

357

Iron deficiency anaemia secondary to blood loss (chronic)

194

1287

1.52

7.11

1.1

7.02

7.72

u/ml

0.05

140

Tooth eruption problems

306

2194

1.40

7.09

1.1

4.32

4.26

u/ml

0.01

318

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1536

8090

1.16

7.08

1.1

7.96

5.85

u/ml

0.52

124

1129

Dental caries 3, only avohilmo

1365

5953

1.18

7.06

1.1

9.12

5.20

u/ml

1.08

141

832

Tinnitus

299

2156

1.40

7.05

1.1

3.86

7.66

u/ml

1.12

265

Nasal polyp

229

1574

1.47

7.04

1.1

2.01

9.03

u/ml

4.05

196

Ménière disease

128

773

1.68

7.04

1.1

5.60

6.77

u/ml

—

Other disorders of bladder

133

811

1.66

7.01

1.1

27.25

6.60

u/ml

0.48

Disorders of choroid and retina

1041

6353

1.20

6.98

1.1

12.54

6.44

u/ml

1.15

752

Palmar fascial fibromatosis [Dupuytren]

146

912

1.61

6.96

1.1

27.81

7.57

u/ml

—

Acute renal failure

208

1406

1.49

6.95

1.1

23.20

8.46

u/ml

—

130

Abnormal involuntary movements

186

1231

1.53

6.94

1.1

6.23

7.07

u/ml

0.10

150

Obesity and other hyperalimentation

1018

8467

1.20

6.93

1.1

3.60

5.57

u/ml

1.61

115

1217

Other general symptoms and signs

482

1.86

6.92

1.1

5.41

5.28

u/ml

0.01

Diseases of appendix

1236

9612

1.18

6.91

1.1

6.42

5.21

u/ml

0.30

142

1367

Diabetic nephropathy, excluding more controls

184

1009

1.54

6.91

1.1

24.41

3.76

u/ml

0.98

Obsessive-compulsive disorder

139

864

1.64

6.89

1.1

3.97

4.46

u/ml

0.10

151

Other respiratory diseases principally affecting the interstitium

181

1192

1.53

6.87

1.1

16.06

7.39

u/ml

0.62

Phobic anxiety disorders

262

1858

1.43

6.86

1.2

1.1

11.71

5.62

u/ml

0.51

307

Anomalies of dental arch relationship, including avohilmo

353

2356

1.36

6.85

1.1

3.27

5.76

u/ml

1.28

317

Disorders of mineral metabolism

110

643

1.74

6.84

1.1

4.27

5.93

u/ml

—

Crohn disease (strict definition, require KELA, min 2 HDR)

115

682

1.72

6.83

1.1

11.39

3.62

u/ml

0.41

101

Other inflammation of eyelid

187

1244

1.52

6.82

1.1

2.78

7.79

u/ml

1.35

146

Injury, poisoning and certain other consequences of external causes

1083

4553

1.20

6.80

1.1

6.34

5.09

u/ml

0.31

143

699

Sequelae with surgical and medical care as external cause

247

1735

1.44

6.79

1.1

7.76

8.18

u/ml

0.04

178

Seborrhoeic dermatitis

125

758

1.67

6.77

1.1

19.37

4.02

u/ml

0.40

Moderate visual impairment, binocular

186

2.42

6.77

1.1

—

15.01

—

Crowding of teeth, including avohilmo

207

1158

1.50

6.77

1.1

1.58

6.81

u/ml

2.50

156

Artrosis, including avohilmo

1341

6297

1.17

6.74

1.1

5.11

5.68

u/ml

0.19

159

885

Other obstetric conditions, not elsewhere classified

761

4037

1.23

6.72

1.1

3.55

3.99

u/ml

0.12

695

Lichen simplex chronicus

264

2.17

6.69

1.1

11.04

4.10

u/ml

—

Inflammatory disease of uterus

273

1963

1.41

6.64

1.1

5.28

5.86

u/ml

0.09

304

Appendicitis, broad definition

1224

9579

1.17

6.63

1.1

6.46

5.21

u/ml

0.31

141

1365

Viral infections characterized by skin and mucous membrane lesions

608

4879

1.25

6.58

1.1

6.58

6.35

u/ml

0.05

671

Primary gonarthrosis, bilateral

567

3943

1.26

6.57

1.1

3.85

9.25

u/ml

2.37

388

Deficiency of other B group vitamins

159

2.53

6.53

1.1

13.27

6.42

u/ml

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

281

3383

0.73

6.53

1.1

4.46

8.73

u/ml

1.69

332

Diabetes mellitus

1733

9062

1.14

6.43

1.1

6.65

5.48

u/ml

0.32

154

1315

Diabetes medication

1711

9107

1.15

6.42

1.1

6.70

5.51

u/ml

0.32

150

1304

Covid-19 confirmed case

402

3078

1.32

6.42

1.1

3.56

6.87

u/ml

1.32

393

Enlarged lymph nodes

220

1530

1.45

6.42

1.1

2.92

7.69

u/ml

1.94

201

Fracture of shoulder and upper arm

472

3689

1.29

6.40

1.1

4.42

7.70

u/ml

1.51

442

Obesity

1008

8450

1.19

6.37

1.1

3.60

5.56

u/ml

1.60

115

1216

Diabetes, insulin treatment (Kela reimbursement)

1575

8396

1.15

6.35

1.1

7.81

5.79

u/ml

0.50

127

1159

Acute appendicitis

1150

9281

1.17

6.33

1.1

6.60

5.12

u/ml

0.36

134

1345

Excessive attrition of teeth

725

3206

1.24

6.33

1.1

2.40

5.49

u/ml

3.29

432

Disorders of continuity of bone

149

961

1.57

6.32

1.1

15.80

4.26

u/ml

0.71

134

Trigger finger

189

1282

1.49

6.29

1.1

2.60

7.95

u/ml

1.73

167

Adverse effects, not elsewhere classified

323

2407

1.35

6.28

1.1

4.31

6.29

u/ml

0.62

331

Spondyloarthritis

252

1803

1.41

6.27

1.1

4.76

7.23

u/ml

0.46

258

Injuries to the elbow and forearm

1104

8511

1.18

6.27

1.1

9.27

5.63

u/ml

0.94

118

1110

Abnormal results of function studies

124

767

1.64

6.27

1.1

2.38

5.02

u/ml

—

Vitreous haemorrhage

124

767

1.64

6.25

1.2

1.1

37.66

5.73

u/ml

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

439

1.86

6.23

1.2

1.1

5.99

4.58

u/ml

—

Bleeding

1096

6786

1.18

6.20

1.1

7.19

6.63

u/ml

0.08

826

Other and unspecified follicular disorders

348

1.97

6.19

1.1

2.04

5.45

u/ml

0.73

Asthma-related pneumonia

436

3387

1.29

6.17

1.1

13.05

7.74

u/ml

0.49

400

Benign neoplasm of other and unspecified endocrine glands

171

1142

1.51

6.17

1.1

13.59

5.68

u/ml

0.51

125

Chronic periodontitis

171

1141

1.51

6.17

1.1

7.93

6.61

u/ml

0.16

138

ILD, hospital admissions 1, main diag only

138

879

1.59

6.15

1.1

21.67

9.40

u/ml

—

Orchitis and epididymitis

542

1.75

6.14

1.1

6.54

7.38

u/ml

—

Disorders of refraction and accommodation

447

3482

1.29

6.13

1.1

10.18

6.34

u/ml

0.41

489

Colectomy operation

193

1323

1.47

6.10

1.1

15.79

8.50

u/ml

0.30

129

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

315

2349

1.35

6.08

1.1

3.04

7.47

u/ml

1.75

325

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

483

3987

0.79

6.05

1.1

3.95

6.57

u/ml

1.21

484

Diplopia

170

1139

1.51

6.04

1.1

6.76

6.81

u/ml

0.00

136

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

483

3986

0.79

6.04

1.1

3.95

6.57

u/ml

1.21

484

Intracranial injury

854

6915

1.20

6.04

1.1

5.87

6.33

u/ml

0.11

916

Glucosamine medication

539

3431

1.26

6.04

1.1

4.93

10.70

u/ml

2.11

262

Other and unspecified visual disturbances

135

861

1.59

6.03

1.1

6.60

5.28

u/ml

0.23

109

Diabetes, varying definitions

1714

9010

1.14

6.02

1.1

6.62

5.52

u/ml

0.29

155

1297

Actinic keratosis

335

2393

1.34

6.01

1.1

17.14

11.19

u/ml

0.36

123

Benign paroxysmal vertigo

354

2690

1.33

6.01

1.1

9.04

8.38

u/ml

0.07

301

Polyp of the female genital tract

525

2419

1.27

6.01

1.1

4.01

5.95

u/ml

0.55

340

Asthma, hospital admissions 3, pneumonia

436

3401

1.29

5.99

1.1

13.05

7.73

u/ml

0.49

401

Asthma-related pneumonia or sepsis

436

3401

1.29

5.99

1.1

13.05

7.73

u/ml

0.49

401

6-mercaptopurine

319

1.99

5.92

1.2

1.1

23.42

5.11

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

180

1227

1.48

5.89

1.1

12.28

7.47

u/ml

0.38

151

ILD, hospital admission 2, with pulmonary infections

587

1.71

5.89

1.2

1.1

29.51

9.21

u/ml

—

Infective dermatitis

151

993

1.54

5.87

1.1

1.88

4.93

u/ml

—

122

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

180

1228

1.48

5.87

1.1

12.28

6.48

u/ml

0.48

144

Other CVD (FINNGEN)

123

602

1.62

5.85

1.1

6.72

10.68

u/ml

—

Benign neoplasm of other and unspecified endocrine glands

171

1156

1.50

5.84

1.1

13.59

4.92

u/ml

0.57

124

Supplementary factors related to causes of morbidity and mortality classified elsewhere

444

3491

1.28

5.83

1.1

6.80

6.40

u/ml

0.06

467

Specific personality disorders

422

3300

1.29

5.82

1.1

3.47

5.29

u/ml

0.72

514

Seronegative rheumatoid arthritis

153

1011

1.53

5.82

1.1

3.96

8.82

u/ml

—

119

Osteomyelitis

456

1.80

5.81

1.1

3.58

6.08

u/ml

—

Other/unspecified enthesopathies, not elsewhere classified

115

712

1.63

5.81

1.1

3.56

8.82

u/ml

—

Memory loss

102

613

1.68

5.78

1.2

1.1

5.92

11.08

u/ml

0.46

Anorexia (incl.atypical)

130

832

1.59

5.77

1.1

4.56

5.13

u/ml

0.11

126

Thyroiditis

116

723

1.63

5.75

1.1

0.81

4.66

u/ml

2.24

Correction of physiology of bite - demanding therapy visit

125

794

1.60

5.74

1.1

2.74

4.06

u/ml

—

117

Certain disorders involving the immune mechanism

256

1868

1.38

5.73

1.1

9.39

7.33

u/ml

0.20

232

Spondylopathies (FG)

213

1508

1.43

5.71

1.1

3.38

7.29

u/ml

1.25

240

Other ulcerative colitis

564

1.71

5.69

1.1

0.65

3.87

u/ml

—

Hydrocele

105

639

1.66

5.65

1.1

6.29

8.29

u/ml

—

Sulfasalazine

414

3241

1.29

5.64

1.1

3.21

5.52

u/ml

1.03

491

Postmenopausal atrophic vaginitis

348

1587

1.33

5.63

1.1

4.61

8.34

u/ml

0.91

182

Diabetic neuropathy

121

760

1.60

5.63

1.1

52.90

5.93

u/ml

—

Persistent mood disorders

286

2132

1.35

5.59

1.1

5.65

7.26

u/ml

0.29

276

Hyperkinetic disorders

235

1681

1.40

5.56

1.1

3.41

4.30

u/ml

0.27

260

Other (seronegative) rheumatoid arthritis, wide

244

1776

1.39

5.55

1.1

4.16

7.70

u/ml

1.07

186

Other bursopathies

153

1022

1.51

5.54

1.1

2.34

8.03

u/ml

1.72

115

Varicose veins

817

5182

1.20

5.54

1.1

6.76

7.88

u/ml

0.24

587

Type 2 diabetes, wide definition

1059

5910

1.17

5.54

1.1

6.20

6.70

u/ml

0.12

765

ILD, hospital admissions

148

984

1.52

5.48

1.1

19.79

8.65

u/ml

0.65

Chondropathies

235

1705

1.39

5.48

1.1

1.72

5.51

u/ml

2.81

239

Other and unspecified effects of external causes

450

3575

1.27

5.47

1.1

5.69

5.61

u/ml

0.02

510

Benign lipomatous neoplasm

369

2859

1.30

5.47

1.1

6.04

7.65

u/ml

0.26

339

Other predominantly sexually transmitted diseases, not elsewhere classified

332

2540

1.32

5.47

1.1

4.30

4.99

u/ml

0.17

405

Endometriosis of ovary

292

2187

1.34

5.46

1.1

2.82

5.57

u/ml

1.52

323

Injuries to the wrist and hand

1654

10615

1.13

5.45

1.1

4.70

5.48

u/ml

0.39

182

1458

Hypo-osmolality and hyponatraemia

180

1242

1.46

5.44

1.1

4.93

11.64

u/ml

—

112

Trigeminal neuralgia

488

1.75

5.44

1.1

9.78

5.62

u/ml

—

Cutis laxa senilis

3.35

5.44

1.2

1.1

—

10.65

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

310

2354

1.33

5.40

1.1

10.77

5.50

u/ml

0.34

344

Disorders of sclera, cornea, iris and ciliary body

797

6718

1.19

5.38

1.1

3.62

6.32

u/ml

2.12

912

Ocular pain

129

839

1.56

5.36

1.1

4.99

4.14

u/ml

—

122

Cluster headache, wide

359

1.88

5.35

1.0

1.1

2.14

4.05

u/ml

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

129

839

1.56

5.34

1.1

2.82

5.01

u/ml

0.93

135

Malignant neoplasm of breast

509

4539

0.80

5.34

1.1

3.84

6.98

u/ml

1.54

517

Car occupant injured in other and unspecified transport accidents

303

2297

1.33

5.32

1.1

3.54

5.87

u/ml

0.70

333

Cardiovascular diseases (excluding rheumatic etc)

1352

6824

1.15

5.31

1.1

6.73

4.70

u/ml

0.70

178

1106

Benzodiazepine use

1610

10146

1.13

5.30

1.1

3.02

5.55

u/ml

3.58

148

1410

Struck by thrown, projected or falling objec

433

1.79

5.30

1.1

4.85

5.14

u/ml

—

Diabetic retinopathy

367

1788

1.30

5.27

1.1

22.32

4.29

u/ml

1.18

144

Postmenopausal bleeding

363

1532

1.31

5.27

1.1

5.22

8.21

u/ml

0.66

174

Other and unspecified injuries of wrist and hand

383

1.84

5.27

1.1

2.76

5.64

u/ml

—

Other complications of surgical and medical care, not elsewhere classified

142

946

1.52

5.27

1.1

0.64

5.02

u/ml

—

119

Injuries to the shoulder and upper arm

1208

8817

1.15

5.26

1.1

4.73

6.09

u/ml

0.79

127

1115

Other interstitial pulmonary diseases

148

994

1.50

5.24

1.1

19.79

8.54

u/ml

0.66

Interstitial lung disease

148

994

1.50

5.24

1.1

19.79

8.54

u/ml

0.66

Interstitial lung disease endpoints

148

994

1.50

5.24

1.1

19.79

8.54

u/ml

0.66

Mental disorders, not otherwise specified

150

1013

1.50

5.23

1.1

6.06

4.27

u/ml

0.40

161

Otitis externa

310

2365

1.32

5.20

1.1

17.42

7.10

u/ml

0.66

309

218

1578

1.40

5.19

1.1

6.11

5.43

u/ml

0.10

224

Other contact dermatitis

123

797

1.56

5.19

1.1

1.52

3.95

u/ml

—

115

Other noninflammatory disorders of vulva and perineum

156

1064

1.48

5.17

1.1

10.36

7.24

u/ml

0.22

154

Premenstrual syndrome

128

2.53

5.17

1.1

3.38

4.34

u/ml

—

Abrasion of teeth

435

2538

1.27

5.16

1.1

6.29

5.99

u/ml

0.03

327

Ankylosing hyperostosis [Forestier]

2.93

5.16

1.0

1.1

—

8.40

—

Radial styloid tenosynovitis [de Quervain]

557

1.68

5.16

1.0

1.1

13.56

5.21

u/ml

—

Fracture of lower leg, including ankle

785

6607

1.19

5.15

1.1

7.58

6.00

u/ml

0.29

863

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

300

3183

0.76

5.14

1.1

1.81

7.82

u/ml

5.06

362

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1427

8180

1.14

5.11

1.1

4.76

5.78

u/ml

0.47

153

1075

Recurrent dislocation and subluxation of joint

115

737

1.58

5.10

1.1

2.45

4.48

u/ml

0.88

122

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

814

4359

1.19

5.10

1.1

4.49

5.04

u/ml

0.18

101

694

Embedded teeth, including avohilmo

187

1326

1.43

5.07

1.1

4.78

4.32

u/ml

0.08

200

Unspecified acute lower respiratory infection

197

1408

1.41

5.05

1.1

3.82

6.57

u/ml

0.68

204

Elevated blood glucose level

109

692

1.59

5.04

1.1

13.91

4.79

u/ml

—

Scoliosis

142

956

1.50

5.03

1.1

4.59

5.24

u/ml

0.09

140

Other noninflammatory disorders of uterus, except cervix

298

1539

1.33

5.02

1.1

6.31

8.08

u/ml

0.23

180

Other strabismus

357

2784

1.29

4.99

1.1

2.48

7.18

u/ml

3.31

383

Immunodeficiencies

449

1.75

4.98

1.2

1.1

22.89

5.83

u/ml

—

Other hammer toe(s) (acquired)

196

1313

1.41

4.98

1.1

26.76

9.25

u/ml

0.47

124

Other necrotizing vasculopathies (FG)

426

1.76

4.98

1.1

0.78

8.70

u/ml

—

Malignant neoplasm of breast, HER2-negative

492

4445

0.81

4.95

1.1

3.89

7.22

u/ml

1.61

498

Bruxism

208

2.14

4.95

1.1

2.62

6.38

u/ml

—

Endometriosis diagnosis and infertility diagnosis occurring together

203

1467

1.40

4.94

1.1

2.21

5.32

u/ml

1.95

245

Haemangioma, any site

119

775

1.56

4.94

1.1

5.00

4.64

u/ml

0.03

103

Nonsuppurative otitis media

445

3086

1.26

4.93

1.1

7.18

4.13

u/ml

0.66

430

Hypermetropia

112

720

1.58

4.93

1.1

4.60

8.81

u/ml

—

Other and unspecified injuries of lower leg

120

784

1.55

4.92

1.1

2.94

4.55

u/ml

0.47

108

STROKE

765

4477

1.19

4.92

1.1

6.23

6.76

u/ml

0.11

585

Benign neoplasm: Adrenal gland

549

1.66

4.91

1.1

18.21

3.94

u/ml

0.54

Other acute lower respiratory infections

761

6147

1.19

4.90

1.1

4.55

6.24

u/ml

0.73

796

Maternal care for known or suspected abnormality of pelvic organs

514

2885

1.24

4.89

1.1

4.81

3.70

u/ml

0.33

521

Fall on and from stairs and steps

331

2572

1.30

4.87

1.1

13.51

7.02

u/ml

0.52

312

Impotence

298

1.90

4.86

1.1

5.50

8.25

u/ml

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

294

1560

1.32

4.86

1.1

19.16

8.04

u/ml

0.48

210

Lactose intolerance, other/unspecified

264

1.98

4.85

1.2

1.1

3.96

6.42

u/ml

—

Dental caries 2 and operation codes, only avohilmo

1280

6971

1.14

4.85

1.1

3.19

5.98

u/ml

3.03

161

859

Congenital malformations of genital organs

180

1271

1.43

4.84

1.1

3.82

5.21

u/ml

0.45

203

Vulvovaginal ulceration/inflammation in other diseases

114

741

1.57

4.82

1.1

2.26

4.81

u/ml

0.80

123

Polymyalgia rheumatica

127

843

1.52

4.80

1.1

9.03

10.35

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

258

1944

1.34

4.77

1.1

2.00

6.22

u/ml

3.14

234

Varicose veins of other sites

538

1.66

4.77

1.1

5.04

5.50

u/ml

0.04

Herpesviral [herpes simplex] infections

172

1215

1.43

4.76

1.0

1.1

5.29

4.33

u/ml

0.14

161

Childhood asthma (age<16)

293

1778

1.32

4.75

1.1

4.11

4.77

u/ml

0.12

317

Ulcer of lower limb, not elsewhere classified

136

918

1.49

4.74

1.1

35.30

6.62

u/ml

—

Bicipital tendinitis

366

1.80

4.74

1.1

1.07

3.53

u/ml

—

Monoamine oxidase A inhibitors

150

1033

1.47

4.74

1.1

1.03

8.73

u/ml

2.45

115

Phlebitis and thrombophlebitis (not including DVT)

274

2084

1.32

4.73

1.1

2.87

8.88

u/ml

2.11

253

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1519

9177

1.13

4.72

1.1

8.12

5.28

u/ml

0.87

155

1251

Childhood asthma (age<16), excluding more controls

293

1780

1.32

4.70

1.1

4.11

4.70

u/ml

0.10

317

Fracture of forearm

809

6475

1.17

4.66

1.1

11.46

6.15

u/ml

0.97

811

Diabetic retinopathy, excluding more controls

318

1378

1.31

4.66

1.1

20.12

3.63

u/ml

0.94

116

Other and unspecified tonsillitis

631

4477

1.20

4.65

1.1

3.14

4.62

u/ml

1.13

762

Other abnormal immunological findings in serum

193

2.14

4.65

1.2

1.1

11.26

5.72

u/ml

—

237

1564

1.35

4.63

1.1

26.33

12.13

u/ml

—

Other menopausal disorders

416

1911

1.26

4.62

1.1

2.42

6.52

u/ml

2.41

265

Other specified/unspecified inflammatory spondylopathies

490

1.68

4.60

1.1

4.58

4.79

u/ml

—

Stenosis and insufficiency of lacrimal passages

125

837

1.51

4.58

1.2

1.1

1.56

7.06

u/ml

2.09

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

485

3969

1.23

4.58

1.1

3.01

4.89

u/ml

0.89

664

Alopecia areata

270

1.94

4.57

1.2

1.1

12.58

6.05

u/ml

—

Haemangioma and lymphangioma, any site

128

862

1.50

4.57

1.0

1.1

5.00

4.43

u/ml

0.05

114

Social phobias

159

1118

1.44

4.56

1.1

3.95

4.25

u/ml

0.05

190

Other septicaemia

391

3066

1.26

4.56

1.1

17.93

7.70

u/ml

0.48

336

Nail disorders

118

782

1.53

4.55

1.1

3.04

4.83

u/ml

—

108

therapeutic use

194

2.10

4.55

1.2

1.1

6.53

6.00

u/ml

—

Gout, FINNGEN

242

1818

1.34

4.55

1.1

12.38

9.54

u/ml

0.21

154

Adhesive capsulitis of shoulder

197

1435

1.38

4.55

1.1

5.07

8.44

u/ml

0.52

181

Cluster headache, strict

335

1.83

4.54

1.1

2.38

4.25

u/ml

—

Abnormal blood-pressure reading, without diagnosis

379

1.77

4.53

1.1

5.32

6.62

u/ml

—

Lung cancer and mesothelioma

1043

0.60

4.53

1.1

38.90

13.09

u/ml

—

Other problems related to primary support group, including family circumstances

217

1569

1.36

4.50

1.1

8.86

5.82

u/ml

0.51

240

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.14

4.49

1.1

—

10.79

—

Vasomotor rhinitis (mode)

103

665

1.57

4.48

1.0

1.1

3.95

4.60

u/ml

0.07

D07AA Corticosteroids, weak (group I)

256

1945

1.33

4.48

1.1

8.35

5.10

u/ml

0.31

268

Other abnormal auditory perceptions

100

2.60

4.47

1.0

1.1

1.55

12.29

u/ml

—

Azathioprine

224

1671

1.35

4.47

1.1

6.44

5.68

u/ml

0.09

253

Melanocytic naevi

436

3542

1.24

4.44

1.1

5.74

5.97

u/ml

0.04

492

Calcific aortic valvular stenosis, including rheumatic fever

240

1767

1.33

4.44

1.1

18.69

10.28

u/ml

0.32

101

Calcific aortic valvular stenosis, diagnosis (helper)

239

1761

1.33

4.42

1.1

18.69

10.28

u/ml

0.32

101

Operations 2 for CAVS

239

1761

1.33

4.42

1.1

18.69

10.28

u/ml

0.32

101

Benign lipomatous neoplasm

369

2943

1.26

4.42

1.1

6.04

7.87

u/ml

0.31

350

Family history of malignant neoplasm

171

1225

1.41

4.42

1.1

3.03

6.28

u/ml

0.87

168

Pedal cyclist injured in transport accident

320

2511

1.28

4.41

1.1

4.39

6.39

u/ml

0.42

348

ILD medications: azathioprine

224

1675

1.35

4.40

1.1

6.44

6.11

u/ml

0.04

256

Other abnormal uterine and vaginal bleeding

343

1926

1.28

4.40

1.1

5.34

7.06

u/ml

0.20

251

Acute pancreatitis

211

1563

1.36

4.39

1.1

6.22

8.17

u/ml

0.24

183

Opening and dilatation of root channel of tooth

103

669

1.56

4.39

1.1

9.82

3.66

u/ml

0.69

101

Superficial injury of lower leg

362

2885

1.26

4.38

1.1

5.97

5.24

u/ml

0.14

389

Medical treatment for female infertility

433

3516

1.24

4.38

1.1

1.66

4.76

u/ml

4.42

608

Special screening examination for neoplasms

245

1.94

4.37

1.1

1.04

6.08

u/ml

—

Benign neoplasm: Descending colon

413

1.72

4.36

1.1

0.92

5.47

u/ml

—

Septicaemia

442

3461

1.23

4.35

1.1

17.05

7.56

u/ml

0.53

381

Disturbance of activity and attention

216

1592

1.36

4.33

1.1

2.99

4.19

u/ml

0.39

249

Suppurative and unspecified otitis media

676

5080

1.19

4.33

1.1

8.32

4.83

u/ml

0.59

738

Any event in cancer register

1255

8408

0.88

4.33

1.1

3.64

5.68

u/ml

1.49

179

1137

Coxarthrosis, primary

614

4476

1.19

4.33

1.1

5.05

9.43

u/ml

1.64

401

Agoraphobia

378

1.76

4.32

1.2

1.1

9.15

5.01

u/ml

—

Bulimia nervosa (incl. atypical)

508

1.65

4.32

1.1

3.32

4.58

u/ml

0.29

Meniscus derangement

745

4343

1.18

4.31

1.1

3.17

6.37

u/ml

2.27

604

Statin medication

1194

5892

1.14

4.31

1.1

7.73

5.28

u/ml

0.52

145

888

Disturbances of smell and taste

326

1.81

4.30

1.0

1.1

6.17

5.70

u/ml

—

Heart failure and antihypertensive medication

274

1386

1.31

4.28

1.2

1.1

22.78

9.45

u/ml

0.62

181

Calcific aortic valvular stenosis, operated

239

1771

1.33

4.27

1.1

18.69

10.27

u/ml

0.32

102

Calcific aortic valvular stenosis

239

1771

1.33

4.27

1.1

18.69

10.27

u/ml

0.32

102

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

527

4334

1.21

4.27

1.1

6.27

5.02

u/ml

0.34

652

Spontaneous abortion

845

4955

1.17

4.25

1.1

4.96

4.79

u/ml

0.04

731

Dental pulpitis 1

1906

8954

1.11

4.24

1.1

7.37

5.39

u/ml

0.52

178

1263

Rheumatoid arthritis, including avohilmo

491

4058

1.22

4.22

1.1

3.01

7.76

u/ml

3.11

472

Otalgia

117

788

1.50

4.22

1.1

7.42

5.08

u/ml

—

107

Dental pulpitis 4

1905

8950

1.11

4.21

1.1

7.37

5.39

u/ml

0.52

178

1263

Gluteal tendinitis

307

1.82

4.19

1.2

1.1

0.58

4.70

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

1903

8945

1.11

4.18

1.1

7.43

5.39

u/ml

0.54

176

1263

Cyst of kidney

449

1.67

4.17

1.1

2.57

8.13

u/ml

—

Cluster headache, wide,, including avohilmo

535

1.61

4.17

1.0

1.1

1.96

4.15

u/ml

0.74

Polycystic ovarian syndrome, broad definition

243

1858

1.32

4.17

1.1

1.55

4.23

u/ml

2.97

309

Atrial fibrillation and flutter with reimbursement

310

1552

1.29

4.17

1.1

9.28

8.36

u/ml

0.09

202

Allergic urticaria

135

938

1.46

4.16

1.1

2.02

5.13

u/ml

1.33

134

Personality disorders

470

3878

1.22

4.15

1.1

3.52

5.33

u/ml

0.69

601

Other and unspecified disorders of vitreous body

447

3647

1.22

4.15

1.1

6.05

8.88

u/ml

0.64

354

Psoriasis vulgaris

235

1786

1.33

4.15

1.1

2.57

6.84

u/ml

2.04

225

Melanocytic naevi

436

3574

1.23

4.11

1.1

5.74

6.77

u/ml

0.19

497

Explicit Sepsis

490

3890

1.21

4.11

1.1

12.54

7.31

u/ml

0.37

460

Other necrotizing vasculopathies

513

1.62

4.11

1.1

0.85

5.94

u/ml

—

Gonarthrosis,primary

1109

6136

1.14

4.10

1.1

6.06

7.27

u/ml

0.31

103

721

Psoriasis

370

2981

1.25

4.10

1.1

2.43

7.09

u/ml

3.43

400

Mandibular retrognathia

125

857

1.48

4.09

1.0

1.1

9.07

4.32

u/ml

0.43

123

Acute pharyngitis

245

1866

1.31

4.07

1.1

4.36

5.82

u/ml

0.47

311

Spirochaetal infections, other/unspecified

105

697

1.52

4.06

1.1

4.23

5.05

u/ml

—

Strabismus

402

3266

1.24

4.06

1.1

2.41

6.99

u/ml

3.80

441

Disorders of adult personality and behaviour

498

4143

1.21

4.05

1.1

3.31

5.25

u/ml

0.85

642

Zoster [herpes zoster]

200

1491

1.35

4.04

1.1

5.01

7.48

u/ml

0.48

151

Haemangioma and lymphangioma, any site

128

886

1.46

4.03

1.0

1.1

5.00

5.69

u/ml

0.06

116

Maternal care related to the fetus and amniotic cavity and possible delivery problems

873

4454

1.16

4.03

1.1

6.40

4.51

u/ml

0.52

113

744

Lesion of plantar nerve

524

1.61

4.02

1.1

4.25

5.92

u/ml

—

Malignant neoplasm of breast, HER-positive

297

3697

0.79

4.01

1.1

1.81

8.60

u/ml

5.75

384

Dental pulpitis 4, only avohilmo

1926

9127

1.10

4.00

1.1

7.20

5.40

u/ml

0.47

181

1270

Maternal care for other conditions predominantly related to pregnancy

414

3343

1.23

4.00

1.1

6.01

4.24

u/ml

0.28

584

Endometriosis ASRM stages 3,4

383

3109

1.24

4.00

1.1

4.06

5.76

u/ml

0.44

434

Other diseases of peritoneum

379

1.72

3.99

1.1

1.13

4.55

u/ml

—

Superficial injury of shoulder and upper arm

151

1079

1.41

3.98

1.1

2.28

5.91

u/ml

1.44

140

Dental pulpitis 1, only avohilmo

1929

9146

1.10

3.98

1.1

7.76

5.40

u/ml

0.67

186

1271

Non-small cell lung cancer, squamous, helper endpoint

208

0.24

3.97

1.0

1.1

—

17.23

—

Non-small cell lung cancer, squamous

208

0.24

3.97

1.0

1.1

—

17.23

—

Benign neoplasm: Adrenal gland

581

1.57

3.97

1.1

18.21

5.17

u/ml

0.48

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1457

8185

1.12

3.96

1.1

7.84

4.88

u/ml

0.98

139

1147

1457

8185

1.12

3.96

1.1

7.84

4.88

u/ml

0.98

139

1147

Polyhydramnios

639

1.55

3.95

1.1

1.53

3.81

u/ml

—

129

Other disorders of Eustachian tube

255

1.88

3.95

1.1

4.38

4.22

u/ml

—

Haemangioma, any site

119

816

1.48

3.95

1.1

5.00

5.84

u/ml

0.08

106

DVT of lower extremities

207

1557

1.34

3.94

1.1

5.66

8.89

u/ml

0.71

170

Idiopathic pulmonary fibrosis

410

1.68

3.94

1.1

22.80

14.92

u/ml

—

Medical abortion

1173

5641

1.13

3.93

1.1

6.76

4.89

u/ml

0.45

145

773

Umbilical hernia

315

2505

1.26

3.92

1.1

9.25

6.83

u/ml

0.28

330

Atrial fibrillation and flutter

428

2284

1.23

3.91

1.1

6.25

6.95

u/ml

0.11

335

Angina pectoris

638

3657

1.18

3.90

1.1

15.21

8.86

u/ml

0.54

342

Unspecified kidney failure

583

1.56

3.89

1.1

16.75

10.95

u/ml

—

Valvular heart disease excluding rheumatic fever

520

3173

1.20

3.87

1.1

9.84

7.78

u/ml

0.25

351

Other viral diseases

482

4005

1.21

3.87

1.1

7.29

5.69

u/ml

0.22

587

Non-rheumatic valve diseases

516

3144

1.20

3.86

1.1

9.84

7.63

u/ml

0.27

346

Other noninflammatory disorders of vagina

123

853

1.46

3.86

1.1

1.35

7.96

u/ml

2.15

124

Sacroiliitis, not elsewhere classified

515

1.60

3.84

1.1

2.24

3.53

u/ml

—

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

204

0.24

3.83

1.0

1.1

—

21.87

—

Acute lymphadenitis

651

1.53

3.82

1.1

9.20

4.04

u/ml

0.94

Causalgia

147

2.17

3.81

1.1

—

8.67

—

Malignant neoplasm

1129

7546

0.88

3.80

1.1

5.10

5.89

u/ml

0.21

162

984

Alcoholic liver disease

643

1.52

3.79

1.1

9.22

8.11

u/ml

—

Diabetes mellitus in pregnancy

697

3878

1.17

3.78

1.1

4.88

3.73

u/ml

0.19

694

169

1173

1.37

3.77

1.1

34.95

14.88

u/ml

—

Conduction disorders

293

1926

1.27

3.74

1.1

3.31

8.11

u/ml

1.88

190

AV-block

150

980

1.40

3.74

1.1

4.88

7.02

u/ml

—

Cutaneous abscess, furuncle and carbuncle

350

2835

1.24

3.74

1.1

9.63

6.21

u/ml

0.23

411

Duodenal ulcer

573

1.55

3.72

1.1

7.70

7.21

u/ml

—

Other diseases of blood and blood-forming organs, wide

269

2115

1.28

3.72

1.1

12.90

7.65

u/ml

0.35

244

Idiopathic urticaria

225

1.92

3.71

1.3

1.1

2.10

6.50

u/ml

—

Deep bite

190

1246

1.35

3.71

1.1

11.28

4.93

u/ml

0.42

156

Dermatitis due to substances taken internally

497

1.59

3.67

1.1

2.04

4.11

u/ml

—

Sacrococcygeal disorders, not elsewhere classified

276

1.81

3.67

1.1

0.99

5.67

u/ml

—

Care involving dialysis

576

1.54

3.67

1.1

54.84

7.21

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

373

3049

1.23

3.65

1.1

5.17

8.13

u/ml

0.86

369

Acute bronchitis

528

4369

1.19

3.64

1.1

4.63

6.91

u/ml

0.81

567

Early onset COPD, excluding more controls

210

1603

1.32

3.62

1.1

16.99

7.57

u/ml

0.29

205

Amenorrhoea

143

1033

1.40

3.62

1.1

1.74

6.89

u/ml

2.28

169

Other fall from one level to another

307

2460

1.25

3.62

1.1

5.63

5.80

u/ml

0.03

321

Thyroid crisis or storm

5.76

3.61

1.0

1.1

—

16.52

—

Generalized epilepsy

500

1.59

3.61

1.1

2.17

4.73

u/ml

0.75

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

653

5614

1.17

3.58

1.1

4.33

5.42

u/ml

0.43

849

Other specified/unspecified soft tissue disorders

391

1.66

3.58

1.0

1.1

1.05

5.71

u/ml

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

438

1.62

3.57

1.1

2.74

6.79

u/ml

—

Benign neoplasm: Descending colon

438

1.62

3.55

1.1

0.92

8.03

u/ml

—

Colorectal cancer

212

1626

1.31

3.55

1.1

5.31

11.28

u/ml

0.94

128

Covid-19 suspected case

219

2820

0.77

3.55

1.0

1.1

2.16

5.62

u/ml

3.04

416

Diseases of the myoneural junction and muscle

134

959

1.41

3.55

1.1

3.54

7.25

u/ml

—

104

Scleritis and episcleritis

614

1.52

3.54

1.1

1.42

4.57

u/ml

1.54

Hypertrophy of breast in women and men

305

2453

1.25

3.52

1.1

3.64

6.44

u/ml

1.00

347

Hypotension

142

1027

1.39

3.51

1.1

6.72

9.86

u/ml

—

Convulsions, not elsewhere classified

325

2597

1.24

3.51

1.1

4.11

7.58

u/ml

0.99

356

Other disorders of adrenal gland

417

1.63

3.51

1.1

2.62

6.59

u/ml

—

Cardiac murmurs and other cardiac sounds

146

1051

1.39

3.49

1.1

20.35

7.09

u/ml

0.51

134

Ankylosing spondylitis

113

787

1.45

3.49

1.1

2.52

6.16

u/ml

—

113

Pregnancy with abortive outcome

1229

5747

1.12

3.49

1.1

7.95

4.89

u/ml

0.85

145

787

Other degenerative diseases of the nervous system

280

1684

1.27

3.48

1.1

3.31

9.01

u/ml

1.35

223

Cluster headache, strict, including avohilmo

513

1.56

3.46

1.0

1.1

2.09

4.25

u/ml

—

Generalized epilepsy, strict definition

260

1.81

3.45

1.1

1.34

6.24

u/ml

—

Maternal care for other known or suspected fetal problems

516

2798

1.19

3.41

1.1

8.45

3.51

u/ml

1.03

516

Unspecified abortion

539

1.54

3.41

1.1

10.18

7.35

u/ml

—

Gout, idiopatic and unspecified

196

1499

1.31

3.37

1.1

16.09

9.19

u/ml

—

122

Primary coxarthrosis, bilateral

266

2116

1.26

3.37

1.1

4.74

10.71

u/ml

0.86

169

Heterophoria

126

903

1.41

3.36

1.1

2.04

5.59

u/ml

1.25

129

Lichen sclerosus et atrophicus

126

903

1.41

3.34

1.1

8.49

6.64

u/ml

0.11

Disorders of breast

802

6527

1.14

3.34

1.1

2.92

5.77

u/ml

3.09

114

832

Iridocyclitis

292

2352

1.25

3.33

1.1

3.21

7.77

u/ml

1.73

302

L04AD Calcineurin inhibitors

138

1005

1.39

3.33

1.2

1.1

18.16

6.21

u/ml

—

144

Other benign neoplasms of connective and other soft tissue

129

929

1.40

3.33

1.1

10.16

5.65

u/ml

0.21

117

Acute pancreatitis (for exclusion)

211

1634

1.30

3.33

1.1

6.22

7.62

u/ml

0.17

193

Additional codes for the location of defect, injury or illness

502

1.55

3.32

1.1

1.79

4.72

u/ml

—

Benign neoplasm of eye and adnexa

117

829

1.42

3.31

1.1

3.80

4.85

u/ml

0.21

Failed induction of labour

121

865

1.42

3.31

1.1

3.11

3.02

u/ml

0.02

141

L04AA Selective immunosuppressants

292

2355

1.25

3.30

1.1

6.12

6.74

u/ml

0.09

316

Episcleritis

527

1.54

3.30

1.1

1.42

4.60

u/ml

1.40

Exposure to other and unspecified inanimate mechanical forces

665

1.48

3.29

1.1

21.66

5.00

u/ml

0.81

Colorectal adenocarcinoma

174

1315

1.33

3.28

1.0

1.1

5.28

8.75

u/ml

0.35

Childhood allergy (age < 16)

338

2279

1.23

3.28

1.1

6.50

4.54

u/ml

0.42

350

Placenta praevia

626

1.49

3.28

1.1

2.09

2.97

u/ml

0.38

118

Biological medication for rheuma

237

1869

1.28

3.27

1.1

3.06

6.43

u/ml

1.05

288

Spontaneous rupture of synovium and tendon

608

1.49

3.27

1.1

3.71

6.14

u/ml

—

Habitual aborter

295

1.74

3.27

1.1

1.46

4.30

u/ml

—

Agranulocytosis

141

1034

1.38

3.27

1.1

4.88

5.97

u/ml

0.14

126

Other CVD

170

1281

1.33

3.26

1.1

5.73

8.57

u/ml

—

101

Combinations of oral blood glucose lowering drugs

286

2304

1.25

3.26

1.1

4.49

8.76

u/ml

0.87

261

Medicines for HER+ breast cancer

336

3975

0.82

3.24

1.1

1.98

8.11

u/ml

5.48

420

Congenital malformations of ovaries, fallopian tubes and broad ligaments

105

735

1.45

3.23

1.0

1.1

4.31

4.75

u/ml

—

128

Acute nasopharyngitis (common cold)

161

1200

1.34

3.22

1.1

8.48

6.06

u/ml

0.32

199

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

472

3807

0.84

3.21

1.1

7.88

9.08

u/ml

0.13

383

Vitamin deficiency, wide

411

1.60

3.21

1.0

1.1

11.72

6.24

u/ml

—

Vitamin deficiency

411

1.60

3.21

1.0

1.1

11.73

6.24

u/ml

—

Antepartum haemorrhage, not elsewhere classified

171

1297

1.33

3.21

1.1

3.97

3.64

u/ml

0.08

244

Placental disorders

111

2.25

3.21

1.1

2.65

5.15

u/ml

—

Polyarthritis, unspecified

288

1.73

3.21

1.1

4.69

4.03

u/ml

—

Exclusions for E4_PCOS_CONSORTIUM

1311

7423

1.11

3.20

1.1

3.47

5.40

u/ml

1.54

163

1016

Retention of urine

301

2060

1.24

3.20

1.1

9.74

8.22

u/ml

0.13

197

Cerebral palsy and other paralytic syndromes

144

1065

1.36

3.17

1.1

1.11

4.98

u/ml

—

136

Otitis media, unspecified

199

1419

1.30

3.16

1.1

19.99

4.40

u/ml

0.69

187

Localized swelling, mass and lump of skin and subcutaneous tissue

388

3237

1.20

3.15

1.1

2.15

6.68

u/ml

3.52

414

Other benign neoplasms of connective and other soft tissue

129

939

1.39

3.15

1.1

10.16

6.04

u/ml

0.19

117

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

194

1.89

3.14

1.1

1.98

14.93

u/ml

—

Other disorders of conjunctiva

153

1144

1.35

3.13

1.1

7.54

8.73

u/ml

0.11

108

Injury of muscle and tendon at wrist and hand level

168

1274

1.33

3.13

1.0

1.1

3.12

6.13

u/ml

0.78

183

Other peripheral vertigo

107

755

1.43

3.13

1.0

1.1

2.46

6.49

u/ml

—

Pacemaker

273

2136

1.25

3.12

1.1

11.11

11.49

u/ml

0.03

149

Immunodeficiency with predominantly antibody defects

261

1.76

3.12

1.2

1.1

29.93

6.62

u/ml

—

Dystonia

486

1.54

3.11

1.1

8.86

6.42

u/ml

—

Familial hypercholesterolemia

144

1068

1.36

3.10

1.0

1.1

16.40

9.33

u/ml

—

Other peripheral vascular diseases

103

723

1.44

3.10

1.1

8.83

4.62

u/ml

—

Olecranon bursitis

375

1.62

3.10

1.1

0.82

7.48

u/ml

—

Transplanted organ and tissue status

116

832

1.41

3.09

1.2

1.1

29.89

7.14

u/ml

0.64

119

Laparoscopic right hemicolectomy

337

1.65

3.09

1.1

2.99

7.20

u/ml

0.53

Superficial injury of wrist and hand

305

2494

1.23

3.07

1.1

8.06

5.83

u/ml

0.30

363

Non-allergic asthma (mode)

244

1928

1.26

3.06

1.1

4.24

7.70

u/ml

0.69

254

Presence of other functional implants

584

3567

1.16

3.04

1.1

9.08

8.56

u/ml

0.05

325

ILD, hospital admissions 3, with pneumonia sepsis

496

1.52

3.04

1.2

1.1

13.52

9.93

u/ml

—

Other diseases of pancreas

537

1.50

3.03

1.1

19.61

6.14

u/ml

—

Anterior Iridocyclitis

260

2093

1.25

3.03

1.1

3.21

7.56

u/ml

1.57

263

Pre-eclampsia or poor fetal growth

569

4910

1.16

3.02

1.1

8.10

4.25

u/ml

0.54

782

Malignant neoplasm, wide definition for exclusion

1176

7701

0.90

3.02

1.1

5.20

5.76

u/ml

0.14

168

1027

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1176

7701

0.90

3.02

1.1

5.20

5.75

u/ml

0.14

168

1028

Misadventures to patients during surgical and medical care

170

1299

1.32

3.02

1.1

4.75

7.10

u/ml

0.34

148

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1176

7700

0.90

3.02

1.1

5.20

5.76

u/ml

0.14

168

1027

Hyperparathyroidism

193

1483

1.29

2.99

1.1

39.82

8.77

u/ml

—

133

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

174

1334

1.31

2.99

1.0

1.1

5.27

11.82

u/ml

0.73

100

Astigmatism

629

1.46

2.98

1.1

31.62

7.12

u/ml

0.58

Anogenital herpesviral [herpes simplex] infection

113

814

1.41

2.98

1.1

3.17

4.09

u/ml

0.19

138

Other spirochaetal diseases

308

2529

1.22

2.98

1.1

4.31

7.45

u/ml

0.87

294

Effects of foreign body entering through natural orifice

313

2575

1.22

2.97

1.1

9.12

6.50

u/ml

0.35

365

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

368

3075

1.20

2.96

1.1

4.30

6.68

u/ml

0.73

424

Acquired clawhand, clubhand, clawfoot and clubfoot

2.83

2.96

1.0

—

12.44

—

Other local infections of skin and subcutaneous tissue

122

890

1.38

2.96

1.1

9.72

5.14

u/ml

—

120

Non-allergic asthma (mode), excluding more controls

244

1937

1.25

2.95

1.1

4.24

7.72

u/ml

0.69

251

Other Crohn's disease

103

731

1.42

2.95

1.1

16.82

3.27

u/ml

0.62

105

Seropositive rheumatoid arthritis

293

2390

1.23

2.95

1.1

3.99

8.65

u/ml

1.78

295

Malignant neoplasm of digestive organs

333

2714

1.21

2.93

1.1

5.02

10.30

u/ml

1.58

230

Atrophic disorders of skin

188

1463

1.29

2.93

1.1

6.44

5.68

u/ml

0.07

164

Benign mammary dysplasia

182

1411

1.30

2.92

1.1

2.80

8.91

u/ml

1.93

151

Haemorrhage in early pregnancy

493

4129

1.17

2.91

1.1

3.94

4.21

u/ml

0.06

648

Burns and corrosions

184

1429

1.30

2.91

1.1

8.09

5.73

u/ml

0.31

209

Reactive arthropathies

111

800

1.40

2.90

1.1

7.45

8.05

u/ml

0.05

117

Benign neoplasm of eye and adnexa

117

851

1.39

2.90

1.1

3.80

5.57

u/ml

0.38

Deep endometriosis

152

1152

1.33

2.90

1.2

1.1

6.20

4.68

u/ml

0.12

149

Noise effects on inner ear

274

1.70

2.89

1.1

6.84

2.50

u/ml

—

Transient global amnesia

625

1.45

2.89

1.2

1.1

9.02

7.33

u/ml

—

Myopia

202

1590

1.28

2.89

1.1

6.74

5.03

u/ml

0.23

241

Cytomegaloviral disease

193

1.85

2.88

1.3

1.1

14.00

8.98

u/ml

—

Artificial joint re-operation

471

1.52

2.87

1.1

7.14

6.40

u/ml

—

Other otitis externa (chronic)

586

1.47

2.85

1.1

2.80

5.00

u/ml

—

Abnormalities of gait and mobility

119

870

1.38

2.85

1.1

46.22

8.11

u/ml

—

Benign neoplasm: Choroid

448

1.54

2.85

1.1

4.17

6.52

u/ml

—

Testicular dysfunction

268

1.70

2.85

1.1

0.72

5.45

u/ml

—

Acute and subacute iridocyclitis

244

1966

1.25

2.85

1.1

3.46

7.32

u/ml

1.17

251

Other infective otitis externa

521

1.49

2.84

1.1

24.29

4.72

u/ml

0.52

Injury of muscle and tendon at hip and thigh level

118

863

1.38

2.84

1.1

6.16

5.60

u/ml

0.07

120

Nondiabetic hypoglycaemic coma

3.39

2.83

1.1

1.0

—

7.60

—

Keratitis

474

4067

1.17

2.82

1.1

4.03

6.39

u/ml

1.10

556

Dermatophytosis

140

1052

1.34

2.82

1.1

3.36

6.63

u/ml

1.12

123

Hidradenitis suppurativa

402

1.57

2.81

1.0

1.1

0.60

4.84

u/ml

—

Conjunctivitis (acute, non atopic)

402

3393

1.19

2.81

1.1

2.82

5.85

u/ml

1.84

461

Nontoxic multinodular goitre

228

1826

1.26

2.81

1.1

7.84

9.73

u/ml

0.14

165

Other/unspecified rheumatoid arthritis

139

1044

1.34

2.81

1.1

5.33

10.13

u/ml

—

Perforation of tympanic membrane

128

950

1.36

2.81

1.1

18.57

4.05

u/ml

—

120

Testicular hypofunction

239

1.74

2.81

1.1

0.72

5.61

u/ml

—

Other abnormal products of conception

651

3799

1.15

2.79

1.1

5.13

4.27

u/ml

0.25

663

Postpartum care and examination

310

1629

1.22

2.79

1.1

3.33

3.67

u/ml

0.06

263

Other disorders of gingiva or/and edentulous alveolar ridge

410

1.55

2.79

1.0

1.1

6.57

6.94

u/ml

—

Superficial injury of ankle and foot

181

1412

1.29

2.79

1.1

4.18

5.85

u/ml

0.43

214

Degeneration of macula and posterior pole

410

2862

1.18

2.79

1.1

16.75

10.59

u/ml

0.42

173

Prepatellar bursitis

324

1.62

2.77

1.1

0.73

5.91

u/ml

—

Dysplasia of cervi uteri

421

2767

1.18

2.76

1.1

3.42

4.69

u/ml

0.62

440

Dialysis, with operation codes

131

978

1.35

2.76

1.2

1.1

36.28

7.18

u/ml

—

128

Unspecific neurodegenerative disorder

302

1712

1.22

2.75

1.1

7.45

14.40

u/ml

—

L02BG Aromatase inhibitors

242

2980

0.81

2.75

1.1

2.23

8.87

u/ml

4.03

283

Synovial cyst of popliteal space [Baker]

549

1.47

2.75

1.1

0.98

9.43

u/ml

—

Postinfectious hypothyroidism

3.09

2.73

1.0

1.1

—

3.05

—

Other keratitis

148

1128

1.32

2.72

1.1

7.04

5.56

u/ml

0.21

155

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

392

3024

1.19

2.72

1.1

3.62

4.52

u/ml

0.33

467

Other benign neoplasms of skin

440

3769

1.17

2.69

1.1

7.58

8.06

u/ml

0.08

423

Familial hypercholesterolemia, with ischemic heart disease

535

1.47

2.69

1.1

25.78

8.03

u/ml

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

351

1.59

2.69

1.1

1.17

5.94

u/ml

—

Peripheral arterial reconstruction

128

956

1.35

2.68

1.1

52.38

7.50

u/ml

—

Deposits [accretions] on teeth

629

1.43

2.68

1.1

12.88

6.17

u/ml

0.75

Congenital malformations and deformations of the musculoskeletal system

150

1143

1.32

2.68

1.1

2.42

4.88

u/ml

1.03

171

Recurrent dislocation of patella

712

1.41

2.68

1.1

2.15

4.55

u/ml

0.85

133

Benign neoplasm: Choroid

455

1.51

2.67

1.1

4.17

6.42

u/ml

—

Purpura and other haemorrhagic conditions

161

1245

1.30

2.67

1.1

2.35

5.23

u/ml

1.50

156

Other coagulation defects

102

739

1.39

2.63

1.1

2.19

3.80

u/ml

0.57

104

Benign neoplasm: Pituitary gland, craniopharyngeal duct

473

1.50

2.63

1.1

7.61

5.27

u/ml

—

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

630

1.43

2.63

1.1

2.00

4.58

u/ml

0.90

Car occupant injured in noncollision transport accident

377

1.56

2.62

1.1

14.60

5.06

u/ml

—

Other cataract

440

2917

1.17

2.62

1.1

10.51

8.47

u/ml

0.25

306

Erysipelas

616

4938

1.14

2.61

1.1

16.69

6.83

u/ml

0.86

589

Benign neoplasm: Pituitary gland, craniopharyngeal duct

474

1.49

2.61

1.1

7.61

4.58

u/ml

—

Benign neoplasm: Skin of other and unspecified parts of face

120

893

1.35

2.61

1.1

12.25

6.16

u/ml

0.75

100

Paroxysmal tachycardia

313

2206

1.20

2.59

1.1

5.23

7.31

u/ml

0.43

324

Psoriatic arthropathies

118

877

1.35

2.59

1.1

1.32

7.11

u/ml

1.90

130

Follicular cysts of skin and subcutaneous tissue

216

1738

1.25

2.59

1.1

6.98

6.82

u/ml

0.02

219

Vestibular neuronitis

100

724

1.39

2.59

1.1

7.81

4.75

u/ml

—

Disorders of orbit

394

1.54

2.59

1.1

2.28

6.31

u/ml

—

Diffuse brain injury

268

1.66

2.58

1.2

1.1

13.64

4.09

u/ml

—

Hypertrophy of breast

271

2236

1.22

2.58

1.1

3.55

6.64

u/ml

1.03

326

Shock, not elsewhere classified

2.48

2.57

1.1

—

19.98

—

Other chondrocalcinosis

2.48

2.57

1.1

—

14.79

—

Spermatocele

394

1.53

2.56

1.1

14.26

11.84

u/ml

—

Malignant neoplasm of skin

475

4131

0.86

2.55

1.1

8.72

9.35

u/ml

0.06

341

Other diseases of arteries and capillaries

709

1.39

2.55

1.2

1.1

16.66

5.32

u/ml

—

Otitis externa, unspecified

150

1158

1.31

2.54

1.1

6.68

5.19

u/ml

0.26

159

Anomalies of pupillary function

202

1.77

2.52

1.2

1.1

3.94

7.06

u/ml

—

Pre-eclampsia or eclampsia

372

3167

1.18

2.51

1.1

7.27

5.23

u/ml

0.15

492

Salpingitis and oophoritis

248

2034

1.23

2.51

1.1

2.24

6.74

u/ml

2.25

261

Other disorders of male genital organs

255

1.67

2.50

1.3

1.0

8.94

3.96

u/ml

—

Viral hepatitis, IBD co-morbidity

478

1.48

2.50

1.1

1.62

7.08

u/ml

—

117

Biomechanical lesions, not elsewhere classified

398

1.53

2.48

1.2

1.1

5.03

7.21

u/ml

—

Maternal care for known or suspected malpresentation of fetus

376

2385

1.18

2.48

1.1

5.78

3.58

u/ml

0.36

444

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

383

3095

0.85

2.47

1.1

9.03

9.86

u/ml

0.07

266

Lyme disease

298

2491

1.20

2.47

1.1

3.21

7.39

u/ml

1.66

289

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

272

1.64

2.47

1.1

2.28

5.79

u/ml

—

Other and unspecified local infections of skin and subcutaneous tissue

112

833

1.35

2.47

1.2

1.1

9.72

4.37

u/ml

—

110

Nontoxic goitre/thyroid nodule

363

3087

1.18

2.47

1.1

5.99

8.07

u/ml

0.25

312

Acute suppurative otitis media

490

3981

1.15

2.46

1.1

9.33

4.39

u/ml

0.75

601

Colorectal cancer, excluding all cancers (controls excluding all cancers)

259

2065

1.22

2.46

1.1

4.50

9.36

u/ml

1.07

174

Psoriatic and enteropathic arthropathies

146

1129

1.30

2.45

1.1

2.62

6.98

u/ml

1.18

163

Paralytic ileus

226

1.70

2.45

1.1

—

9.35

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

394

3165

0.85

2.44

1.1

9.03

9.90

u/ml

0.07

275

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

690

1.39

2.44

1.1

4.20

4.37

u/ml

—

Sequelae of injuries of lower limb

120

904

1.34

2.44

1.1

24.18

4.74

u/ml

0.52

129

Other and unspecified injuries of ankle and foot

449

1.49

2.43

1.1

4.58

5.51

u/ml

0.08

Contact with machinery

109

809

1.36

2.43

1.0

1.1

4.89

7.37

u/ml

0.38

104

Malignant melanoma

1109

0.71

2.43

1.1

6.14

7.92

u/ml

—

107

Benign neoplasm: Skin of other and unspecified parts of face

120

904

1.34

2.43

1.2

1.1

12.25

5.87

u/ml

0.82

Oral leukoplakia and related diseases, including avohilmo

699

1.38

2.42

1.1

1.61

5.48

u/ml

—

Factitial dermatitis

2.86

2.42

1.1

1.0

—

0.91

—

Spinal instabilities

243

1.67

2.40

1.1

1.0

3.95

6.07

u/ml

—

Vertigo of central origin

111

2.02

2.39

1.1

—

10.61

—

Heart failure,strict

480

3009

1.15

2.37

1.1

20.84

8.86

u/ml

0.77

270

Benign neoplasm: Connective and other soft tissue of head, face and neck

147

1.87

2.36

1.1

0.72

10.75

u/ml

—

Disorder of the sleep-wake schedule

184

1.78

2.36

1.0

1.1

1.01

8.67

u/ml

—

Pterygium

176

1.78

2.36

1.2

1.1

6.09

8.53

u/ml

—

Residual foreign body in soft tissue

419

1.49

2.36

1.0

1.1

2.02

5.75

u/ml

—

Reactive arthropathies, FINNGEN

686

1.38

2.36

1.1

2.44

5.22

u/ml

0.93

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

626

1.40

2.35

1.0

1.1

1.32

7.73

u/ml

—

Embedded and impacted teeth

507

3771

1.15

2.35

1.1

3.31

4.15

u/ml

0.51

575

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

937

6932

1.11

2.34

1.1

5.21

4.98

u/ml

0.05

147

967

Delayed puberty

2.18

2.33

1.1

—

11.57

—

Delivery, wide proxy

575

2689

1.14

2.32

1.1

5.81

4.82

u/ml

0.15

337

Amputation

569

1.41

2.31

1.2

1.1

45.22

9.88

u/ml

—

Diagnoses used for exclusion with ILD

259

2152

1.21

2.31

1.1

3.17

7.98

u/ml

2.20

237

Female infertility, associated with anovulation

158

1247

1.28

2.31

1.1

1.22

4.87

u/ml

2.92

219

Pregnancy examination and test

337

1783

1.19

2.30

1.1

2.38

4.39

u/ml

0.68

287

Speech and linguistic disorders, excluding more controls

142

1041

1.30

2.29

1.1

3.98

6.09

u/ml

0.29

161

Pre-eclampsia

350

2991

1.18

2.29

1.1

7.27

5.38

u/ml

0.13

473

Obesity, other/unspecified

503

4412

1.14

2.29

1.1

3.39

6.01

u/ml

1.49

657

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

406

1.50

2.29

1.1

23.20

5.78

u/ml

—

Superficial injury of forearm

137

1063

1.30

2.28

1.1

5.74

5.60

u/ml

0.02

146

Benign neoplasm: Connective and other soft tissue of head, face and neck

149

1.85

2.28

1.1

0.72

10.34

u/ml

—

Open wound of ankle and foot

125

958

1.31

2.27

1.1

0.85

5.15

u/ml

2.42

124

Female infertility, tubal origin

615

1.40

2.27

1.1

0.88

6.65

u/ml

—

120

Parodontitis and operation codes

1172

8355

1.09

2.27

1.1

8.88

5.68

u/ml

0.56

100

1099

Pregnancy, childbirth and the puerperium

494

2253

1.15

2.26

1.1

8.04

4.64

u/ml

0.54

270

Somnolence, stupor and coma

342

1.54

2.26

1.1

11.52

6.49

u/ml

—

Torticollis

157

1.82

2.25

1.1

3.48

8.87

u/ml

—

Nonspecific lymphadenitis

616

1.39

2.24

1.0

1.1

2.01

5.65

u/ml

1.46

Retinal detachments and breaks

342

2920

1.17

2.24

1.1

6.34

9.39

u/ml

0.48

291

Perioral dermatitis

226

1.67

2.21

1.1

1.46

6.30

u/ml

—

Uterine polyps

129

998

1.30

2.20

1.1

2.88

6.77

u/ml

1.03

140

Smoking dependency

729

1.35

2.20

1.1

25.27

5.09

u/ml

—

100

Mental and behavioural disorders due to tobacco

729

1.35

2.20

1.1

25.27

5.01

u/ml

—

102

Gout, strict definition

132

1024

1.29

2.19

1.1

19.00

9.92

u/ml

—

COPD (mode)

274

1822

1.20

2.18

1.1

17.65

9.91

u/ml

0.25

184

Melanocytic naevi, other sites/unspecified

104

782

1.34

2.18

1.1

15.19

4.27

u/ml

0.65

108

Melanocytic naevi, other sites/unspecified

104

782

1.34

2.18

1.1

15.19

4.12

u/ml

0.66

111

Emergency coronary revascularization (for ACS)

357

2986

0.86

2.18

1.1

21.61

10.42

u/ml

0.54

240

malignant neoplasm of male genital organs

206

1600

0.82

2.17

1.0

1.1

4.65

9.41

u/ml

0.76

138

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

411

1.48

2.17

1.1

23.20

5.36

u/ml

—

Other congenital malformations

134

1044

1.29

2.17

1.1

2.86

5.48

u/ml

0.97

166

Inguinal hernia, bilateral

611

1.38

2.16

1.1

0.85

11.05

u/ml

—

Other and unspecified mononeuropathies, also in other diseases

212

1.67

2.15

1.1

—

7.60

—

Inguinal or femoral hernia, bilateral

621

1.38

2.13

1.1

0.83

11.05

u/ml

—

Influenza and pneumonia

1708

10475

1.07

2.13

1.1

7.30

5.21

u/ml

0.71

160

1456

Other congenital malformations of male genital organs

2.33

2.11

1.1

—

10.31

—

Effects of other external causes

300

1.56

2.11

1.1

21.08

6.21

u/ml

—

Diseases of arteries, arterioles and capillaries

692

4632

1.12

2.11

1.1

17.61

7.69

u/ml

0.85

471

Cramp and spasm

414

1.47

2.10

1.1

10.70

4.67

u/ml

—

Pilonidal cyst

127

988

1.29

2.10

1.0

1.1

0.98

5.14

u/ml

2.77

170

Inguinal hernia

718

4351

1.11

2.10

1.1

5.61

6.17

u/ml

0.08

570

Fracture of foot, except ankle

336

2885

1.17

2.09

1.1

5.42

6.17

u/ml

0.15

410

Corns and callosities

565

1.39

2.08

1.1

16.10

3.31

u/ml

—

Fourth [trochlear] nerve palsy

161

1.77

2.08

1.1

—

11.32

—

Diseases of peritoneum

110

840

1.32

2.08

1.0

1.1

1.09

6.25

u/ml

—

101

Burns and corrosions of external body surface, specified by site

140

1104

1.28

2.08

1.1

9.71

4.80

u/ml

0.54

157

Inflammatory disease of cervix uteri

591

1.38

2.08

1.1

2.34

7.14

u/ml

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

270

1.58

2.06

1.2

1.1

3.19

6.00

u/ml

—

Other bacterial diseases

1315

8414

1.08

2.05

1.1

9.33

5.72

u/ml

0.73

109

1098

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

609

1.37

2.04

1.0

1.1

1.32

7.73

u/ml

—

Malignant melanoma of skin

829

0.70

2.04

1.1

5.44

5.75

u/ml

—

Persons encountering health services for specific procedures, not carried out

781

0.69

2.04

1.1

6.41

4.14

u/ml

—

108

Need for immunization against other single viral diseases

179

0.39

2.04

1.0

1.1

—

9.86

—

Organic, including symptomatic, mental disorders

425

2676

1.15

2.04

1.1

25.08

11.29

u/ml

0.30

194

Early lumbar disc prolapse, operated

150

1196

1.26

2.04

1.1

4.83

4.67

u/ml

0.03

233

Ischaemic heart disease, wide definition

886

5043

1.10

2.04

1.1

10.16

7.14

u/ml

0.38

570

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

485

4284

1.14

2.04

1.1

3.01

5.30

u/ml

1.13

672

Endometriosis of rectovaginal septum and vagina

112

861

1.31

2.04

1.2

1.1

7.63

7.58

u/ml

0.00

116

Benign neoplasm: Skin, unspecified

327

1.52

2.03

1.1

9.76

6.80

u/ml

—

Superficial injury of hip and thigh

153

1223

1.26

2.02

1.1

3.53

6.85

u/ml

—

136

Other disorders of the genitourinary system

142

1127

1.27

2.01

1.1

4.05

9.19

u/ml

0.76

106

Dental pulpitis 3, only avohilmo

263

1619

1.19

2.01

1.1

2.26

5.38

u/ml

1.93

247

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

715

1.34

2.01

1.1

4.20

5.33

u/ml

—

Other bursitis of elbow

2.34

2.01

1.0

1.1

—

17.65

—

Oligomenorrhoea

452

1.43

2.01

1.1

2.73

5.72

u/ml

—

Alcohol dependence

207

2495

0.83

2.00

1.1

1.96

5.93

u/ml

—

342

Dementia, including avohilmo

340

2015

1.17

2.00

1.1

5.37

12.92

u/ml

—

Other and unspecified coagulation defects

511

1.40

2.00

1.1

2.59

4.58

u/ml

0.49

Malignant neoplasm of prostate

195

1499

0.82

2.00

1.1

4.79

10.28

u/ml

0.83

124

Inflammation of lacrimal passages (chronic)

112

1.91

1.98

1.1

—

12.73

—

Crohn's disease of large intestine

520

1.40

1.98

1.1

6.97

3.93

u/ml

—

Cholecystitis

131

1031

1.28

1.98

1.1

8.65

6.39

u/ml

—

Parodontitis or/and operation codes

905

5888

0.91

1.97

1.1

9.54

5.15

u/ml

0.69

753

Other diseases of biliary tract

605

1.36

1.97

1.1

5.30

8.51

u/ml

0.35

Localized adiposity

2.54

1.97

1.1

—

3.34

—

Malignant neoplasm of thyroid gland

632

1.36

1.96

1.0

1.1

1.76

4.92

u/ml

1.33

Nephropathy related operations

122

954

1.29

1.95

1.2

1.1

36.28

7.36

u/ml

—

122

Melanocytic naevi of lower limb, including hip

405

1.45

1.94

1.1

3.15

6.20

u/ml

0.45

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1131

0.75

1.93

1.1

4.04

6.69

u/ml

—

103

All influenza (not pneumonia)

187

1538

1.22

1.92

1.1

6.84

5.24

u/ml

0.21

223

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

608

1.36

1.91

1.0

1.1

1.32

8.20

u/ml

—

Family history of other specific disorders

151

1.76

1.91

1.0

1.1

—

6.08

—

Other benign neoplasms of skin

440

3806

1.14

1.91

1.1

7.58

7.61

u/ml

0.00

421

Mandibular retrognathia AND surgery (BSSRO)

292

1.53

1.90

1.0

1.1

3.38

3.50

u/ml

—

Chronic periodontitis, complicated

696

1.33

1.89

1.1

9.19

5.15

u/ml

—

Superficial injury of thorax

170

1388

1.23

1.88

1.1

4.98

6.88

u/ml

0.38

175

Blood alcohol or alcohol intoxication level

251

0.47

1.88

1.0

1.1

—

6.16

—

Premature rupture of membranes

414

2672

1.14

1.88

1.1

3.81

3.35

u/ml

0.10

482

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

149

1808

0.81

1.87

1.1

2.80

7.96

u/ml

1.79

169

Dental pulpitis 3

281

1727

1.18

1.87

1.1

2.33

5.17

u/ml

1.85

269

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

672

1.33

1.86

1.1

8.73

5.34

u/ml

—

Bronchitis, not specified as acute or chronic

715

1.32

1.86

1.1

1.03

5.73

u/ml

—

Coronary revascularization (ANGIO or CABG)

317

2561

0.86

1.86

1.1

22.07

10.13

u/ml

0.56

226

Maternal care for known or suspected disproportion

613

1.35

1.86

1.1

3.14

4.26

u/ml

0.19

115

Pedal cyclist injured in collision with motor vehicle

318

1.50

1.85

1.1

0.67

5.85

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

226

1900

1.19

1.85

1.1

4.73

8.89

u/ml

1.09

178

Congenital malformations of trachea and bronchus

2.17

1.85

1.1

—

10.61

—

Hypertrophic scar

596

1.36

1.84

1.2

1.1

4.60

3.07

u/ml

—

Gout, unspecified

150

1211

1.24

1.84

1.1

18.78

10.12

u/ml

—

Acute laryngitis and tracheitis

204

1675

1.21

1.84

1.1

4.52

4.81

u/ml

0.05

258

Moderate visual impairment, monocular

2.67

1.83

1.1

1.0

—

5.22

—

Liver disorders in diseases classified elsewhere

2.90

1.83

1.0

1.1

—

4.84

—

Melanocytic naevi of lower limb, including hip

410

1.43

1.83

1.1

3.15

5.16

u/ml

0.27

Pedal cyclist injured in other and unspecified transport accidents

141

1133

1.25

1.83

1.1

4.07

5.22

u/ml

0.17

149

Calcific tendinitis of shoulder

511

1.38

1.83

1.1

1.20

8.04

u/ml

—

Other disorders of breast

180

1485

1.22

1.83

1.1

1.57

6.79

u/ml

2.65

193

Malignant melanoma, excluding all cancers (controls excluding all cancers)

105

1345

0.78

1.82

1.1

4.67

9.10

u/ml

0.65

129

Other heart diseases

805

4850

1.10

1.82

1.1

9.45

5.38

u/ml

0.71

101

767

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

745

1.31

1.81

1.1

2.21

5.62

u/ml

1.27

Other disorders of veins

483

4298

1.13

1.81

1.1

3.36

7.01

u/ml

2.09

538

Preterm labour and delivery

410

3616

1.14

1.81

1.1

4.41

5.13

u/ml

0.21

534

Congenital malformations of breast

208

1.62

1.80

1.0

1.1

0.66

4.39

u/ml

—

Seborrhoeic keratosis

211

1769

1.20

1.79

1.1

14.78

8.42

u/ml

0.35

166

Herpesviral keratitis and keratoconjunctivitis

345

1.46

1.79

1.1

7.96

7.01

u/ml

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

581

1.35

1.79

1.0

1.1

1.32

8.20

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

863

6218

1.09

1.79

1.1

5.35

4.59

u/ml

0.16

136

916

Pregnancy hypertension

736

6044

1.10

1.79

1.1

5.07

4.45

u/ml

0.09

920

Disorders of oesophagus in diseases classified elsewhere

109

1.86

1.79

1.1

—

9.43

—

Infectious mononucleosis

152

1237

1.24

1.78

1.1

2.98

4.69

u/ml

0.69

190

Malignant neoplasm of endocrine gland

669

1.33

1.78

1.0

1.1

1.71

4.73

u/ml

1.39

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

105

819

1.29

1.76

1.1

2.13

5.66

u/ml

1.58

100

Injury of blood vessels of thorax

3.02

1.75

1.0

1.1

—

4.12

—

Coxarthrosis, primary, with hip surgery

424

3558

1.13

1.74

1.1

5.76

10.25

u/ml

1.17

286

Dementia in Alzheimer disease

737

0.73

1.73

1.1

—

21.86

—

Prolapse and hernia of ovary and fallopian tube

223

1.57

1.73

1.1

—

4.94

—

Tumor necrosis factor alpha inhibitors

203

1704

1.20

1.73

1.1

3.54

6.60

u/ml

0.75

258

Hypertrophic disorders of skin

655

1.32

1.73

1.2

1.1

4.60

2.99

u/ml

—

Epileptic seizures related to alcohol

0.00

1.73

0.0

1.1

—

7.10

—

Other diseases of gallbladder

323

1.47

1.73

1.0

1.1

5.00

5.30

u/ml

—

Malignant neoplasm of colon

125

998

1.26

1.72

1.1

7.74

8.65

u/ml

0.07

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

173

1279

0.82

1.72

1.1

3.58

8.52

u/ml

1.26

132

Ovarian hyperstimulation (induction)

235

1.56

1.71

1.1

2.78

3.48

u/ml

—

Cerebrovascular diseases (FINNGEN)

415

2624

1.13

1.71

1.1

5.87

6.81

u/ml

0.19

397

Maxillary retrognathism

211

1.59

1.71

1.0

1.1

1.75

8.72

u/ml

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

417

3228

0.88

1.71

1.1

9.05

9.84

u/ml

0.06

287

Hyperlipidaemia, other/unspecified

348

2884

1.14

1.70

1.1

2.17

10.78

u/ml

5.49

264

Mental and behavioural disorders due to alcohol

528

5711

0.90

1.70

1.1

4.24

5.56

u/ml

0.32

819

Colon adenocarcinoma

743

1.30

1.70

1.1

9.23

9.00

u/ml

—

Benign neoplasm: Skin, unspecified

341

1.45

1.70

1.1

9.76

6.49

u/ml

—

Dementia

315

1886

1.16

1.70

1.1

5.69

13.28

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

226

1917

1.18

1.69

1.1

4.73

8.89

u/ml

1.27

187

Other benign neoplasm of uterus: Corpus uteri

2.15

1.68

1.0

1.1

—

10.68

—

Xerosis cutis

1.89

1.68

1.3

1.1

—

3.43

—

Type 2 diabetes

1478

8223

1.07

1.68

1.1

4.21

5.39

u/ml

0.71

126

1149

Other disorders of pigmentation

367

1.43

1.68

1.1

3.72

4.50

u/ml

—

Intermittent heterotropia

711

1.31

1.67

1.1

3.29

6.19

u/ml

0.72

104

Subacute thyroiditis

335

1.45

1.65

1.1

0.66

3.86

u/ml

—

Benign neoplasm: Connective and other soft tissue, unspecified

1.87

1.64

1.1

—

9.44

—

Epilepsy

370

3256

1.14

1.64

1.1

5.17

7.39

u/ml

0.64

456

Basal cell carcinoma

415

3719

0.89

1.64

1.1

9.03

9.63

u/ml

0.05

279

Complications associated with artificial fertilization

246

1.53

1.63

1.1

2.78

4.51

u/ml

—

Other specified and unspecified personality disorders

127

1025

1.25

1.62

1.1

2.31

4.79

u/ml

1.07

165

Chronic periodontitis, including avohilmo

1232

8510

1.07

1.62

1.1

8.96

5.54

u/ml

0.65

106

1124

Benign lipomatous neoplasm of other sites/unspecified

679

1.30

1.62

1.1

5.09

6.74

u/ml

—

Benign leiomyoma with endometriosis

190

1597

1.20

1.62

1.1

7.01

7.20

u/ml

0.01

173

Bacterial, viral and other infectious agents

110

874

1.27

1.61

1.1

1.50

5.98

u/ml

1.88

130

Primary open-angle glaucoma

264

2220

1.16

1.61

1.1

4.29

11.66

u/ml

—

139

Injury of muscle and tendon at forearm level

167

1.64

1.60

1.0

1.1

2.37

8.50

u/ml

—

Intrahepatic Cholestasis of Pregnancy (ICP)

122

983

1.25

1.60

1.1

8.55

4.47

u/ml

0.22

163

Open wound of forearm

109

866

1.27

1.60

1.1

1.96

5.83

u/ml

—

112

Mental and behavioural disorders due to alcohol, excluding acute intoxication

426

4765

0.89

1.60

1.1

5.44

6.27

u/ml

0.13

681

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

162

1174

0.83

1.60

1.1

3.65

9.81

u/ml

1.44

108

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

751

1.28

1.59

1.1

9.23

8.17

u/ml

—

Inflammatory disorders of breast

101

797

1.28

1.58

1.1

4.03

4.64

u/ml

0.12

128

conjunctival haemorrhage

542

1.34

1.58

1.1

10.00

5.88

u/ml

—

Other and unspecified mood [affective] disorders

112

895

1.26

1.58

1.1

2.37

3.66

u/ml

—

146

Secondary parkinsonism, excluding more controls

129

1.72

1.57

1.2

1.1

—

8.34

—

Basal cell carcinoma, including avohilmo

432

3806

0.89

1.57

1.1

9.03

9.63

u/ml

0.05

296

Other benign neoplasm of uterus: Corpus uteri

2.08

1.57

1.0

1.1

—

12.11

—

Superficial injury of neck

224

1.54

1.57

1.1

1.07

4.21

u/ml

—

Contracture of muscle

2.51

1.56

1.1

1.0

—

14.25

—

Artificial joint operation, meniscal resection

1144

7097

1.07

1.55

1.1

8.11

6.21

u/ml

0.32

122

870

Presbyopia

553

1.33

1.55

1.2

1.1

4.86

4.19

u/ml

0.07

Event of undetermined intent

623

1.31

1.55

1.1

2.52

4.92

u/ml

—

Superficial injury of abdomen, lower back and pelvis

191

1614

1.19

1.54

1.1

4.87

4.67

u/ml

0.03

218

Overexertion and strenuous or repetitive movements

123

996

1.24

1.54

1.1

2.93

4.62

u/ml

0.68

135

Other and unspecified corneal deformities and disorders

282

1.47

1.54

1.1

9.28

4.47

u/ml

—

Myocarditis

382

1.40

1.53

1.1

2.15

7.72

u/ml

0.89

Parodontitis

1235

8521

1.07

1.53

1.1

8.96

5.53

u/ml

0.65

106

1125

Single delivery by caesarean section

362

1849

1.14

1.52

1.1

7.23

4.33

u/ml

0.35

328

Use of anticholinesterases

219

1513

1.17

1.52

1.1

10.12

15.91

u/ml

—

N06DA Anticholinesterases

219

1513

1.17

1.52

1.1

10.12

15.91

u/ml

—

Injury of muscle and tendon at lower leg level

156

1297

1.21

1.51

1.1

7.14

6.62

u/ml

0.06

182

Parodontitis or operation codes

1236

8525

1.07

1.51

1.1

8.96

5.53

u/ml

0.65

106

1125

Other appendicitis

104

829

1.26

1.50

1.1

3.30

4.45

u/ml

—

111

Thoracic aortic aneurysm

109

873

1.25

1.50

1.0

1.1

7.60

8.34

u/ml

—

Pedal cyclist injured in noncollision transport accidents

139

1144

1.22

1.50

1.1

8.79

4.69

u/ml

—

163

Peripheral artery operations in Hilmo

748

1.27

1.50

1.2

1.1

43.79

8.87

u/ml

—

Fracture at wrist and hand level

459

4127

1.11

1.50

1.1

3.32

6.41

u/ml

1.36

605

Alcohol use disorder, ICD-based

395

4422

0.89

1.50

1.1

5.51

6.18

u/ml

0.09

633

Viral pneumonia

140

1153

1.22

1.50

1.1

16.11

6.37

u/ml

0.70

151

Primary open-angle glaucoma, strict

214

1827

1.17

1.49

1.1

4.70

12.68

u/ml

—

118

Supervision of normal pregnancy

435

2224

1.12

1.49

1.1

4.09

4.64

u/ml

0.12

375

260

1.48

1.1

4.58

3.52

u/ml

—

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

108

866

1.25

1.48

1.0

1.1

1.39

10.09

u/ml

—

Follicular lymphoma

305

0.59

1.47

1.3

1.1

—

8.13

—

Unspecified mental disorder

602

5496

1.10

1.47

1.1

4.99

5.95

u/ml

0.33

809

Benign neoplasm: Connective and other soft tissue, unspecified

102

1.80

1.47

1.1

—

8.24

—

Abnormal spermatozoa

605

0.71

1.47

1.2

1.1

3.59

10.65

u/ml

—

Malignant neoplasm of rectum

593

1.30

1.46

1.0

1.1

1.50

8.40

u/ml

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

794

6422

1.08

1.44

1.1

4.81

4.76

u/ml

0.01

942

Sleep disorders, other/unspecified

362

1.40

1.44

1.1

1.22

5.08

u/ml

—

Venous thromboembolism

577

5109

1.10

1.44

1.1

3.20

7.95

u/ml

4.06

554

Divergent concomitant strabismus

104

835

1.25

1.43

1.1

1.10

4.76

u/ml

2.61

122

Down's syndrome

2.34

1.43

1.1

—

2.64

—

Other viral diseases, not elsewhere classified

256

2225

1.15

1.42

1.1

9.67

6.57

u/ml

0.23

308

Myeloproliferative diseases (CML excluded)

561

1.31

1.42

1.2

1.1

20.06

6.67

u/ml

—

Contact with heat and hot substances

518

1.32

1.42

1.1

20.63

5.43

u/ml

—

Speech and linguistic disorders

147

1176

1.21

1.41

1.1

3.84

6.58

u/ml

0.43

167

Benign neoplasm of bone and articular cartilage

103

828

1.25

1.41

1.1

0.82

4.30

u/ml

—

117

Obstructed labour due to maternal pelvic abnormality

213

1834

1.17

1.40

1.1

4.92

7.00

u/ml

0.48

259

Sarcoidosis

148

1236

1.20

1.39

1.1

3.80

8.68

u/ml

1.33

146

Disorders of tooth development and eruption

608

1.29

1.39

1.1

5.30

6.48

u/ml

—

Other specified and unspecified disorders of eye and adnexa

331

1.40

1.38

1.1

2.68

5.80

u/ml

—

Fall on and from ladder

529

1.31

1.37

1.1

8.00

6.77

u/ml

0.08

Cleft lip, lip and palate or palate

191

1.54

1.37

1.1

5.10

4.94

u/ml

—

Other diseases of the respiratory system

167

1412

1.19

1.37

1.1

11.07

7.66

u/ml

—

123

Other respiratory disorders and diseases

167

1412

1.19

1.37

1.1

11.07

7.66

u/ml

—

123

Scissor bite

382

1.37

1.1

1.59

8.85

u/ml

—

Bitten or struck by other mammals

156

1313

1.19

1.36

1.1

3.51

5.40

u/ml

0.36

196

Left bundle-branch block

460

1.33

1.36

1.1

0.80

4.33

u/ml

—

Ectopic pregnancy

263

2306

1.15

1.36

1.1

2.73

5.08

u/ml

1.15

359

Specific development disorders of speech and language

706

1.26

1.36

1.1

1.08

8.04

u/ml

—

108

Hydrocephalus in other diseases

0.00

1.36

0.0

1.1

—

17.53

—

Contact with other hot fluids

307

1.42

1.36

1.1

18.88

6.38

u/ml

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

375

1.37

1.35

1.2

1.1

4.46

4.45

u/ml

0.00

Viral infections of the central nervous system

725

1.26

1.35

1.1

4.00

3.77

u/ml

—

102

Alzheimer’s disease (Atypical or mixed), excluding more controls

264

1.41

1.35

1.1

—

23.35

—

Juvenile osteochondrosis

384

1.37

1.35

1.1

1.56

6.13

u/ml

—

Open bite

655

1.28

1.35

1.1

2.82

6.71

u/ml

1.11

Ankylosing spondylitis, ICD10

109

887

1.24

1.35

1.1

2.52

4.33

u/ml

—

124

Other/unspecified reactive arthropathies

637

1.28

1.34

1.1

2.67

4.56

u/ml

—

Other symptoms and signs involving the urinary system

770

1.25

1.34

1.1

7.10

6.14

u/ml

—

Poor fetal growth

232

2020

1.15

1.34

1.1

8.40

4.48

u/ml

0.63

346

Attention to artificial openings

259

0.57

1.34

1.2

1.1

—

10.02

—

Other psoriatic arthropathies

116

951

1.23

1.34

1.1

1.32

5.49

u/ml

2.43

127

Follicular lymphoma, hilmo

296

0.60

1.33

1.3

1.1

—

6.49

—

Valvular operations

114

933

1.23

1.33

1.1

3.72

7.75

u/ml

—

Pseudopolyposis of colon

2.59

1.32

1.2

1.1

—

6.13

—

Emotionally unstable personality disorder

206

1781

1.16

1.31

1.1

2.24

5.31

u/ml

—

282

Bilateral sagittal split ramus osteotomy operation

386

1.36

1.31

1.0

1.1

4.34

4.35

u/ml

—

Hyperprolactinaemia

412

1.35

1.31

1.0

1.1

8.48

4.69

u/ml

—

Other osteochondropathies

675

1.27

1.31

1.0

1.1

2.49

6.85

u/ml

—

101

Hypertrichosis

276

1.43

1.31

1.1

8.84

3.59

u/ml

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.93

1.31

1.0

1.1

—

10.79

—

Viral warts

130

1082

1.21

1.30

1.1

11.95

4.48

u/ml

0.73

153

Primary angle-closure glaucoma

268

1.43

1.28

1.2

1.1

21.16

10.43

u/ml

—

Hypoplasia of dental enamel, including avohilmo

115

0.42

1.28

1.2

1.1

—

15.35

—

Nontraumatic intracranial haemmorrhage

119

1434

0.83

1.27

1.0

1.1

1.13

10.39

u/ml

—

130

Late syphilis

107

1.71

1.27

1.0

1.1

—

9.69

—

Desensitization to allergens

723

1.25

1.27

1.1

3.92

4.97

u/ml

0.21

116

Enteropathic arthropathies

219

1.48

1.27

1.1

1.0

5.42

4.54

u/ml

—

Other complications of labour and delivery, not elsewhere classified

172

1932

0.85

1.27

1.1

2.52

3.13

u/ml

0.31

321

Persons with potential health hazards related to communicable diseases

567

6116

0.92

1.27

1.1

4.68

5.22

u/ml

0.12

943

Thrombocytopenia, unspecified

554

1.29

1.27

1.1

1.00

5.92

u/ml

—

Benign lipomatous neoplasm of other sites/unspecified

705

1.25

1.26

1.1

5.09

8.38

u/ml

—

Vertical strabismus

303

1.40

1.26

1.2

1.1

0.58

6.20

u/ml

—

Other specified transport accidents

2.05

1.25

1.1

1.0

—

6.73

—

Hand

2.05

1.25

1.0

—

17.65

—

Parodontitis, under 40 years

183

1577

1.17

1.24

1.1

3.88

4.25

u/ml

0.09

277

Other puerperal infections

143

1208

1.19

1.24

1.1

1.31

4.31

u/ml

2.65

197

Thalassaemia

2.24

1.24

1.1

—

15.06

—

DVT of lower extremities and pulmonary embolism

404

3644

1.11

1.23

1.1

4.18

8.90

u/ml

2.51

377

Personal history of malignant neoplasm

339

1.37

1.23

1.1

6.70

7.39

u/ml

—

Other inflammation of vagina/vulva

452

1.32

1.23

1.1

1.23

3.86

u/ml

0.95

Contact with and exposure to communicable diseases

478

5205

0.91

1.22

1.1

4.94

5.10

u/ml

0.03

821

Abscess of anal and rectal regions

718

1.25

1.21

1.2

1.1

8.36

7.17

u/ml

0.09

104

Rheumatic valve diseases

143

0.49

1.21

1.0

1.1

—

9.54

—

Abnormal findings on diagnostic imaging of central nervous system

418

1.33

1.20

1.1

2.67

4.88

u/ml

—

Campylobacter enteritis

247

1.43

1.20

1.1

2.68

6.73

u/ml

—

Disorders of psychological development

202

1628

1.16

1.20

1.1

3.38

5.79

u/ml

0.48

229

Parodontitis, under 40 years, or operation codes

183

1582

1.16

1.20

1.1

3.88

4.25

u/ml

0.09

277

2.37

1.20

1.0

1.1

—

1.09

—

Heart failure and bmi 25plus

301

1847

1.13

1.19

1.1

19.21

8.32

u/ml

0.47

140

Crossbite

112

860

1.22

1.19

1.1

1.48

6.93

u/ml

2.12

113

All dysplastic lesions of the vagina

256

1.42

1.19

1.1

1.86

5.86

u/ml

—

Gout due to impairment of renal function

1.96

1.18

1.3

1.1

—

16.78

—

Aortic valve malfunction, age under 60 years

793

1.23

1.18

1.1

3.83

6.25

u/ml

0.45

118

Arthropathic psoriasis

126

1057

1.20

1.18

1.1

1.97

6.41

u/ml

1.69

136

All-cause Heart Failure

496

3269

1.09

1.18

1.1

21.42

9.31

u/ml

0.81

254

Papillary adenocarcinoma of thyroid gland

481

1.30

1.18

1.0

1.1

1.53

6.00

u/ml

—

Adalimumab

120

1003

1.20

1.17

1.1

4.39

5.09

u/ml

—

154

Poisoning by medicine

320

2872

1.12

1.17

1.1

3.60

5.81

u/ml

0.72

436

Crohn's disease NAS

659

1.25

1.17

1.1

4.87

3.74

u/ml

—

105

Pedestrian injured in transport accident

641

1.26

1.17

1.1

10.30

4.44

u/ml

—

Third [oculomotor] nerve palsy

129

0.46

1.17

1.0

1.1

—

9.14

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.85

1.17

1.0

1.1

—

3.00

—

Heart failure, strict

505

3329

1.09

1.17

1.1

20.89

9.20

u/ml

0.80

263

Focal epilepsy, strict definition

166

1926

0.86

1.17

1.1

6.21

7.33

u/ml

0.13

240

Monoarthritis, not elsewhere classified

368

1.34

1.17

1.0

1.1

0.90

4.45

u/ml

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.59

1.17

1.2

1.1

—

7.52

—

Onychogryphosis

2.58

1.16

1.2

1.1

—

Myocardial infarction, without ST-elevation

309

2552

1.12

1.16

1.1

19.00

12.52

u/ml

0.19

197

Hordeolum and other deep inflammation of eyelid

553

1.27

1.16

1.1

4.16

5.96

u/ml

—

Osteonecrosis

447

1.31

1.16

1.1

2.43

4.63

u/ml

—

Other specified disorders of external ear

232

1.43

1.16

1.0

1.1

4.70

10.28

u/ml

—

Explicit bacterial Sepsis

100

822

1.22

1.15

1.1

6.87

5.93

u/ml

—

Other specified disorders of kidney and ureter

266

1.40

1.15

1.2

1.1

20.20

6.50

u/ml

—

Pyoderma gangrenosum

1.89

1.15

1.1

—

9.65

—

Dermatitis due to ingested food

474

1.29

1.14

1.1

3.39

3.67

u/ml

—

Benign neoplasm of bone and articular cartilage

103

851

1.22

1.14

1.1

0.82

5.03

u/ml

—

119

Disorder of lipoprotein metabolism, unspecified

107

887

1.21

1.14

1.1

9.93

7.45

u/ml

0.21

Assault

182

1580

1.16

1.13

1.1

3.24

5.29

u/ml

0.51

267

Prolonged pregnancy

284

2315

1.12

1.13

1.1

5.82

3.45

u/ml

0.64

434

Other endocrine disorders

611

1.25

1.13

1.1

0.87

9.15

u/ml

—

Other disorders of central nervous system

1.73

1.12

1.1

—

3.82

—

Other and unspecified psoriasis

520

1.28

1.12

1.1

3.02

3.94

u/ml

—

All dysplastic lesions of the vulva

450

1.30

1.12

1.1

31.59

4.67

u/ml

—

Acquired keratosis [keratoderma] palmaris et plantaris

2.32

1.12

1.0

—

3.27

—

Wet age-related macular degeneration

117

962

1.20

1.12

1.1

40.46

14.18

u/ml

—

Other sexually transmitted chlamydial diseases

116

973

1.20

1.11

1.0

1.1

2.15

3.34

u/ml

0.49

166

Motor neuron disease

1.68

1.11

1.0

1.1

—

14.27

—

Brain glioblastoma and astrocytoma

138

0.50

1.11

1.0

1.1

—

6.55

—

Psoriatic arthropathies, ICD10

117

983

1.20

1.10

1.1

1.32

5.45

u/ml

2.42

128

All pneumoniae

1553

10218

1.05

1.10

1.1

7.55

5.33

u/ml

0.72

151

1388

Disorders of magnesium metabolism

1.98

1.10

1.1

1.2

—

20.28

—

Myeloproliferative diseases

620

1.25

1.09

1.2

1.1

20.06

5.96

u/ml

—

Non-ischemic cardiomyopathy

252

1837

1.13

1.09

1.1

19.74

9.83

u/ml

0.48

147

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

157

1352

1.16

1.09

1.1

6.03

9.87

u/ml

0.49

105

Maternal care for cervical incompetence

408

1.31

1.09

1.1

0.72

4.93

u/ml

—

Injury of eye and orbit

173

1502

1.16

1.09

1.1

1.84

5.53

u/ml

2.39

237

Nontoxic single thyroid nodule

684

1.23

1.09

1.1

0.88

6.62

u/ml

—

Ulcerative rectosigmoiditis

100

829

1.21

1.09

1.0

1.1

0.88

4.33

u/ml

—

127

Injuries to the head

1731

10778

1.05

1.08

1.1

5.00

5.38

u/ml

0.16

187

1460

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

122

1032

1.19

1.08

1.1

8.55

5.30

u/ml

0.17

171

Mixed conductive and sensorineural hearing loss

111

930

1.20

1.07

1.1

19.19

5.68

u/ml

—

Severe visual impairment, monocular

1.95

1.07

1.0

1.1

—

17.62

—

Pure hyperglyceridaemia

153

1.52

1.07

1.2

1.1

—

7.70

—

Benign neoplasm: Spinal cord

113

1.62

1.07

1.3

1.1

4.78

13.61

u/ml

—

Delivery

655

3219

1.08

1.07

1.1

5.63

5.62

u/ml

0.00

416

Digestive system disorders of fetus and newborn

2.44

1.06

1.2

1.1

—

Other diseases of blood and blood-forming organs

543

1.26

1.05

1.2

1.1

36.16

6.22

u/ml

—

Discontinuity and dislocation of ear ossicles

2.00

1.05

1.2

1.1

—

3.64

—

Burns and corrosions confined to eye and internal organs

280

1.37

1.05

1.0

1.1

1.72

6.08

u/ml

—

Multiple gestation

154

1331

1.16

1.05

1.1

6.43

3.69

u/ml

0.45

252

Disorders of male genital organs in diseases classified elsewhere

2.00

1.05

1.1

1.0

—

7.18

—

Henoch-Schönlein purpura nephritis (HSPN)

2.12

1.04

1.1

—

17.62

—

Pneumonias (Asthma/COPD co-morbidities)

1537

10165

1.05

1.04

1.1

7.50

5.33

u/ml

0.69

150

1380

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1484

9948

1.05

1.04

1.1

7.15

5.44

u/ml

0.51

145

1340

Melanoma in situ

264

0.64

1.04

1.1

—

9.48

—

Tooth agenesis EXCLUDE clefts and syndromes

527

1.26

1.03

1.1

4.45

6.12

u/ml

—

Other disorders of cornea

100

834

1.20

1.03

1.1

6.15

5.97

u/ml

0.02

Mental and behavioural disorders due to cannabinoids

358

0.69

1.03

1.0

1.1

—

3.45

—

Foreign body entering into or through eye or natural orifice

743

1.22

1.03

1.1

8.58

5.40

u/ml

—

Lesion of ulnar nerve

142

1221

1.17

1.03

1.1

4.09

6.83

u/ml

0.41

170

Poisoning by drugs, medicaments and biological substances

358

3261

1.10

1.02

1.1

4.05

5.45

u/ml

0.40

502

Labour and delivery complicated by umbilical cord complications

620

0.77

1.02

1.1

0.63

4.82

u/ml

—

Other or ill-defined heart diseases

403

1.30

1.02

1.1

1.0

1.87

4.29

u/ml

—

Explicit fungal Sepsis

1.91

1.02

1.2

1.0

—

3.87

—

Early onset COPD

210

1858

1.13

1.01

1.1

16.99

6.75

u/ml

0.33

212

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

115

1.59

1.01

1.0

1.1

—

12.89

—

Foreign body in respiratory tract

484

1.27

1.01

1.0

1.1

1.11

5.90

u/ml

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

308

1.34

1.01

1.2

1.1

0.73

9.20

u/ml

—

Atopic conjunctivitis

458

1.28

1.00

1.1

1.04

5.73

u/ml

—

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

132

0.52

1.00

1.0

1.1

—

7.08

—

Other hereditary haemolytic anaemias

1.87

1.00

1.1

1.0

—

6.68

—

Specific developmental disorder of motor function

208

0.60

0.99

1.0

1.1

—

7.17

—

Benign neoplasm: Conjunctiva

257

1.37

0.99

1.1

0.64

8.47

u/ml

—

Family history of certain disabilities and chronic diseases leading to disablement

557

1.25

0.99

1.1

2.81

3.98

u/ml

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

161

1844

0.87

0.99

1.1

4.63

6.39

u/ml

0.26

233

Non-follicular lymphoma

656

1.22

0.99

1.1

4.54

7.21

u/ml

—

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

159

0.56

0.99

1.0

1.1

—

13.84

—

Foreign body on external eye

158

1375

1.15

0.99

1.1

10.10

4.83

u/ml

0.60

202

Adenocarcinoma of pancreas

161

0.55

0.98

1.0

1.1

—

12.61

—

Mental and behavioural disorders due to psychoactive substance use

693

6974

0.94

0.98

1.1

8.31

5.54

u/ml

0.31

992

Benign leiomyoma with endometriosis

190

1676

1.14

0.98

1.1

7.01

7.98

u/ml

0.08

179

Benign neoplasm: Spinal cord

116

1.57

0.98

1.3

1.1

4.78

12.87

u/ml

—

Other and unspecified erythematous conditions

258

1.37

0.98

1.1

2.82

7.27

u/ml

—

297

0.68

0.98

1.1

4.98

8.21

u/ml

—

Sequelae of cerebrovascular disease

288

2282

1.11

0.97

1.1

7.25

10.66

u/ml

0.55

188

Substance abuse

667

6804

0.94

0.97

1.1

8.76

5.61

u/ml

0.33

975

Other malignant neoplasms of skin (=non-melanoma skin cancer)

418

3587

0.92

0.97

1.1

9.42

9.86

u/ml

0.03

267

Parodontitis, under 40 years and operation codes

169

1482

1.15

0.96

1.1

3.88

4.46

u/ml

0.15

261

Bell's palsy

124

1062

1.17

0.96

1.1

3.42

6.17

u/ml

0.69

144

Non-follicular lymphoma, hilmo, excluding all cancers

659

1.22

0.95

1.1

4.54

8.38

u/ml

—

Other and unspecified spinal muscular atrophies

1.79

0.95

1.1

—

14.45

—

Parodontitis, operation under 40 years and operation codes

169

1484

1.14

0.95

1.1

3.88

4.45

u/ml

0.14

262

Other dermatomyositis

1.93

0.95

1.1

—

16.98

—

686

6547

0.94

0.95

1.1

3.86

6.02

u/ml

0.84

930

Pre-eclampsia superimposed on chronic hypertension

1.76

0.94

1.1

—

0.72

—

Contusion of toe(s) without damage to nail

260

1.36

0.94

1.1

6.75

5.50

u/ml

—

Benign neoplasm of mouth and pharynx

110

935

1.18

0.94

1.1

1.48

5.35

u/ml

2.08

103

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

312

1.32

0.94

1.2

1.1

0.73

7.62

u/ml

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

286

2591

1.11

0.93

1.1

4.15

8.65

u/ml

1.67

291

Complications of anaesthesia during pregnancy

2.23

0.93

1.0

—

0.92

—

637

6242

0.94

0.93

1.1

4.07

6.02

u/ml

0.67

879

L04AC Interleukin inhibitors

490

1.25

0.93

1.1

0.48

5.31

u/ml

—

Other diseases of pleura

382

3108

1.09

0.92

1.1

7.30

9.12

u/ml

0.29

281

Melanoma in situ

256

0.66

0.92

1.1

—

5.50

—

Motor disorders

206

0.62

0.91

1.0

1.1

—

8.52

—

Toxic effects of substances chiefly nonmedicinal as to source

137

1189

1.16

0.91

1.1

1.24

5.63

u/ml

3.15

170

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

860

0.82

0.90

1.0

1.1

1.16

6.38

u/ml

—

121

Streptococcal septicaemia

618

1.22

0.90

1.1

9.48

6.87

u/ml

—

Autonomic disorders

185

1.42

0.90

1.1

20.02

5.86

u/ml

—

Loose body in joint

185

1.42

0.90

1.1

5.24

8.05

u/ml

—

Sequelae of burns, corrosions and frostbite

1.95

0.90

1.0

1.1

—

5.20

—

Focal brain injury

438

1.26

0.90

1.1

2.85

7.48

u/ml

—

Chalazion

131

1135

1.16

0.89

1.1

4.97

5.55

u/ml

0.07

144

Maternal care for known or suspected fetal abnormality and damage

285

2303

1.10

0.89

1.1

3.43

3.76

u/ml

0.08

423

MS-disease / Multiple Sclerosis

102

867

1.18

0.89

1.2

1.1

1.18

3.57

u/ml

1.84

137

Early lumbar disc prolapse operation

152

1332

1.15

0.89

1.1

4.83

5.02

u/ml

0.03

228

Ischemic heart diseases

877

5194

1.06

0.89

1.1

10.21

6.98

u/ml

0.41

589

Sequelae of other and unspecified infectious and parasitic diseases

562

0.78

0.89

1.1

0.68

3.29

u/ml

—

Seropositive rheumatoid arthritis, wide

293

2668

1.10

0.88

1.1

3.99

8.50

u/ml

1.76

298

Motor neuron disease (with DMD)

103

1.57

0.88

1.0

1.1

—

12.33

—

340

0.72

0.87

1.1

4.98

13.88

u/ml

—

Coronary angioplasty

256

2172

0.90

0.87

1.1

16.53

10.77

u/ml

0.31

183

Other specific arthropathies, wide

195

1.40

0.87

1.1

3.06

8.18

u/ml

—

Cholinergic urticaria

1.85

0.87

1.0

1.1

—

1.20

—

Benign neoplasm: Conjunctiva

264

1.34

0.87

1.1

0.64

7.82

u/ml

—

Amiodarone users

638

0.80

0.86

1.2

1.1

14.18

9.57

u/ml

—

In situ neoplasms

356

3689

0.92

0.86

1.1

5.62

6.39

u/ml

0.14

405

Scleritis

120

1.52

0.86

1.2

1.1

—

5.66

—

Acanthosis nigricans

1.98

0.85

1.0

—

20.90

—

Nosocomial condition (hospital)

1.81

0.85

1.3

1.1

—

17.15

—

Increased muscle tone

1.79

0.85

1.1

1.0

—

12.54

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

129

1123

1.15

0.85

1.1

8.14

5.59

u/ml

0.14

174

Obstructive hydrocephalus

138

0.57

0.84

1.1

—

12.41

—

Anisometropia and aniseikonia

283

1.32

0.84

1.0

1.1

1.50

8.75

u/ml

—

Retinal breaks without detachment

151

1329

1.14

0.84

1.1

6.03

8.28

u/ml

0.24

140

Congenital malformations of uterus and cervix

275

1.32

0.83

1.1

2.78

5.37

u/ml

—

Demyelinating diseases of the central nervous system

118

1022

1.16

0.83

1.1

1.12

4.29

u/ml

2.57

153

Assault by hanging, strangulation and suffocation

1.93

0.83

1.0

1.1

—

21.00

—

Impetigo

507

1.23

0.83

1.1

10.49

5.09

u/ml

—

Other obstetric trauma

736

1.19

0.83

1.0

1.1

2.00

3.80

u/ml

0.84

124

Other and unspecified injuries of thorax

165

0.60

0.82

1.1

—

8.88

—

Other/unspecified seropositive rheumatoid arthritis

288

2632

1.10

0.82

1.1

4.15

8.54

u/ml

1.63

295

Tuberculosis of other organs

138

1.46

0.82

1.1

—

12.09

—

Benign neoplasm of mouth and pharynx

110

949

1.16

0.82

1.1

1.48

7.19

u/ml

2.84

102

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

215

1.36

0.81

1.1

14.68

6.95

u/ml

—

Tuberculosis of other organs, strict

155

1.43

0.81

1.1

—

11.10

—

Twin gestation

147

1296

1.14

0.81

1.1

6.43

3.78

u/ml

0.43

244

Contusion of ankle

401

1.26

0.80

1.1

6.38

5.75

u/ml

—

Severe combined immunodeficiency [SCID] with reticular dysgenesis

0.00

0.80

0.0

1.2

—

20.52

—

Traction detachment of retina

1.69

0.79

1.3

1.1

—

16.33

—

Suicide or other Intentional self-harm

346

3194

1.09

0.79

1.1

3.71

5.78

u/ml

0.44

482

Problems related to lifestyle

131

1148

1.15

0.79

1.1

1.04

5.43

u/ml

—

178

Unspecified human immunodeficiency virus [HIV] disease

0.51

0.79

1.0

1.1

—

3.37

—

Malignant neoplasm of rectosigmoid junction

1.57

0.79

1.0

1.1

—

13.00

—

Other and unspecified myopathies

620

1.20

0.78

1.1

4.51

6.47

u/ml

—

Alzheimer disease, including avohilmo

224

1461

1.11

0.78

1.1

10.12

15.58

u/ml

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

1.80

0.77

1.0

—

9.08

—

Maxillary prognathism

1.73

0.77

1.2

1.1

—

18.35

—

Gestational [pregnancy-induced] hypertension

448

4175

1.07

0.77

1.1

2.23

4.72

u/ml

2.61

670

Acute hepatitis B

1.79

0.77

1.0

1.1

—

4.42

—

Meningitis, viral

1.79

0.77

1.2

1.1

—

1.08

—

Foreign body granuloma of skin and subcutaneous tissue

2.22

0.77

1.0

1.1

—

1.10

—

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

421

3055

1.08

0.77

1.1

4.83

9.19

u/ml

1.47

285

Other disorders of electrolyte and fluid balance, not elsewhere classified

1.72

0.76

1.0

1.1

—

15.49

—

Motor disorders, excluding more controls

188

0.65

0.76

1.0

1.1

—

8.10

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

102

881

1.16

0.76

1.1

3.59

6.00

u/ml

0.51

137

Pigmented purpuric dermatosis

1.66

0.76

1.1

1.0

—

1.21

—

Sequelae of tuberculosis

1.53

0.76

1.1

—

28.15

—

Gonarthrosis, primary, with knee surgery

523

4008

1.07

0.76

1.1

7.28

9.09

u/ml

0.17

369

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

1.62

0.75

1.2

1.1

—

15.24

—

Traumatic amputation of wrist and hand

306

1.28

0.75

1.1

8.28

8.72

u/ml

—

Benign neoplasm: Skin of trunk

360

1.26

0.75

1.1

2.19

6.39

u/ml

—

Benign neoplasm of middle ear and respiratory system

596

1.20

0.75

1.2

1.1

1.73

6.86

u/ml

1.65

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

514

0.79

0.74

1.1

3.81

8.37

u/ml

—

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

602

0.81

0.74

1.1

2.48

8.16

u/ml

—

Single spontaneous delivery

637

3200

1.06

0.74

1.1

3.61

5.64

u/ml

0.79

414

Other obstructed labour

108

941

1.15

0.73

1.1

2.63

7.20

u/ml

1.50

152

Hyperfunction of pituitary gland

589

1.20

0.73

1.1

7.17

4.04

u/ml

—

Diabetes insipidus

1.57

0.73

1.0

1.1

—

15.79

—

Corneal scars and opacities

211

1.34

0.72

1.1

9.28

5.62

u/ml

—

Peripheral artery disease

349

2603

1.08

0.72

1.1

29.68

10.77

u/ml

0.70

195

Sequelae of injuries of head

452

1.22

0.72

1.1

2.77

5.05

u/ml

—

Benign neoplasm: Nasopharynx

1.64

0.72

1.1

—

13.63

—

Hyperaldosteronism

211

1.34

0.72

1.0

1.1

1.18

5.07

u/ml

—

Schizophrenia or delusion, excluding more controls

408

3779

1.07

0.72

1.1

15.51

5.92

u/ml

0.50

605

L01XX Other antineoplastic agents

362

1.25

0.72

1.2

1.1

0.78

8.23

u/ml

—

Eustachian salpingitis and obstruction

114

999

1.15

0.72

1.0

1.1

1.52

3.16

u/ml

1.50

154

Visual field defects

673

1.18

0.71

1.1

9.25

5.16

u/ml

—

Stroke, including SAH

543

4264

0.94

0.71

1.1

6.84

8.79

u/ml

0.40

404

Hypothyroidism, autoimmune, DX-based

1.74

0.71

1.4

1.1

—

12.34

—

Other and unspecified degenerative diseases of nervous system

126

1.44

0.70

1.1

—

9.61

—

Unspecified privation

115

1010

1.14

0.70

1.1

19.21

4.82

u/ml

0.78

122

Other drug-induced secondary parkinsonism

1.66

0.69

1.1

—

14.83

—

Sequelae of transport accidents

1.69

0.69

1.0

1.1

—

4.15

—

Hereditary motor and sensory neuropathy

1.62

0.69

1.0

1.1

—

0.95

—

Benign neoplasm: Nasopharynx

1.62

0.69

1.1

—

20.90

—

Effects of air pressure and water pressure

1.69

0.69

1.0

1.1

—

3.57

—

Occlusion and stenosis of arteries, not leading to stroke

1.57

0.69

1.1

1.0

—

8.45

—

Infections of breast associated with childbirth

483

1.21

0.69

1.0

1.1

1.96

3.71

u/ml

—

Background retinopathy and retinal vascular changes

161

1.38

0.69

1.0

1.1

—

7.50

—

LeFortI or BSSRO operation

483

1.21

0.68

1.1

4.34

3.93

u/ml

—

Pedestrian injured in collision with car, pick-up truck or van

222

1.32

0.68

1.1

1.0

14.90

8.00

u/ml

—

Caught, crushed, jammed or pinched in or between objects

483

1.21

0.68

1.1

5.02

4.83

u/ml

—

Other erythematous conditions

302

1.27

0.68

1.1

2.82

7.53

u/ml

—

Adjustment and management of implanted device

136

1210

1.13

0.68

1.1

7.92

7.51

u/ml

—

Other (not insulin) diabetes medications

1343

7800

1.04

0.68

1.1

3.82

5.58

u/ml

1.31

112

1056

Seminoma of testis

0.54

0.68

1.0

1.1

—

3.38

—

L02BA Anti-estrogens

158

1756

0.90

0.68

1.0

1.1

1.22

8.35

u/ml

3.75

218

Nezelof syndrome

1.66

0.68

1.1

—

14.90

—

Corneal ulcer

214

1953

1.10

0.67

1.1

2.06

7.59

u/ml

3.35

261

Acute alcohol intoxication

223

2437

0.91

0.67

1.1

2.06

6.53

u/ml

4.11

338

Renal tubulo-interstitial diseases

1191

8784

1.04

0.67

1.1

10.28

5.52

u/ml

1.05

103

1127

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

0.55

0.67

1.0

1.1

—

17.18

—

Melanocytic naevi of trunk

136

1212

1.13

0.67

1.1

2.23

4.63

u/ml

1.02

171

Benign neoplasm: Skin of trunk

366

1.24

0.67

1.1

2.19

6.09

u/ml

—

Varicella [chickenpox]

457

1.21

0.67

1.1

4.94

7.49

u/ml

0.33

Other congenital malformations of circulatory system

214

0.70

0.67

1.0

1.1

—

7.02

—

Other factor of the environment

111

1.46

0.67

1.1

—

8.89

—

Contracture of joint

111

1.46

0.66

1.1

—

1.53

—

Pleural effusion

982

0.86

0.66

1.1

9.78

8.78

u/ml

—

Unstable angina pectoris

305

2342

1.08

0.66

1.1

12.22

11.51

u/ml

0.03

177

Chronic iridocyclitis

476

1.20

0.66

1.0

1.1

2.33

4.96

u/ml

—

Melanocytic naevi of other and unspecified parts of face

587

1.18

0.65

1.1

3.25

4.25

u/ml

0.14

Schizophrenia

163

1804

0.90

0.65

1.1

9.48

5.20

u/ml

—

270

Dissocial personality disorder

154

0.64

0.65

1.0

1.1

—

2.31

—

Major coronary heart disease event

628

4412

0.95

0.64

1.1

13.83

8.40

u/ml

0.47

433

Benign neoplasm: Other/unspecified site

127

0.62

0.64

1.3

1.1

—

8.00

—

Specific development disorders of scholastic skills

600

1.18

0.64

1.1

5.37

6.10

u/ml

—

100

Antenatal screening

434

2294

1.07

0.64

1.1

3.76

4.76

u/ml

0.23

391

Collapsed vertebra, not elsewhere classified

1.65

0.62

1.1

—

16.96

—

Hyperosmolality and hypernatraemia

1.56

0.62

1.1

1.0

—

17.10

—

Malignant immunoproliferative diseases

1.65

0.62

1.0

1.2

—

20.70

—

Coronary atherosclerosis

678

4161

1.05

0.62

1.1

12.85

8.11

u/ml

0.43

438

Open wound of lower leg

154

1390

1.11

0.62

1.0

1.1

12.06

6.35

u/ml

0.25

168

Aortic aneurysm

151

1337

1.11

0.62

1.1

7.21

8.69

u/ml

0.12

105

Deaf mutism, not elsewhere classified

1.68

0.62

1.0

1.1

—

3.88

—

Complications of labour and delivery

1066

5716

1.04

0.61

1.1

5.87

5.02

u/ml

0.17

149

786

Suppurative otitis media, unspecified

253

1.27

0.61

1.1

28.90

5.94

u/ml

—

Peritonsillar abscess

278

2580

1.08

0.61

1.1

2.90

6.04

u/ml

1.79

411

Benign lipomatous neoplasm of of intra-abdominal organs

0.00

0.61

0.0

1.2

—

20.14

—

Benign neoplasm: Duodenum

165

1.34

0.61

1.0

1.1

—

7.99

—

Benign neoplasm: Skin of eyelid, including canthus

145

1307

1.11

0.60

1.0

1.1

7.58

6.83

u/ml

0.06

139

Benign neoplasm: Short bones of upper limb

148

1.36

0.60

1.2

1.1

—

8.24

—

Benign neoplasm: Short bones of upper limb

148

1.36

0.60

1.2

1.1

—

8.47

—

Immunodeficiency associated with other major defects

0.00

0.60

0.0

1.0

—

22.16

—

Abnormality of white blood cells, not elsewhere classified

1.55

0.60

1.0

1.1

—

2.98

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

232

2141

1.09

0.60

1.1

1.67

6.33

u/ml

—

340

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

105

1183

0.89

0.59

1.1

3.31

8.13

u/ml

1.24

118

Other congenital malformations of skin

418

1.20

0.59

1.1

5.86

5.65

u/ml

—

Fracture of skull and facial bones

242

2238

1.08

0.59

1.1

6.66

6.69

u/ml

0.00

333

Use of levodopa decarbox-comt-inhibitor

174

0.69

0.59

1.1

—

10.58

—

Post-traumatic hydrocephalus, unspecified

0.00

0.59

0.0

1.1

—

Benign neoplasm: Duodenum

166

1.33

0.59

1.0

1.1

—

8.41

—

Secondary parkinsonism

166

1.33

0.59

1.2

1.1

—

8.48

—

Distal bite

526

1.18

0.58

1.1

18.08

6.97

u/ml

0.29

Acute thyroiditis

1.74

0.58

1.2

1.1

—

4.23

—

Lifestyle-related condition

106

1.43

0.58

1.1

—

10.26

—

Diving or jumping into water causing injury other than drowning or submersion

1.50

0.58

1.0

1.1

—

5.67

—

Type 1 diabetes, wide definition, subgroup 2

115

0.60

0.58

1.0

1.1

—

9.17

—

Seropositive rheumatoid arthritis, strict definition

134

1486

0.90

0.58

1.0

1.1

3.21

6.50

u/ml

0.72

158

Long labour

382

3543

0.94

0.58

1.1

3.60

4.38

u/ml

0.24

584

Endometriosis of fallopian tube

1.50

0.58

1.0

—

1.03

—

Tubulo-interstitial nephritis, not specified as acute or chronic

604

1.16

0.58

1.1

5.04

7.33

u/ml

—

Acute appendicitis, with complications

208

1914

1.09

0.58

1.1

7.21

6.95

u/ml

0.03

259

Benign neoplasm: Other and unspecified parts of mouth

275

0.76

0.57

1.1

—

9.05

—

Complications of other internal prosthetic devices, implants and grafts

283

1.24

0.57

1.1

0.96

8.05

u/ml

—

Kela-code for behavioural disturbances in mental retardation

1.53

0.57

1.0

1.1

—

3.31

—

Lagophthalmos

0.58

0.57

1.0

1.1

—

18.38

—

malignant neoplasm of female genital organs

119

1325

0.90

0.56

1.1

4.01

10.33

u/ml

1.44

122

Puerperal sepsis

136

1503

0.90

0.56

1.1

6.31

6.89

u/ml

0.05

200

Benign neoplasm: Other and unspecified parts of mouth

274

0.76

0.56

1.1

—

7.64

—

Contusion of other and unspecified parts of foot

569

1.17

0.56

1.1

3.74

6.43

u/ml

0.44

Melanocytic naevi of trunk

136

1229

1.11

0.56

1.1

2.23

5.18

u/ml

1.34

173

Benign neoplasm: Spinal meninges

1.55

0.56

1.0

1.1

—

13.11

—

Benign neoplasm: Spinal meninges

1.55

0.56

1.0

1.1

—

17.32

—

Peptic ulcer

1.55

0.56

1.2

1.1

—

13.10

—

Scar conditions and fibrosis of skin

403

1.20

0.55

1.1

3.76

3.62

u/ml

—

Cleft hard palate NOS

1.53

0.55

1.1

—

11.79

—

Benign neoplasm of male genital organs

123

0.65

0.55

1.0

1.1

—

4.09

—

Benign neoplasm: Other/unspecified site

126

0.63

0.55

1.3

1.1

—

11.56

—

Otorrhagia

1.59

0.54

1.0

1.2

—

14.87

—

Benign neoplasm: Skin of eyelid, including canthus

145

1317

1.10

0.54

1.0

1.1

7.58

8.14

u/ml

0.04

132

Drug-induced systemic lupus erythematosus

1.49

0.54

1.1

—

8.28

—

Abnormalities of forces of labour

159

1452

1.10

0.54

1.1

4.14

6.25

u/ml

0.31

260

All dysplastic lesions of the cervix uteri

397

4190

0.94

0.54

1.1

3.39

4.88

u/ml

0.81

671

Melanoma in situ of other and unspecified parts of face

1.49

0.54

1.1

—

26.94

—

Sequelae of intentional self-harm, assault and events of undetermined intent

1.47

0.53

1.0

—

11.96

—

Malignant neoplasm of other and unspecified parts of tongue

0.61

0.52

1.0

1.1

—

11.81

—

Other disorders of amniotic fluid and membranes

232

2137

1.08

0.52

1.1

2.01

3.42

u/ml

1.20

398

Use of rasagiline

152

1.32

0.52

1.3

1.1

—

8.25

—

Symptoms and signs involving emotional state

296

1.22

0.52

1.0

1.1

0.86

6.15

u/ml

—

Benign neoplasm of middle ear and respiratory system

620

1.15

0.52

1.2

1.1

1.73

7.54

u/ml

1.95

Alcohol use disorder, Swedish definition

597

5793

0.96

0.52

1.1

4.20

5.80

u/ml

0.43

822

Benign neoplasm of other and unspecified female genital organs

388

1.19

0.51

1.0

1.1

1.38

6.09

u/ml

—

Guttate psoriasis

145

0.68

0.51

1.0

1.1

—

6.29

—

Aneurysms, operations, SAH

126

1389

0.91

0.51

1.0

1.1

4.60

8.90

u/ml

—

139

Tic and related disorders

153

1.32

0.51

1.1

—

8.16

—

Other disorders starting during childhood or adolescence

759

0.87

0.50

1.0

1.1

1.13

7.76

u/ml

—

104

Myotonic disorders

1.45

0.50

1.0

—

3.68

—

Social disorders starting during childhood or adolecense, excluding more controls

106

0.65

0.49

1.0

1.1

—

5.79

—

Focal epilepsy

198

2134

0.93

0.49

1.1

5.36

7.36

u/ml

0.35

272

Drug-induced tremor

1.57

0.49

1.0

1.1

—

4.80

—

Congenital malformations of anterior segment of eye

1.46

0.48

1.2

1.1

—

1.81

—

Multiple delivery

1080

0.90

0.48

1.2

1.1

14.23

6.07

u/ml

0.67

175

Hypermobility syndrome

681

1.14

0.48

1.1

0.83

3.82

u/ml

—

119

Secondary parkinsonism+Parkinsonism in other disease

172

1.29

0.48

1.2

1.1

—

10.24

—

Overjet

325

1.20

0.48

1.1

4.26

7.29

u/ml

—

Impacted teeth

332

2918

1.06

0.48

1.1

2.64

4.03

u/ml

1.30

438

Hyperprolactinaemia, drug-induced

1.51

0.48

1.0

—

3.20

—

Biological medicines for asthma

137

1.33

0.48

1.2

1.1

—

10.48

—

Tic and related disorders

155

1.30

0.47

1.1

—

9.17

—

Accidental poisoning by and exposure to other gases and vapours

1.48

0.47

1.4

1.1

—

4.07

—

Kidney transplant status

457

1.16

0.47

1.2

1.1

46.72

5.81

u/ml

—

Atlantoaxial subluxation

1.47

0.47

1.0

1.1

—

11.78

—

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

288

0.79

0.47

1.1

3.37

8.54

u/ml

—

Alcohol abuse counselling and surveillance

165

0.72

0.47

1.2

1.1

—

5.95

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

129

1178

1.10

0.46

1.1

8.14

6.18

u/ml

0.10

179

Histrionic personality disorder

1.45

0.46

1.0

1.1

—

10.80

—

Other disorders of breast and lactation associated with childbirth

243

0.78

0.46

1.1

2.00

4.22

u/ml

—

Melanocytic naevi of other and unspecified parts of face

608

1.14

0.46

1.1

3.25

5.87

u/ml

0.42

Burns and corrosions of multiple body regions

0.60

0.46

1.0

1.1

—

3.83

—

Evidence of alcohol involvement determined by level of intoxication

119

0.67

0.46

1.0

1.1

—

7.89

—

Open wound of head

596

5633

1.04

0.46

1.1

4.47

7.01

u/ml

0.84

735

Seminoma of testis, excluding all cancers (controls excluding all cancers)

0.61

0.46

1.0

—

3.42

—

Retained placenta and membranes, without haemorrhage

168

1553

1.08

0.46

1.1

7.08

5.89

u/ml

0.08

219

Ptosis of eyelid

816

1.12

0.46

1.1

0.70

8.96

u/ml

—

Cushing syndrome

103

1.37

0.46

1.1

—

6.11

—

Lumbosacral root disorders, not elsewhere classified

0.58

0.45

1.2

1.1

—

9.82

—

Superficial injury of ankle and foot, unspecified

1.42

0.45

1.1

1.0

—

12.80

—

Foreign body in ear

192

1.26

0.45

1.0

1.1

—

8.40

—

Convergent concomitant strabismus

705

1.12

0.44

1.2

1.1

6.97

4.50

u/ml

—

112

Other pleural conditions

629

1.13

0.44

1.1

9.54

9.59

u/ml

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

686

1.13

0.44

1.1

3.12

5.86

u/ml

0.74

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

237

2425

0.94

0.44

1.1

6.77

8.28

u/ml

0.24

239

Mixed hyperlipidaemia

266

1.21

0.43

1.1

—

7.41

—

Viral pneumonia (unknown virus, not influenza)

602

1.13

0.43

1.1

6.80

4.08

u/ml

—

Contact with hot air and gases

1.44

0.43

1.0

1.1

—

5.01

—

Isolated patent ductus arteriosus

1.59

0.43

1.2

1.1

—

19.66

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS